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General introduction
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Cardiometabolic disease is one of the leading causes of death in high-income countries (1). 
Cardiometabolic disease comprises cardiovascular disease, diabetes, and chronic kidney 
damage. These conditions often coexist, and the prevalence of one condition increases the risk 
of the other conditions. One of the strategies to tackle cardiometabolic disease is early 
detection by means of screening. Unfortunately, not all groups in a society participate equally 
well in screening initiatives, widening already existing health inequalities. These populations 
are, therefore, referred to as ‘underserved’. What do we know about these underserved 
groups; what are their reasons for not participating in cardiometabolic screening?  
 
 
BACKGROUND: CARDIOMETABOLIC SCREENING  
 
Prevalence of cardiometabolic diseases: cardiovascular disease, diabetes, 
and chronic kidney damage 
In the Netherlands, over 1 million individuals have cardiovascular disease, representing 
almost 6% of the population (2). Another million persons have diabetes, and approximately 
1.7 million individuals have chronic kidney damage, representing 10% of the population (3, 
4). Of the individuals with diabetes, approximately 1 out of 5 is not aware of this (3); of the 
individuals with chronic kidney damage, this number is 2 out of 5 (4). Worldwide, 
cardiometabolic diseases yearly cause approximately 17.5 million deaths due to 
cardiovascular disease and 1.5 million deaths due to diabetes (5). Chronic kidney damage acts 
mostly as a risk factor for cardiovascular disease and diabetes, and is less often the actual 
direct cause of death. Approximately three quarters of these diseases can be prevented by 
tackling major overarching risk factors such as smoking, poor diet, and inadequate physical 
activity (6). For this, an early identification of individuals who will benefit most from 
preventive interventions is essential. One way of doing this is by means of cardiometabolic 
screening.  
 




History of cardiometabolic screening in the Netherlands 
Early detection of individuals at risk enables prevention of these chronic conditions, for 
example by stimulating individuals to take actions regarding their lifestyle. This will lead to 
health gains, but also to social gains due to reductions in sick leave and prolonged social 
participation (7). In the early 2000’s, a fast rise occurred in initiatives in the Netherlands 
concerning early detection of cardiometabolic disease and other lifestyle-related diseases. An 
explorative investigation in 2007 of cardiovascular health checks in primary care revealed 15 
promising initiatives (7). The number of initiatives was even larger when taking the full range 
of cardiometabolic disease and healthcare settings into account. The primary care initiatives 
varied in their recruitment method, follow-up, and setting, but all seemed promising in 
systematically identifying individuals at high risk of cardiovascular disease. Despite this 
variation, and the dominant curative orientation of the healthcare system at the time, various 
important stakeholders in the field (such as municipal health services, health funds, and 
primary care professionals) were willing to create public support and to influence the political 
agenda regarding this preventive activity. The time was right to strive for a national structure 
for early detection, with a crucial role for the connection between preventive and curative 
healthcare. This was also stressed by the Ministry of Health, Wellbeing, and Sports in 2007, 
giving priority to preventing and postponing disease by lifestyle measures and paying 
attention to early detection of high-risk groups (8). The increasing interest from the various 
stakeholders resulted in a gradual paradigm shift in healthcare from purely curative and 
demand-driven care, towards care including various types of prevention (9). The development 
and refinement of risk prediction models, such as the SCORE and FINDRISK, contributed 
positively to these changes (10, 11).  
This paradigm shift resulted in various initiatives from the Dutch government, non-profit 
organizations, and commercial companies to raise awareness among the public of the 
importance of assessing risk profiles and to encourage individuals at risk to take action to 
prevent these diseases (12). However, several threats regarding the proliferation of these 
initiatives were identified. First, the diversity in health checks and screening tools was 
confusing to the general public as well as healthcare providers. Secondly, the quality of some 
health checks was questionable, and for lay persons it was expected to be difficult to 
distinguish the higher from the lower quality checks. Thirdly, health professionals lacked 
sufficient skills and knowledge for coaching high-risk individuals, resulting in individuals at 
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high-risk who did not know what to do to reduce their risk or where to go for follow-up, as 
this was not arranged in regular health care (12). 
One of the health professionals who was perceived to have a central role in the identification 
of cardiometabolic disease was the general practitioner (GP) (9). GPs play a central and 
coordinating role in the Dutch healthcare system, and every individual is registered at a GP’s 
office. The threshold to visit the GP is very low, with 75% of individuals visiting their GP 
annually and basic healthcare insurance covering the costs of the consultations. The 
relationship of trust between GP and patient made the GP practice the most appropriate 
setting for programmatic approaches to prevention (with the annual flu vaccination program 
and screening for cervical cancer as successful examples). In addition, it was known that a 
large proportion of the Dutch GPs had a positive attitude towards primary prevention of 
cardiometabolic disease (13).  
These advantages of the primary care system, as well as the threats regarding the various 
health check initiatives, fuelled the need for an evidence-based integrated approach to 
prevention, well embedded in regular primary health care (12). In 2011, the Dutch college of 
General Practitioners (NHG), the Dutch National Association of General Practitioners (LHV), 
and the Netherlands Society of Occupational Medicine (NVAB) worked together with three 
health foundations (the Netherlands Heart Foundation, the Dutch Diabetes Research 
Foundation, and the Dutch Kidney Foundation) to develop an evidence-based guideline to 
improve the early detection and follow-up of individuals at increased risk of cardiometabolic 
disease. This guideline was called “Preventieconsult, module Cardiometabool risico” 
(Prevention consultation, module cardiometabolic risk). 
 
Prevention consultation, module Cardiometabolic risk  
Individuals aged 45 to 70 years, without known cardiometabolic disease and not using anti-
hypertensive or lipid lowering drugs, were the target group for the Prevention consultation. 
For Hindustani Surinamese individuals the lower age limit was set at 35 years because of their 
genetically increased risk of diabetes, as will be explained below. The Prevention consultation 
followed a two-stage approach, see figure 1. 
The Prevention consultation was embedded in primary care, although GPs did not receive 
additional reimbursement for actively approaching their patients, as this was considered 
selective prevention. In the Netherlands, selective prevention is not covered by the health care 
insurance companies. Health insurance companies only reimbursed so-called indicated 




prevention, targeted at persons with an already known increased risk. Thus, when a patient 
had a risk score above the threshold, follow-up actions were considered indicated prevention 
and could be reimbursed by the usual tariffs for a consultation.  
 
 
Figure 1. Two-stage approach Prevention consultation 
 
Before the guideline was published in its definite form in 2011, three pilots had been 
conducted to test the feasibility in a general practice setting (9, 12, 14, 15). The researchers 
concluded that it was indeed feasible to implement the guideline in general practice. However, 
based on these experiences some adjustments were made: 
• An active invitation by means of a personal letter was chosen, because it was much 
more effective than simply putting up a poster and having leaflets available at the 
practice. 
• Because age turned out to be a major determinant of risk, all men over the age of 60 
years and women over the age of 65 years automatically received a high-risk score. It 
was deemed justifiable for those groups to be invited to consult the GP immediately. 
• A written HRA (in addition to the online version) was also made available, to increase 
response. 
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In the Prevention consultation the screening process is divided into two distinct stages. The 
first stage is an (online) Health Risk Assessment (HRA): by means of a quick and low-
threshold questionnaire the entire eligible population is narrowed down to a population 
estimated to be at high-risk of cardiometabolic disease. Only this high-risk population is then 
invited for the second stage, comprising two practice consultation at the GP’s office to further 
establish an individual’s 10-year risk of cardiometabolic disease and discuss options. Below, 
we describe the two stages in more detail.  
 
Stage one: Online Health Risk Assessment 
The Health Risk Assessment (HRA) is an integrated risk estimation for the three above 
mentioned cardiometabolic diseases and the outcome is a prediction of the incidence of any of 
these three diseases (12). The HRA was specifically developed for individuals without already 
diagnosed cardiometabolic disease, hypertension, or hypercholesterolemia, and is, therefore, 
suitable for the general public or high-risk groups. The HRA incorporates components from 
the SCORE risk function and the FINDRISK questionnaire (10, 11). Scores for each item are 
gender-specific and the sum score indicates the total risk estimation. For the questions and 
scores for each item see figure 2. The HRA is available online at www.testuwrisico.nl 
[www.testyourrisk.nl].  
As can be seen in figure 1, HRA completers can be categorized in having a risk below or 
above the threshold. Individuals with a risk below threshold can be further classified in having 
risk factors or not. Individuals without risk factors only receive general lifestyle advice, to 
stimulate them to remain in the ‘green’ domain. Those with one or more cardiometabolic risk 
factors receive lifestyle advice tailored to the individual’s risk profile. Individuals with a risk 
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Stage two: Practice Consultations 
High-risk individuals according to the HRA are advised to visit the GP (or practice nurse) for 
two so-called Practice Consultations (PC), see again figure 1. During the first consultation the 
anamnesis of the 10-year risk of cardiovascular mortality and/or a diagnosis of diabetes is 
assessed. This risk profile includes lab work (serum cholesterol ratio and glucose level), blood 
pressure measurements, and a verification of the HRA items (figure 2). The second 
consultation consists of composing and communicating the risk profile, providing tailored 
lifestyle advice, and/or starting with (preventive) drug treatment (e.g. lipid lowering drugs). 
The tailored lifestyle advice can consist of an evidence-based lifestyle program in the local 
community, or a referral to a dietician for dietary advice or a physiotherapist for exercise 
programs. 
Studies indicate that two-stage screening could be a cost-effective strategy (16, 17). The cost-
effectiveness of the Prevention consultation specifically is currently investigated (18). A pre-
requisite for cost-effectiveness is reaching those who benefit most, in other words: those who 
are at highest risk. Unfortunately, individuals participating in health checks are more often the 
health-conscious, higher-educated, affluent people (9, 19). Participation is lower among 




CARDIOMETABOLIC SCREENING AMONG UNDERSERVED 
GROUPS 
 
Underserved groups  
Some groups in a society are underserved regarding health profits to be gained from 
cardiometabolic screening. 
In the Netherlands, these groups are those of native Dutch origin with a low SES and certain 
non-Western immigrant groups. On the one hand this is due to an increased susceptibility to 
cardiometabolic disease, generally because of an unfavourable genetic makeup and/or 
unhealthier lifestyle habits (21, 22). On the other hand these groups are more vulnerable to be 
(unintentionally) excluded from screening initiatives because the one-size-fits-all approach 
does not reach them or does not appeal to them (20). This increased susceptibility and 
vulnerability are described in the next paragraphs. 




Susceptibility to cardiometabolic disease  
Mortality from cardiovascular disease is higher among those with a low socioeconomic status 
(23). Additionally, individuals with a low SES have an increased risk of type 2 diabetes, 
particularly in high-income countries like the Netherlands (24). A low SES is also associated 
with measures of chronic kidney damage: lower estimated glomerular filtration rate (eGFR), 
higher albuminuria, and unfavourable eGFR/ albuminuria ratios, and with renal failure (25).  
The prevalence of cardiovascular disease is more than two times higher (10.6%) among 
Turkish than among native Dutch (5.0%), even when adjusting for lifestyle factors, 
educational level, and other health-related factors (figure 3) (26). The prevalence of diabetes 
is almost two times higher (5.6%) among Turkish than among native Dutch (3.1%) (27). 
Additionally, the age of onset is typically a decade lower for Turkish than for native Dutch. 
The age-standardized prevalence of chronic kidney disease is more than two and a half times 
higher (8.0%) among Turkish than among native Dutch (3.0%) (28).  
 
 
Figure 3. Prevalence of cardiometabolic disease among non-Western groups when compared to native Dutch 
(26-29) 
 
As can be seen in figure 3 the prevalence of cardiovascular disease does not differ 
substantially between Moroccans (5.4%) and native Dutch (5.0%) (26). The mortality due to 
cardiovascular disease is even lower among Moroccan males than among native Dutch males, 
with a relative risk of 0.51 (21). However, the prevalence of diabetes is more than two and a 
half times higher (8.0%) among Moroccans than among native Dutch (3.1%) (27). When 
adjusting for sociodemographic factors and physical activity, the prevalence of diabetes is 
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even three and a half times higher among Moroccans than among native Dutch (27). 
Additionally, the age of onset is typically two decades younger for Moroccans than for native 
Dutch. The age-standardized prevalence of chronic kidney disease is more than two times 
higher (6.0%) among Moroccans than among native Dutch (3.0%) (28). 
Mortality due to cardiovascular disease is higher among Surinamese than among native 
Dutch, both for males and females (21). Surinamese individuals have a higher risk of diabetes, 
and at a younger age. This is especially so for the Hindustani Surinamese. The prevalence of 
diabetes is four times higher among Hindustani Surinamese than among native Dutch, and 
two times higher among Creole Surinamese than among native Dutch (figure 3) (29). For the 
age group of 35-44 years, this comes down to 16.7% of Hindustani Surinamese having 
diabetes, 8.1% of Creole Surinamese, and 4.2% of native Dutch. For the age group of 45-60 
years, prevalences are 35.0%, 19.0%, and 8.2%, respectively. Hindustani Surinamese have a 
two and a half time higher (7.6%) prevalence of chronic kidney disease than native Dutch, 
and Creole Surinamese a one and half time higher prevalence (4.6%) (28).   
 
Vulnerability due to limited access to screening 
In recent years, in the Netherlands as well as in other European countries, (quality-adjusted) 
life expectancy has increased. However, this increase has not been equal for all groups within 
society. The largest increases have been seen among the highest educated, resulting in a 
health gap (30). This gap has been widening in the period from 2001 to 2011: inequalities in 
mortality as well as in health-related quality of life increased between the highest and lowest 
educated. In 2001, the difference in quality-adjusted life expectancy between the low and the 
highly educated was 7.4 healthy years for men and 6.3 for women. By 2011 this difference 
had increased to 8.1 health years for men and to 7.1 healthy years for women (30). 
Next to the fact that those with a low socio-economic status and certain non-Western 
immigrant groups have an increased risk of cardiometabolic disease, it has been shown that 
these groups are more vulnerable to be (unintendedly) excluded from health checks (20). 
Those with greater clinical need or risk factors, thus, take up health checks unequally. This 
differential uptake may lead to suboptimal health gains from cardiometabolic screening and, 
thus, contributes to the widening of health inequalities in society. This may be even more so 
for a cardiometabolic health check with a two-stage screening approach, as individuals may 
drop out on two separate occasions. Therefore, it is important to investigate why underserved 
groups do or do not participate in two-stage cardiometabolic screening.  




Determinants of participation  
Most of the literature regarding determinants of cardiometabolic screening concerns (non-
)attendance among the general population. From this literature we can conclude that health-
conscious patients more frequently follow up an invitation for a health check as they see the 
importance and advantages of doing so. Individuals without health problems have a more 
negative attitude and do not recognize the necessity of screening because they consider 
themselves to be in good health (20, 31, 32). Contrastingly, it has also been found that 
individuals with already existing health problems less often attend health checks. Perhaps 
these individuals lack personal relevance as they already have regular contact with primary 
care for their health complaints (32). Next, not wanting to know one’s risk and fear (for the 
outcome and the consequences of that outcome) seem to play a distinct role in non-attendance 
among the general population (20, 31, 33, 34). Finally, individuals with unhealthy lifestyle 
habits (such as smoking) seem to be more reluctant to visit a GP for lifestyle advice wanting 
to avoid comments on their unhealthy behaviour (35). 
Few studies specifically investigated (non-)participation in cardiometabolic screening among 
non-Western immigrants or individuals with a lower SES. Moreover, those studies that do 
report determinants among underserved populations exclusively focus on physical 
assessments at a doctor's office (one-stage screening), not two-stage screening with risk 
stratification as a first step. Some of the determinants that we find in the literature regarding 
one-stage cardiometabolic screening have to do with the invitation method. A multi-strategy 
approach combining mailed letters, telephone calls, and/or especially face-to-face strategies 
seems useful for increasing uptake in underserved groups (36). Determinants from these 
studies may also provide insight into determinants of participation in two-stage screening, 
although decision making can be expected to differ when potential participants have to weigh 
pros and cons twice. 
Underserved groups have been studied in the context of participation in another form of 
screening, namely cancer screening. Results from these studies theoretically also provide 
insight into reasons for (non-)participation in cardiometabolic screening. However, the risk 
perceptions and beliefs regarding cancer differ substantially from those regarding 
cardiometabolic diseases: perceived risk and worries are much higher for cancer than for 
CMD (37).  
Clearly, the reasons of members of underserved groups to participate in two-stage 
cardiometabolic screening or not need to be investigated further.   
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AIM OF THIS THESIS 
 
With the high burden of cardiometabolic disease among non-Western immigrants in the 
Netherlands and native Dutch with a low SES, their participation in preventive screening is 
eminent. It is, therefore, worrisome that these groups are particularly underrepresented in 
screening initiatives, as this may widen health inequalities in a society. To increase 
participation of these underserved groups in two-stage cardiometabolic screening, insight into 
the motivation and determinants of participation of these groups is essential. This dissertation 
describes the CHECK’D (Cardiometabolic Health check Evaluating Cardiometabolic and 
Kidney Disease) study. The aim of the CHECK’D study was to get insight into the 
(psychosocial) determinants of participation of underserved groups in both stages of the 
Dutch cardiometabolic health check (Prevention consultation, module cardiometabolic risk) 
as well as the actual response and participation rates in the two stages. 
We pursued a systematic inventory of these determinants of participation and used a 
comprehensive theoretical framework for this purpose: the I-change model (figure 4). The I-
change model explains health behaviours and has been applied in studies among native and 
immigrant populations (38-41). Health check attendance can be seen as a health behaviour 
and in that sense can be studied using this model. Another reason that we selected this model 
is that it provides the opportunity to get a comprehensive insight into the factors influencing 
participation as it integrates ideas from several theories: the transtheoretical model 
(motivational stages of change), theory of planned behaviour, social cognitive theory, the 
health belief model, and goal setting theories. The model states that behaviours are 
determined by a person’s motivation or intention, as well as his or her abilities to carry out the 
behaviour. Attitudes, social influences, and self-efficacy expectations influence a person’s 
motivation and are determined by predisposing (e.g. current lifestyle), information (e.g. 
source of delivery), and awareness (e.g. knowledge and risk perception) factors.  
 





Figure 4. The I-change model, from http://www.maastricht-university.eu/hein.devries/interests/change 
 
 
OUTLINE OF THIS THESIS 
 
Chapter 2 describes a qualitative study among underserved groups on their determinants of 
(hypothetical) participation in the first stage (the HRA) and in the second stage (the PC). In 
Chapter 3, the response and participation rates of underserved groups in both the HRA and the 
PC are described. Chapter 4 and 5 cover the determinants among underserved groups of 
(actual) participation in the HRA and the PC, respectively. Chapter 6 describes the yield of 
the PC among underserved groups. The thesis ends with a summary and discussion. 
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Exploring determinants influencing vulnerable groups regarding (non-)participation in the 
Dutch two-stage cardiometabolic health check, comprising a health risk assessment (HRA) 
and prevention consultations (PCs) for high-risk individuals.  
 
Methods 
Qualitative study comprising 21 focus groups with non-Western (Surinamese, Turkish, 
Moroccan) immigrants aged 45–70, adult children from one of these descents, native Dutch 
with a lower socioeconomic status, and healthcare professionals working with these groups.  
 
Results 
Reasons for not completing the HRA included (flawed) risk perceptions, health negligence, 
(health) illiteracy, and language barriers. A face-to-face invitation from a reliable source and 
community outreach to raise awareness were perceived as facilitating participation. Reasons 
for not attending the PCs overlapped with completing the HRA but additionally included risk 
denial, fear about the outcome, its potential consequences (lifestyle changes and medication 
prescription), and disease-related stigma.  
 
Conclusion 
Reasons for not completing the HRA were mainly cognitive, whereas reasons for not 
attending the PCs were also affective. Practice implications: when designing a two-stage 
health check, choice of invitation method seems important, as does training healthcare 
professionals in techniques to effectively handle patients’ (flawed) risk perceptions and 
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In most Western countries (including The Netherlands) mortality and morbidity of 
cardiovascular disease, diabetes, and kidney failure are higher for people with a lower 
socioeconomic status (SES) and for non-Western immigrants (1, 2). Moroccan, Turkish, and 
especially Hindustani Surinamese immigrants are at higher risk of developing diabetes (3). 
Prevalence of cardiovascular disease is particularly high in the latter two groups (4–6). Health 
checks are currently implemented to identify those at increased risk of cardiometabolic 
disease (CMD) (7–9). However, individuals participating in health checks are more often 
health-conscious, higher-educated, affluent people (10, 11). Participation is lower among 
people with a heightened risk, e.g. individuals of non-Western descent or with a lower SES 
(12). Few studies specifically investigated (non-)participation in cardiometabolic health 
checks of non-Western immigrants or lower SES groups. The literature mostly concerns 
(non-)attendance in cancer screening or cardiometabolic screening in the general population 
(13–16). Results from studies on cancer screening might provide reasons for (non-
)participation generalizable to cardiometabolic screening. However, risk perceptions and 
beliefs regarding cancer differ from those regarding CMD: perceived risk and worries are 
higher for cancer than for CMD (17). Thus, more insight into determinants of (non-
)participation in a cardiometabolic health check is needed, specifically among vulnerable 
groups to enable them to make an informed decision about participation. Several studies 
concluded that a two-stage approach could be a cost-effective screening strategy for 
cardiometabolic risk (18, 19). The Dutch cardiometabolic health check follows a two-stage 
approach and comprises a short risk stratification tool (health risk assessment: HRA) for 
people aged 45–70 years, and two prevention consultations (PCs) including a blood test with 
the GP for those at increased risk according to the HRA. During the PCs patients receive 
information about their risk profile, followed by lifestyle advice and, if necessary, medication 
prescription. However, this approach implies that patients can refrain from participation on 
two separate occasions, which may represent an even greater problem among difficult-to-
reach groups. Indeed, pilot studies showed substantial dropout rates in both stages (20). In-
depth research focusing on determinants related to (not) completing a HRA and (non-
)participation in subsequent PCs separately is scarce. Moreover, vulnerable groups require 
special attention. Therefore, this study investigates which informational, practical, and 
1
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psychosocial determinants influence the decision of different vulnerable groups to (not) 





Sample and recruitment  
This study was approved by the Medical Ethical Committee of the Leiden University Medical 
Center (CME-09-126). Participants’ verbal informed consent was audio-taped. Purposive 
sampling by key persons was used to conduct focus groups with non-Western immigrants 
(45–70 years, except Surinamese: 35–70 years because of their higher diabetes risk); adult 
children of non-Western immigrants (18–45 years); lower SES native Dutch (45–70 years); 
and health professionals working with the target population. Key persons (educational 
coordinators and managers or employees of community/cultural organizations or local 
community health services) were well-known persons within a community who used their 
status and contacts to recruit people willing to participate. Potential participants were 
approached by e-mail, telephone, or face-to-face, and we also made use of flyers and posters, 
distributed mainly in colleges and secondary vocational education institutes. The rationale for 
also conducting focus groups with health professionals was their ample experience with the 
target population in relation to health (screening) initiatives and their ability to reflect on 
what would (not) work, and why. Health professionals were recruited through our network 
for primary care research in which 90 regional general practices work together in scientific 
research. Focus groups were held separately for each ethnic group. For immigrants, focus 
groups were purposively held separately for males and females. The rationale for also 
conducting focus groups among adult children of immigrants was that they usually have a 
better command of the Dutch language and frequently act as brokers for their parents in the 
Dutch healthcare system. Two focus groups were held in each subgroup. Due to the large 
number of subgroups, it was not possible to use data saturation as a criterion for individual 
subgroups. However, by combining results from the adult children, immigrants, native Dutch, 
and health professionals, we reached saturation on group level. Focus group characteristics 
are presented in Table 1.  
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Data collection  
Focus groups were held between February and July 2010 at locations familiar to participants, 
where they felt safe and at-ease. All focus groups with immigrants and one with adult 
children were performed at their own community/cultural organizations, during the evening. 
The other focus groups with adult children were held at their educational institution during 
free hours between classes. One focus group with native Dutch was held at a community 
health service where the participants regularly attended recreational activities or health 
classes, the other was held at the participants’ own general practice, both around lunch time. 
The focus groups with health professionals were held at the research center. One female 
researcher (IG) was trained to be facilitator and another female researcher (MC) was 
observer/notetaker. During focus groups at community/cultural organizations a female staff 
member of the same ethnic background was observer/notetaker. Focus groups were held 
primarily in Dutch, were audio-taped, and lasted 1–2 h. The observer/notetaker translated 
when participants did not speak Dutch or preferred to speak in their native language. The 
interview protocol was pilot tested with members of our target population and consisted of 
two parts (see Appendix for an example protocol). First, HRA invitation strategies and 
Table 1. Characteristics of the focus groups




  Turkish 1  ; 1 5 ; 10 Turkish associations
  Moroccan 1  ; 1 10 ; 8 Community organisation
  Hindustani 1  ; 1 7 ; 8 Community organisation
  Creole 1  ; 1 5 ; 7 Community organisation
Adult children
  Turkish 1  ; 2 7 ; 7 ; 8 Senior secondary vocational education and Turkish 
activity centre
  Moroccan 2 2 ; 8 Senior secondary vocational education and higher 
professional education
  Hindustani 1 4 Higher professional education
  Creole 1 2 Higher professional education
  Mixa 1 4 Senior secondary vocational education
Dutch lower socio-
economic status 
1  ; 1  ; 
1
4 ; 5 ; 8 Community health service and general practice
Health professionals 2 3 ; 3 General practices
 Focus group held with males.  Focus group held with females.  Focus group held with both males and females.
a Hindustani and Creole.
1
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determinants influencing HRA participation were discussed. Second, risk communication and 
determinants influencing PCs participation were discussed. The interview protocol was based 
on the constructs from the Integrated change model (I-change model) (Fig. 1), which has 
been applied in studies on screening attendance and smoking behaviour in native and 
immigrant populations (21–24). The I-change model aims to explain health behaviours and 
incorporates elements from health behaviour theories such as the Health Belief Model (25), 
Protection Motivation Theory (26), Theory of Planned Behaviour (27), and Precaution 
Adoption Process Theory (28). The model states that behaviours are determined by a person’s 
motivation or intention to carry out a behaviour and is the result of a person’s intentions, 
abilities, and barriers. Attitudes, social influences, and self-efficacy expectations influence a 
person’s motivation and are determined by various distal factors, such as predisposing (e.g. 
current lifestyle), information (e.g. source of delivery), and awareness (e.g. knowledge) 
factors. The rationale for choosing this model was that health check attendance could be seen 
as a health behaviour and in that sense be studied with this comprehensive model. 
 
 
Figure 1. The I-change model, from http://www.maastricht-university.eu/hein.devries/interests/change 
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Data analysis  
Audio-tapes were transcribed verbatim. The remarks of the participants without command of 
the Dutch language were transcribed and translated by the ethnicity-matched observer. Data 
analysis was done on all focus group transcripts combined and facilitated by Atlas.ti 6.2 
software. Most coding was performed deductively with codes based on the determinants of 
the I-change model, and partly inductively when a new code emerged. To increase reliability, 
coding was independently performed by two researchers (IG and MC) until consensus was 
reached, which was after five interviews (29, 30). After this, the other transcripts were coded 
by IG and only discussed with MC in case of doubt about the appropriate code. Alike the 
codes, themes were partly identified in advance and partly derived from the data. Thematic 
content analysis (including merging or subdividing codes and allocating to themes) was 
performed by IG and MC and validated among members of the research team (WA, AS, SvD, 






In total, 125 participants took part in the focus groups, of whom 119 filled out the 
background information questionnaire. Table 2 presents these participants characteristics. 
Many Surinamese participants were retired and participants in the other groups were often 
unemployed or disabled. Female participants mainly reported housekeeping as their 
occupation in daily life. The majority of the adult children (mainly female) combined their 
education or job with housekeeping. 
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Methods of invitation  
Information factors  
A personal invitation for participation in the HRA during a GP or home visit was preferred to 
an invitation by letter, telephone, or online. Face-to-face contact was believed to result in 
more reliable results because people would receive practical help and be more honest. 
Additionally, it was thought to be a useful way of spending time in the waiting room. The GP 
was seen as a reliable source. Nevertheless, a good relationship and trust were considered 
essential for participation. Participants emphasized the importance of regional/national 
publicity and repetition regarding the availability of the HRA to get acquainted with it and for 
branding to occur. It was proposed to notify people in advance that they would soon receive 
an invitation, to provide reminders, and to make use of social networks for word-of-mouth 
publicity. 
 
Determinants regarding participation in the HRA  
Tables 3 and 4 present an overview of reasons respectively decreasing and increasing the 
likelihood of participation in the HRA. Reasons are categorized under I-change constructs and 
more specific determinants. Ethnic group(s) for whom the reason was most prominent is 
mentioned, as well as a detailed description of the reason, with an illustrative quote for a 
selection of reasons. 
 
Predisposing factors  
Participants believed that women would be more likely to participate than men. A lack of 
physical symptoms would be a reason for some to participate (Quote 1.2, Table 4), whereas 
for others it would not. Already having a disease made participants more prone to participate, 
as would a family history of CMD. An exception were the Hindustani participants (a group 
genetically predisposed to CMD), who expressed the view of Hindustanis being more passive 
in general (Quote 1.3, Table 3). Passiveness was not expressed as a typical group trait among 
other ethnicities, but was recognized as an individual trait affecting participation (i.e. being 
lazy/lax). Dissatisfaction with the Dutch healthcare system was a reason for many Turkish 
and Moroccan participants to prefer a health check in their home country.
1
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Awareness factors  
Completing the HRA would be too difficult for some due to health illiteracy, i.e. they would 
be less able to understand the HRA and its accompanying information on CMD. Many 
participants were aware of health checks being offered for a variety of health conditions by 
various sources. Previous experience with a health check would not make participants more 
reluctant to participate, provided that it concerned a different health condition (Q 2.1, Table 
4). It was believed that many people would not participate while feeling less at risk than 
others. They would compare their own perceived healthy lifestyle with that of others and, 
possibly unrealistically, would conclude that participation would not be useful for them (Q 
2.2, Table 3). Simultaneously, it was presumed that many participants desired a sense of 
certainty about their risk status, even when they believed that they had a low risk. 
 
Motivation factors  
Most participants had a positive attitude and elaborated on the advantages of participating. 
Nevertheless, participants knew many people who would have a negative or indifferent 
attitude. Although fear of being ill was deemed important, participants (especially the 
healthcare professionals) considered it wrong to deliberately use fear as a motivational 
strategy (Q 3.3, Table 3). This could make people more afraid of the outcome and the possible 
consequences of a high-risk status (i.e. having to make lifestyle changes). Although 
participants tended to be reluctant admitting this, social influences seemed to play a major 
role in the decision-making, both emotionally and practically. For example, some participants 
were afraid that the test results would be known by others besides the GP who would then 
know that they were ill and, consequently, would judge or mistreat. Encouraging would be 
having family members or important others advising them to participate or participating 
themselves (Q 4.2, Table 4). Sometimes, participation seemed unnecessary for patients who 
believed in a God or other external influences causing disease (i.e. external locus of control). 
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Barriers and ability factors  
Participants usually found questionnaires and invitation letters too extensive and complicated. 
It was strongly advised to formulate these texts as concisely and simply as possible. Because 
Turkish and Moroccan participants also faced a language barrier (Q 4.2, Table 3), in many 
families the children would translate (Q 4.2, Table 4). Among Surinamese and Dutch 
participants it was not common to ask the children for help. Finally, especially among the 
Dutch groups, it was emphasized that participation would be free. Summarizing, reasons for 
not completing the HRA were mainly cognitive and included rational cost–benefit 
considerations incorporating (flawed) risk perceptions, health negligence, (health) illiteracy, 
and language barriers. 
 
Risk communication  
Information factors  
The message of a high-risk HRA result should be formulated simply and briefly, but not too 
directly and information about its consequences should be provided. Surinamese and Dutch 
participants felt strongly about the voluntary nature of PCs participation. Consequently, 
providing a prescheduled date for the appointments would have adverse effects. The ensuing 
face-to-face contact and physical examinations during the PCs made the relationship between 
the participants and their GP even more important. They felt that the GP should be reassuring 
and make an effort to come to them, i.e. into the community. 
 
Determinants regarding participation in PCs  
Tables 5 and 6 present an overview of (additional) determinants respectively decreasing and 
increasing the likelihood of participation in the PCs. 
 
Predisposing factors  
Similar predisposing factors mentioned for HRA (non-)participation were raised again when 
discussing the PCs. An additional factor mentioned was that the older generation would be 
more likely to visit their GP than the younger generation (Q 1.1, Table 6). However, at a 
certain age (i.e. around 70 years) people would not see the point of prevention anymore (Q 
1.1, Table 5). 
 
1
14549-Groenenberg_BNW.indd   37 27-03-17   12:58
38 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































14549-Groenenberg_BNW.indd   38 27-03-17   12:58




Awareness factors  
An important cue to action would be the confrontation with an unfavourable test result (Q 2.1, 
Table 6), after which many would go to the PCs to gain more certainty about their risk and 
disease status. However, some would not go and might use a high-risk status as a ‘license to 
misbehave’ (Q2.1, Table 5). According to the participants, these people might think that it 
would no longer be necessary to put much effort into behaving healthily as they already have 
a high risk. 
 
Motivation factors  
Participants believed that many would be convinced of the necessity of screening after 
receiving a high-risk HRA result (Q 3.1, Table 6). However, they also believed that for some 
an increased risk would come as such a shock that they would not believe it. Participants 
thought that fear would be so strong that it would translate into helplessness or fatalism (Q 
3.2, Table 5). Also, an external locus of control played a role in the perceived pointless-ness 
of participation. Among the Turkish groups, a feeling of being treated like a ‘guinea pig’ was 
common. Notable was the more prominent role of gossip, especially among the Turkish and 
Moroccan groups. They were afraid that a bad test result would be passed on, for example, by 
ethnicity-matched translators, while (severe) illness was perceived as something private and 
often seen as a taboo. 
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Barriers and ability factors  
Turkish and Moroccan participants would again face a language barrier and ask their children 
for translation. The difficulty of the verbal information (i.e. health illiteracy) provided during 
the PCs was recognized as a problem for all groups. For the HRA, costs were mainly an issue 
among the Dutch groups, while this aspect was expressed among all groups when discussing 
PCs participation. Compensation for possible costs would be an important facilitating factor. 
Time concerns were also expressed (Q 4.3, Table 5), although participants felt that people 
should make time for PCs (Q 4.3, Table 6). For the Dutch groups this involved arranging time 
off from work, and for the Turkish and Moroccan groups this involved the prolonged stay in 
their home country during the summer vacation. In addition, during the period of Ramadan 
many would be reluctant, or even prohibited, to attend the PCs. Summarizing, reasons for not 
attending the PCs overlapped with reasons for not completing the HRA but additional reasons 
were notably more affective and included negative emotional responses and related coping 
strategies incorporating risk denial, fear about the outcome, its potential consequences 
(lifestyle changes and medication prescription), and disease-related stigma. 
 
 
DISCUSSION AND CONCLUSION 
  
Discussion  
In this study we have identified factors influencing (non-)participation in a two-stage 
cardiometabolic health check among difficult-to-reach, vulnerable populations. The kind of 
invitation and the source was thought to influence the decision-making process, as recognized 
by studies in the general population (31– 33). A multi-strategy approach combining mailed 
letters, telephone calls, and/or especially face-to-face strategies seems useful for increasing 
uptake in vulnerable groups (34). Combined with an awareness campaign and/or a more 
community-involved GP, uptake may be further increased. Nonetheless, a good relationship 
with their GP and sufficient trust in the Dutch healthcare system would benefit this invitation 
(32, 33). In line with the literature among the general population, our vulnerable participants 
expected health-conscious patients to more frequently follow-up an invitation for the HRA as 
they would see the importance and advantages of doing so (12, 15). This contrasting a more 
negligent group, comprising men and individuals without health problems who would have a 
more negative attitude and not recognize the necessity of screening. Feeling healthy was also 
1
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seen as hampering the acceptance of a high-risk HRA outcome as it would not fit the patient’s 
illness perceptions (35). Participants also expected these negligent patients to regularly 
engage in denial strategies to cope with an increased risk, for example, by minimizing their 
personal vulnerability by comparing their own behaviour with that of others behaving in even 
less healthy ways (i.e. downward social comparisons), or the stereotype person at risk (36). 
Consequently, they would not see the purpose of further testing at the GP, which may be 
labelled as a ‘defensive bias’ (37). Negative emotional reactions were mentioned as a 
response to a high-risk HRA result and most prominently as a reason for nonparticipation in 
the PCs. Fear was also the most distinct emotional reaction and reason for non-attendance 
among the general population (12, 15). Others concluded that avoiding further testing is a way 
of managing fears caused by an increased risk and explained it as a strategy for individuals to 
ease the stigma and guilt associated with the perceived personal responsibility for their risk 
status: they wanted to postpone screening until they had made progress through lifestyle 
changes (38). The current study adds that refraining from further testing may follow from the 
wish not to be treated differently, fuelling the fear of gossip, especially among Turkish and 
Moroccan patients. For Turkish and Moroccan patients, the poorer command of the Dutch 
language would be a problem when completing the HRA, it could hinder a trusting 
relationship with their GP and, consequently, their PCs’ attendance. The deployment of 
ethnicity-matched translators seems a logical solution, but may pose a problem considering 
the fear of gossip (passing on negative screening outcomes to others). 
 
Strengths and limitations  
Carrying out focus groups with adult children of immigrants is an innovative approach and 
worked best among the Turkish and Moroccan children: we obtained more extensive 
information because they were generally more outspoken and assertive. Focus groups with 
adult children of immigrant groups seem especially useful when these children are 
accustomed to being involved in their parents’ decision-making. The results from focus 
groups with these adult children were verified among the immigrant groups and combined 
with data from the healthcare professionals. By this way of triangulation, we looked at the 
data from multiple angles composing a complete as possible picture. To further increase the 
internal validity, the design and analysis of this study were embedded in an encompassing 
theoretical framework, allowing room for inductively derived determinants. The I-change 
model seems important in explaining the decision of (non-)participation in a health check, 
1
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particularly the HRA. Regarding the decision of attending the PCs, the model could be 
improved by adding coping determinants for dealing with an increased risk. Finally, to ensure 
reliability we have structurally organized the data, including audio-taping of interviews, using 
an analysis software program and a coding tree, keeping a log, and double-coding. Some 
limitations to the study should be discussed. First, we had to pre-set the number of focus 
groups, which led to small and diverse groups of participants. Some focus groups did not 
consist of the intended minimum of six participants, which could have led to less interaction 
between participants. These aspects may have diminished generalizability of findings. 
Previous studies, however, found comparable results suggesting a certain level of 
generalizability to other types of screening and populations. Second, although we presented 
inferences for one or more of the separate ethnic groups only if strongly present, they have to 
be interpreted with caution. Third, in the few cases the observer/notetaker had to translate 
misunderstandings and loss of profundity may have occurred. Fourth, participants did not 
have the opportunity to comment or correct the transcripts, possibly impeding internal validity 
of the study. Finally, participants were highly motivated to participate in the study, therefore, 
a selection bias might have occurred. Nevertheless, all participants verbalized potential doubts 




The purpose of this study was to provide an overview of informational, practical, and 
psychosocial factors influencing the (non-)participation in a two-stage cardiometabolic health 
check among difficult-to-reach, vulnerable populations. Even though similarities between 
determinants influencing (non-)participation in the HRA and the PCs were manifold, 
important differences were also noted. When considering filling out the HRA, more cognitive 
aspects, including rational cost–benefit considerations, were prominent. After a high-risk 
HRA result and the subsequent decision to (not) participate in the PCs, cognitive aspects 
would still play a role but more importantly would trigger negative affective responses and 
related coping aspects to deal with these emotions. We had expected to find distinct 
determinants for (non-)participation in cardiometabolic screening among non-Western 
immigrants and lower SES native Dutch. However, the majority of observed determinants 
seemed similar to determinants found in previous studies among the general population or 
studies focusing on cancer screening. This suggests that though perceived risk of and worries 
1
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about cancer are higher than about CMD, determinants influencing the decision to participate 
in screening may not differ much. These determinants may not vary substantially between 
ethnicities except for language barriers and possibly the larger impact of gossip and taboos 
among Turkish and Moroccan immigrants. 
 
Clinical implications  
Findings from this study can be used to design new or adapt existing two-stage 
cardiometabolic health checks for vulnerable groups. Regarding the first stage, i.e. inviting 
people to complete a short non-invasive HRA, choice of invitation strategy seems crucial. A 
multi-strategy approach, including a face-to-face strategy, may be important in increasing 
uptake, especially when combined with an awareness campaign and/or a more community-
involved GP. Written or verbal translations must be provided for non-native participants. 
Finally, as flawed risk perceptions and attitudes regarding screening are common, individuals 
should be presented with accurate information on risks and (dis)advantages of screening to 
support them in making informed choices about participation (32). Regarding the second 
stage, i.e. inviting people to attend PCs for further testing, negative emotional responses and 
defensive coping strategies have to be taken into account. Minimizing one’s risk and feelings 
of personal vulnerability does not necessarily mean that high-risk individuals are not receptive 
to information (36). GPs or other healthcare professionals should explore these emotions and 
fears regarding further testing, in order to, again, support informed choices. Additionally, 
there is a need to take social context into account, especially since many non-Western cultures 
can be characterized as group cultures (36). To increase acceptance of ‘being different’ due to 
having a high-risk or CMD, it is suggested to involve family and friends in the patient’s 
lifestyle advice and/or treatment. Additionally, the topic of cardiometabolic risk should be 
brought to the attention of key figures within the community, who can help eliminate some of 





The authors thank all organizations for their cooperation in conducting focus groups at their 
locations, and the key persons in particular for recruiting participants and providing 
translations if necessary. 
1
14549-Groenenberg_BNW.indd   44 27-03-17   12:58






MC, SD, WG, and AS filed the proposal for this study. The design, execution, and analysis 
were mainly done by IG and MC, in close collaboration with the research team. The paper 
was written by IG and critically revised by all authors. All authors had full access to all of the 
data in the study and can take responsibility for the integrity of the data and the accuracy of 
the data analysis. IG is guarantor.  
 
Funding  
This study was funded by the Dutch Heart Foundation, the Dutch Diabetes Foundation, and 
the Dutch Kidney Foundation in a collaboration called LekkerLangLeven [Living nice and 
long], grant number 2008.20.005. The views presented in this manuscript are those of the 
authors and do not necessarily reflect those of the study funders.  
 
Competing interests  
None of the authors have other financial relationships with organizations that might have an 
interest in the submitted work.  
 
Ethical approval  
This study was approved by the Medical Ethical Committee of Leiden University Medical 
Center (CME-09-126).  
 
Data sharing  
Anonymized transcripts and coding tree are available from the corresponding author.  
 
Transparency  
The lead author (IG) affirms that the manuscript is an honest, accurate, and transparent 
account of the study being reported; that no important aspects of the study have been omitted; 
and that any discrepancies from the study as planned have been explained. 
 
1
14549-Groenenberg_BNW.indd   45 27-03-17   12:58
46 









Focus groups; interview protocol native Dutch lower SES  
 
Checklist 
• Name tags and markers.  
• Recording equipment.  
• Informed consent forms.  
• Flip-over.  
• Coffee, tea, and snacks.  
• Gift certificates.  
• Example invitations (for participation in HRA and PC).  
• Yellow, pink, green, and blue post-its and pens.  
• Educational materials on cardiometabolic diseases. 
 
Opening  
Facilitator and observer/notetaker introduce themselves.  
Explanation about the study and reason for the choice of participants.  
What is expected of the participants. It concerns opinions and experiences of the participants. Answers given 
are never wrong. Everyone is expected to join the discussion.  
Data will be treated anonymously and confidentially, which also means: everything discussed by the group 
will stay within the group.  
The discussion will be audio taped, transcribed, and then erased (Informed consent).  
Interested in report of findings?  
Duration: approximately 2 h. In between: short break with coffee/tea and snacks.  
Afterwards: gift certificate (and depending on time of day: meal).  
Questions? 
 
Introduction round  
Name (or pseudonym), age, family status, reason for participation. 
 
Opening question  
(1) Has anybody ever heard of a health check?  
If yes: could you explain what it is?  
(A) Have you ever participated in such a check?  
(B) Do you know people who have participated in such a check?  
(C) What was your/their experience with it?  
If no: what do you think of when you hear this term?  
Explanation about the Health Check, the HRA specifically. 
 
Questions about the HRA  
(2) Imagine that the GP sends an invitation to participate in a health check, how would your family react?  
(A) Who opens the mail?  
(B) Who would know about the invitation?  
(C) Who decides what would be done with the invitation?  
 
(3) Here I have got two example invitations for such a health check, attentively read both of them. What is 
your first impression?  
(A) What should be included in the invitation by all means, and what should not?  
(B) Did you notice anything about the formulation of the message? If necessary ‘help out’: one of them is 
gain framed, while the other is loss framed. What would work better?  
1
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(C) What would be the most effective way of inviting (written/ by telephone/face-to-face/other)?  
(D) Additions. . .  
(E) Anecdote!  
 
(4) What would be reasons for you (or your neighbour/brother or sister/best friend) not to participate in the 
HRA?  
(A) Any biological (physical) reasons? Would women or men be more inclined to fill out the test?  
(B) Any psychological reasons, for example character traits?  
(C) Would young or older people be more inclined to fill out the test?  
(D) How would important others react? Would others find it important to fill out the test? Would others fill 
out the test?  
(E) Trust in health care system/doctors/researchers?  
(F) (Religious) locus of control? Do you have control over your health? Are external causes the reason for 
getting ill?  
(G) Knowledge and awareness (‘health literacy’)? Publicity? Relationship with GP  
(H) Communication/interaction?  
(I) Emotional?  
(J) Name 3 advantages.  
(K) Name 3 disadvantages.  
(L) Name 3 barriers which would prevent you from filling out the test.  
(M) Name 3 things which would make it easier for you to fill out the test.  
 
(5) What would be reasons for you (or your neighbour/brother or sister/best friend) to participate in the HRA?  
(A) till (M) as above.  




Questions about the PCs  
Explanation about the Health Check, the PCs specifically.  
(6) Again we have made two example invitations, attentively read both of them. What is your first 
impression?  
(A) What should be included in the invitation by all means, and what should not?  
(B) Did you notice anything about the formulation of the message? If necessary ‘help out’: one of them is 
gain framed, while the other is loss framed. What would work better?  
(C) Would a prescheduled date and time work?  
(D) Would you prefer to be approached differently for this than what we discussed about the HRA?  
(E) Additions . . .  
 
(7) What would be reasons for you (or your neighbour/brother or sister/best friend) not to participate in the 
PCs?  
(A) Any biological (physical) reasons? Would women or men be more inclined to go to the PCs?  
(B) Any psychological reasons, for example character traits?  
(C) Would young or older people be more inclined to go to the PCs?  
(D) How would important others react? Would others find it important to go to the PCs? Would others go to 
the PCs?  
(E) Trust in health care system/doctors/researchers?  
(F) (Religious) locus of control? Do you have control over your health? Are external causes the reason for 
getting ill?  
(G) Knowledge and awareness (‘health literacy’)? Publicity? Relationship with GP?  
(H) Communication/interaction?  
(I) Emotional?  
(J) Name 3 advantages.  
(K) Name 3 disadvantages.  
(L) Name 3 barriers which would prevent you from attending the PCs.  
(M) Name 3 things which would make it easier for you to attend the PCs.  
 
(8) What would be reasons for you (or your neighbour/brother or sister/best friend) to participate in the PCs?  
(A) till (M) as above.  
What would be solutions for the problems mentioned earlier?  
1
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Ethnic minority and native Dutch groups with a low socioeconomic status (SES) are 
underrepresented in cardiometabolic health checks, despite being at higher risk. We 
investigated response and participation rates using three consecutive inexpensive-to-costly 
culturally adapted invitation steps for a health risk assessment (HRA) and further testing 
of high-risk individuals during prevention consultations (PC). 
 
Methods 
A total of 1690 non-Western immigrants and native Dutch with a low SES (35–70 years) from 
six GP practices were eligible for participation. We used a ‘funnelled’ invitation design 
comprising three increasingly cost-intensive steps: (1) all patients received a postal invitation; 
(2) postal non-responders were approached by telephone; (3) final non-responders were 
approached face-to-face by their GP. The effect of ethnicity, ethnic mix of GP practice, and 
patient characteristics (gender, age, SES) on response and participation were assessed by 
means of logistic regression analyses. 
 
Results 
Overall response was 70% (n=1152), of whom 62% (n=712) participated in the HRA. This 
was primarily accomplished through the postal and telephone invitations. Participants from 
GP practices in the most deprived neighbourhoods had the lowest response and HRA 
participation rates. Of the HRA participants, 29% (n=207) were considered high-risk, of 
whom 59% (n=123) participated in the PC. PC participation was lowest among native Dutch 
with a low SES. 
 
Conclusions 
Underserved populations can be reached by a low-cost culturally adapted postal approach 
with a reminder and follow-up telephone calls. The added value of the more expensive face-
to-face invitation was negligible. PC participation rates were acceptable. Efforts should be 
particularly targeted at practices in the most deprived areas.
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Cardiometabolic disease (CMD), namely cardiovascular disease (CVD), diabetes mellitus 
(DM), and kidney failure, is a leading cause of death in high-income countries (1). CMD 
risk is related to low socioeconomic status (SES) and a non-Western origin (2, 3). In The 
Netherlands, CVD prevalence and mortality are particularly high among Surinamese and 
Turkish people (4, 5). Turkish, Moroccans, and especially Hindustani Surinamese have a 
higher DM risk (6). As CMD is largely preventable, focus has shifted towards primary 
prevention among high-risk individuals and, as a result, health checks have been implemented 
in various countries (7–9). A non-Western origin and a low SES are associated with lower 
health check attendance (10). This selective non-attendance contributes to inequalities in 
health gains from screening. Efforts to increase participation of these underserved (difficult-
to-reach, high-risk) populations are therefore relevant, and a prerequisite for cost-
effectiveness (11, 12).  
Attempts to increase participation in health checks in the general population usually compared 
postal, telephone, and face-to-face strategies in parallel (13–17). In general, a postal invitation 
combined with telephone reminders was most effective in cancer screening attendance (14). 
However, studies taking ethnicity or SES into account tend to find the more labour-intensive, 
expensive face-to-face strategies or combinations of strategies, to be most effective (13, 15–
17). In The Netherlands, only this ‘case-finding’ approach is currently reimbursed by basic 
health insurance (18). Nevertheless, a strategy with a sequential inexpensive-to-costly 
‘funnel’ invitation procedure might be more cost-effective. We investigated response and 
participation in a health check by using such a funnel design that encompassed three 
consecutive culturally targeted and personalised invitation steps: first, a postal invitation to 
eligible individuals, second, a telephone invitation for postal non-responders, third, a face-to-
face invitation for telephone non-responders. We assessed both response and participation, 
with response referring to the patient’s awareness of the screening and providing a response 
as to whether or not (s)he intended to participate, and participation to actual participation in 
the health check.  
Another way of increasing cost-effectiveness entails using a two-stage health check approach, 
which usually refers to employing a non-invasive and low-cost risk stratification tool for all 
individuals, followed by more expensive biometric and blood testing for high-risk individuals 
(12, 19). The Dutch cardiometabolic health check follows such a two-stage approach. Stage 
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one comprises a short health risk assessment (HRA) consisting of six risk factor questions 
(20, 21) for people aged 45–70 years. Patients have to calculate their own HRA risk score. In 
case of an increased risk according to the HRA, patients are advised to attend a prevention 
consultation (PC) at the GP (stage two). However, in the general population it has been shown 
that patients then refrain from participation on two separate occasions (HRA and PC), 
possibly leading to even higher non-participation rates among underserved populations (22). 
Therefore, we examined HRA participation and subsequent PC participation after receiving 
an increased HRA risk score, as well as the effect of ethnicity, ethnic mix of GP practice, and 
patient characteristics (gender, age, SES) on participation.  
Summarizing, our research questions were: 
1. What are response and participation rates among different underserved populations after a 
postal invitation to complete the HRA? 
2. To what extent can response and HRA participation among postal non-responders from the 
different groups be increased by telephone and by a subsequent face-to-face invitation by the 
GP among remaining non-responders? 
3. What proportion of high-risk HRA participants attends the PC, and does this vary between 





Study population and setting 
Between May 2012 and December 2013, patients from six general practices in deprived 
neighbourhoods in the Netherlands were invited for the cardiometabolic health check. Patients 
had to be Turkish, Moroccan, or Surinamese, or native Dutch with a low SES. As ethnicity is 
not registered by the GP, ethnic origin was deduced from family name, after which the 
classification was checked by the GP. He/she also selected the native Dutch patients with a 
low SES. The SES status was then corroborated by a neighbourhood SES score. A low SES 
score represents a low neighbourhood social status and consists of the average income and the 
proportion of low-income, low-educated, and unemployed individuals (23). Patients had to be 
45–70 years old. The lower age limit for the Hindustani Surinamese was 35 years because of 
their genetically increased risk of DM. Exclusion criteria were having (had) CMD, use of 
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antihypertensive/lipid-lowering drugs, or having a complete cardiometabolic risk profile 
within the previous year (see Additional file 1). 
Ethical approval was obtained from the Medical Ethics Committee of the Leiden University 
Medical Centre. Participation in the study followed an ‘opt-out procedure’: patients could sign 
a reply card declining participation. 
 
Three-step invitation strategy for stage one: HRA participation 
The HRA consisted of six short questions on age, smoking status, BMI, waist circumference, 
and family history of CVD or DM. Three culturally targeted and personalised invitation steps 
for the HRA were tested following a funnel design. 
 
Step one 
Eligible patients were invited by a personalised, GP-signed letter. Enclosed were the HRA 
and an information brochure (both with ethnic specific pictures), a tape measure for 
measuring waist circumference, a reply card declining participation, and a stamped return 
envelope addressed to the GP. The formulation was simplified to fit the generally lower health 
literacy levels of our target population. Turkish and Moroccan patients received Turkish or 
Arabic versions, respectively, in addition to the Dutch materials. After two weeks of non-
response, patients received a reminder package. A detailed description of the (cultural) 
adaptations made in the invitation, HRA, and information brochure can be found in 
Additional file 2. 
 
Step two 
After another two weeks of non-response, patients were called by a trained research assistant 
on behalf of the GP. Turkish and Moroccan patients were called by Turkish, Arabic, and 
Berber (which is an oral only language) speaking research assistants. The conversation 
was structured by a script supporting patients in making an informed decision about (non-
)participation. When a participant decided to participate, the HRA was immediately 
completed by telephone and the HRA risk score was calculated by the research assistant. The 
national telephone directory was consulted when telephone numbers were missing, unlisted, 
or inoperative. Patients were approached with a maximum of four call attempts.  
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After four failed call attempts, patients were invited face-to-face when visiting their GP for an 
unrelated consultation. GPs received a pop-up in the electronic patient file of a non-
responding patient. The GPs followed a short version of the telephone script to help patients 
make an informed decision about (non-)participation. When a participant decided to 
participate, the HRA was immediately completed at the GP practice and the HRA risk score 
was calculated by the practice nurse. The face-to-face invitation period lasted six months, 
which was deemed long enough since ethnic minorities and native Dutch patients with a low 
SES are known to consult the GP up to once or twice a month (24, 25). If patients had not 
visited the practice within this period, they were classified as final non-responders. 
 
Stage two: PC participation among high-risk individuals 
Participants had to calculate their own HRA risk score. Participants with a low risk score were 
referred to the Dutch health check website where advice for maintaining or improving their 
lifestyle was provided. Participants with a high-risk score were advised to attend the PC. This 
advice was provided either written, by phone, or face-to-face, depending on the relevant 
invitation step. Patients themselves were responsible for making an appointment with the GP. 
During the first PC, the biometric HRA measures were checked (weight, height, and blood 
pressure) and lab work on fasting glucose and cholesterol levels was completed. During the 
second PC, the results were discussed, the cardiometabolic risk profile was drawn, lifestyle 
advice was provided, and medication was prescribed if necessary (26). Because we only 




The main outcome measures were response, HRA participation, and PC participation. The 
secondary outcome measure was HRA risk score.  
Response was defined as ‘yes’ if an individual provided a reaction as to whether he/she 
wanted to participate in the HRA or not and ‘no’ if an individual did not respond at all. It was 
calculated as a percentage of all patients. Telephone response was calculated as the proportion 
of postal non-responders, who picked up the phone and indicated an intention to participate or 
not. Finally, face- to-face response was calculated as the proportion of telephone non-
responders, who were approached face-to-face by their GP and indicated an intention to 
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participate or not. Additionally, to take into account the fact that not all patients visited their 
GP for an unrelated consultation in the research period, face-to-face response was also 
calculated as a percentage of those telephone non-responders who actually visited their GP.  
HRA participation was defined as ‘yes’ if the HRA was completed and ‘no’ if the HRA was 
not completed. It was calculated as the proportion of responders of each specific invitation 
step.  
HRA risk score was defined as low or high risk and was calculated as the proportion of HRA 
participants.  
PC participation was defined as ‘yes’ if the PC was attended when having a high-risk HRA 
score and ‘no’ if the PC was not attended. It was calculated as the proportion of individuals 
with a high-risk HRA score. 
 
Covariates 
Patient characteristics were: ethnicity (native Dutch/Turkish/Moroccan/Surinamese), gender 
(male/female), age (30-45/45-50/50-55/55-60/60-65/65+ years), and neighbourhood SES 
score (>0/0 till −2/-2 till −4/<−4). A low SES score equals a low SES. The average SES score 
in the Netherlands in 2010 was 0.17 (−7.25 till 3.19), whereas in our study it was −2.14 
(−6.23 till 2.88) [23]. The ethnic mix of GP practice variable was divided in three groups: 
predominantly non-Western patient population, approximately equal combination, and 
predominantly native Dutch with a low SES patient population. Invitation steps were: mail, 
phone, and face-to-face. 
 
Data analysis 
Descriptive analyses were applied to describe the patient population. Differences in patient 
characteristics between the ethnic groups were assessed by means of ANOVA. Univariate 
logistic regression was used to assess whether patient characteristics were or ethnic mix 
of GP practice was related to response and participation rates. Odds ratios (ORs) regarding the 
influence of ethnicity on outcome measures were corrected for relevant covariates (p-value 
<0.05) by means of multivariate logistic regression. As the populations who responded to the 
various invitation steps logically differed, results were stratified by invitation step. 
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Of the 1690 individuals eligible for invitation, 43 had an unknown or wrongly classified 
ethnicity, two had started antihypertensives right before start of the study, and one had 
missing contact details. Exclusion from analyses resulted in 1644 eligible individuals. Slightly 
more males (54%) than females (46%) were invited (Table 1). The Moroccan group consisted 
of more males than the native Dutch and Surinamese groups. Participants were on 
average 50 years old. The native Dutch were older and the Surinamese were younger than the 
other ethnic groups. The native Dutch and the Turkish had a higher and a lower SES score 
than the other ethnic groups, respectively. 
 
Response 
Total response (those who indicated an intention to participate or not) was 70% (n=1152) of 
our underserved populations (Fig. 1). Of all individuals invited, 41% (n=681) responded to 
the postal invitation (Table 2). Of the postal non-responders, 46% (n=443) responded by 
telephone. Finally, of all telephone non-responders, 5% (n=28) responded face-to-face. When 
we only considered those non-responders who attended their GP for an unrelated consultation 
during the research period of 6 months (n=225), response was 12%. Face-to-face results are 
not presented in the tables as numbers were too small. A comparison between (postal or 
telephone) responders (n=1125) and non-responders (n=520) revealed that those left over for 
face-to-face recruitment were more often men (p 0.001) and individuals with a low SES 
score (p 0.001). 
The higher odds of response among native Dutch groups disappeared when adjusting for 
relevant covariates. This was mainly explained by differences regarding ethnic mix of GP 
practice (Table 3). The native Dutch in predominantly non-Western practices did not respond 
more often than the other ethnic groups, and even significantly less than the Turkish (OR 
0.52, 95% CI 0.31-0.88, p=0.014). Additionally, response was higher for all ethnic groups in 
the mixed and predominantly native Dutch practices when compared to the predominantly 
non-Western practices (Table 2). 
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Figure 1. Flowchart response and participation by postal, telephone, and face-to-face invitation step, with 
response referring to the patient’s awareness of the screening and providing a response as to whether or not 
(s)he intended to participate, and participation to actual participation in the health check 
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[Hier graag invoegen: ‘Table 2. Response in postal and telephone steps’] 
 
Table 2. Response in postal and telephone steps
Postal Telephonea
Response Odds ratio (95% CI) Response
Odds ratio 
(95% CI)
Total group (n=1644) 41% (n=681) 46% (n=443)
Univariate analyses
  Ethnicity Dutchc (n=437) 49% (n=214) 1.00 57% (n=126) 1.00
Turkish (n=353) 45% (n=158) 0.84 (0.64-1.12) 47%   (n=91)  0.67 (0.46-0.99)*
Moroccan (n=344) 39% (n=134)  0.67 (0.50-0.89)* 40%   (n=84)   0.51 (0.35-0.75)**
Surinamese (n=510) 34% (n=175)   0.54 (0.42-0.71)** 42% (n=142)   0.57 (0.40-0.80)**
  Gender Malec (n=882) 39% (n=343) 1.00 42% (n=225) 1.00
Female (n=762) 44% (n=338)  1.25 (1.03-1.53)* 51% (n=218)  1.48 (1.14-1.91)*
  Age 35-45 (n=259) 27%   (n=70)   0.51 (0.37-0.70)** 46%   (n=87) 0.90 (0.63-1.28)
45-50c (n=595) 42% (n=250) 1.00 49% (n=168) 1.00
50-55 (n=392) 45% (n=176) 1.12 (0.87-1.45) 49% (n=106) 1.02 (0.72-1.43)
55-60 (n=213) 46%   (n=98) 1.18 (0.86-1.61) 44%   (n=51) 0.84 (0.55-1.28)
60-65 (n=120) 48%   (n=58) 1.29 (0.87-1.91) 36%   (n=22) 0.58 (0.33-1.02)
65+ (n=65) 45%   (n=29) 1.11 (0.66-1.85) 25%     (n=9)  0.35 (0.16-0.77)*
GP practiceb Dutchc (n=361) 50% (n=179) 1.00 61% (n=111) 1.00
Mix (n=193) 54% (n=105) 1.21 (0.86-1.72) 56%   (n=49) 0.80 (0.48-1.35)
Non-Western (n=1090) 36% (n=397)    0.58 (0.46-0.74)** 41% (n=283)    0.44 (0.32-0.62)**
SES score > 0c (n=470) 46% (n=217) 1.00 54% (n=137) 1.00
0 till -2 (n=386) 41% (n=160) 0.83 (0.63-1.08) 47% (n=106) 0.75 (0.52-1.07)
2 till -4 (n=267) 39% (n=104) 0.74 (0.55-1.01) 35%   (n=57)   0.46 (0.30-0.68)**
< -4 (n=521) 38% (n=200)  0.73 (0.56-0.94)* 45% (n=143)  0.68 (0.49-0.95)*
  Ethnicity Dutchd (n=437) 49% (n=214) 1.00 57% (n=126) 1.00
Turkish (n=353) 45% (n=158) 1.43 (0.98-2.08) 47%   (n=91) 1.11 (0.68-1.82)
Moroccan (n=344) 39% (n=134) 0.88 (0.64-1.22) 40%   (n=84) 0.66 (0.43-1.01)
Surinamese (n=510) 34% (n=175) 1.23 (0.83-1.81) 42% (n=142) 0.93 (0.57-1.89)
a As percentage of postal non-responders. b Predominant composition of patient population. c Reference category univariate 
analyses. d Reference category multivariate analyses, corrected for relevant variables (gender, age, ethnic mix of GP prac-
tice, and/or SES score). * ** 
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Stage one: HRA participation 
Of the 1152 responders, 62% (n=712) participated in the HRA (Table 4). Participation rates 
among postal responders (n=448, 66%) were comparable to those among telephone 
responders (n=260, 59%). The participation rate of face-to-face responders was only 14% 
(n=4). Just as with response, the ethnic differences in HRA participation disappeared when 
adjusting for relevant covariates, in particular ethnic mix of GP practice. In the predominantly 
native Dutch practices, the native Dutch patients participated more often in the HRA than the 
non-Western patients (Table 3). However, in the predominantly non-Western and mixed 
practices, the native Dutch had comparable or lower HRA participation rates than the other 
ethnic groups (not significant). 
 
Stage two: HRA risk result and PC participation 
Of the HRA participants, 29% (n=207) had a high-risk result (Table 5). When correcting for 
relevant covariates, the significantly lower risk score of Surinamese participants disappeared. 
This was mainly explained by age differences between groups. For Hindustani Surinamese, 
the age threshold to be invited for the HRA was lower due to their genetic higher risk of DM. 
The risk formula, however, was not adjusted for this heightened risk. Of the high-risk 
individuals, 59% (n=123) participated in the PC. All non-Western groups had higher odds of 
PC participation when compared to the native Dutch. We found no differences in risk score 
and in PC participation between the postal versus the telephone step. 
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[Hier graag invoegen: ‘Table 4. Participation rates of responders to postal and telephone steps’]  Table 4. Participation rates of responders to postal and telephone steps 
Postal (response n=681) Telephone (response n=443)
Participation Odds ratio (95% CI) Participation
Odds ratio 
(95% CI)
Total group (n=1152) 66% (n=448) 59% (n=260)
Univariate analyses
Ethnicity Dutcha (n=347) 76% (n=163) 1.00 55%   (n=69) 1.00
Turkish (n=258) 58%   (n=91) 0.43 (0.27-0.66)** 65%   (n=59) 1.52 (0.87-2.65)
Moroccan (n=222) 60%   (n=81) 0.48 (0.30-0.76)* 56%   (n=47) 1.05 (0.60-1.83)
Surinamese (n=325) 65% (n=113) 0.57 (0.37-0.89)* 60%   (n=85) 1.23 (0.76-2.00)
Gender Malea (n=576) 64% (n=218) 1.00 55% (n=123) 1.00
Female (n=576) 68% (n=230) 1.22 (0.89-1.68) 63% (n=137) 1.40 (0.96-2.05)
Age 35-45 (n=161) 63%   (n=44) 0.86 (0.49-1.49) 57%   (n=50) 0.75 (0.44-1.28)
45-50a (n=427) 66% (n=166) 1.00 64% (n=108) 1.00
50-55 (n=287) 66% (n=117) 1.00 (0.67-1.51) 54%   (n=57) 0.65 (0.39-1.06)
55-60 (n=156) 67%   (n=66) 1.04 (0.64-1.72) 51%   (n=26) 0.58 (0.31-1.09)
60-65 (n=83) 59%   (n=34) 0.72 (0.40-1.29) 55%   (n=12) 0.67 (0.27-1.63)
65+ (n=38) 72%   (n=21) 1.33 (0.57-3.13) 78%     (n=7) 1.94 (0.39-9.66)
GP practice Dutcha (n=295) 79% (n=141) 1.00 51%   (n=57) 1.00
Mix (n=159) 72%   (n=76) 0.71 (0.40-1.23) 55%   (n=27) 1.16 (0.59-2.28)
Non-Western
(n=698)
58% (n=231) 0.38 (0.25-0.57)** 62% (n=176) 1.56 (1.00-2.43)*
SES score > 0a (n=364) 70% (n=152) 1.00 54%   (n=74) 1.00
0 till -2 (n=268) 71% (n=113) 1.03 (0.66-1.61) 56%   (n=59) 1.07 (0.64-1.78)
-2 till -4 (n=169) 71%   (n=74) 1.06 (0.63-1.76) 63%   (n=36) 1.46 (0.77-2.75)
< -4 (n=351) 55% (n=109) 0.51 (0.34-0.77)** 64%   (n=91) 1.49 (0.92-2.40)
Ethnicity Dutchb (n=347) 76% (n=163) 1.00 55%   (n=69) 1.00
Turkish (n=258) 58%   (n=91) 0.94 (0.50-1.76) 65%   (n=59) 1.09 (0.53-2.22)
Moroccan (n=222) 60%   (n=81) 0.71 (0.41-1.23) 56%   (n=47) 0.93 (0.52-1.66)
Surinamese (n=325) 65% (n=113) 1.31 (0.69-2.49) 60%   (n=85) 0.88 (0.45-1.71)
a Reference category univariate analyses. b Reference category multivariate analyses, corrected for relevant 
variables (ethnic mix of GP practice and/or SES score). * ** 
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Strengths and weaknesses 
We developed materials matching the (cultural) preferences of underserved populations 
facilitating response and HRA participation possibilities. These adjustments were based on 
information derived from the literature and the results of focus groups (27). This approach, 
Table 5. HRA risk score and participation in PC
HRA risk score Participation in PCa
High Odds ratio (95% CI) Yes
Odds ratio 
(95% CI)
Total group (n=714) 29% (n=207) 59% (n=123)
Univariate analyses
Ethnicity Dutchc (n=232) 35%   (n=82)    1.00 46%  ( n=38) 1.00
Turkish (n=150) 37%   (n=56)    1.09         (0.71-1.67) 68%   (n=38) 2.44 (1.20-4.97)*
Moroccan (n=132) 30%   (n=40)    0.80         (0.50-1.26) 68%   (n=27) 2.41 (1.09-5.31)*
Surinamese (n=200) 15%   (n=29)    0.31         (0.19-0.50)** 69%   (n=20) 2.57 (1.05-6.32)*
Gender Malec (n=344) 38% (n=130)    1.00 63%   (n=82) 1.00
Female (n=370) 21%   (n=77)    0.43         (0.31-0.60)** 53%   (n=41) 0.67 (0.38-1.18)
Age 35-45 (n=95)   2%     (n=2)    0.14         (0.03-0.61)*   0%     (n=0) -
45-50c (n=277) 13%   (n=36)    1.00 67%   (n=24) 1.00
50-55 (n=174) 28%   (n=48)    2.55         (1.57-4.13)** 69%   (n=33) 0.91 (0.36-2.29)
55-60 (n=93) 55%   (n=51)    8.13       (4.75-13.92)** 53%   (n=27) 0.51 (0.23-1.16)
60-65 (n=47)   91%   (n=43)   71.97   (24.37-212.50)** 58%   (n=25) 0.63 (0.27-1.49)
65+ (n=28) 96%   (n=27) 180.75  (23.82-1371.33)** 52%   (n=14) 0.49 (0.19-1.29)
GP 
practiceb
Dutchc (n=198) 31%   (n=62)    1.00 53%  ( n=33) 1.00
Mix (n=103) 37%   (n=38)    1.28         (0.78-2.12) 50%   (n=19) 0.88 (0.39-1.97)
Non-Western 
(n=413)
26% (n=107)    0.77         (0.53-1.11) 66%   (n=71) 1.73 (0.91-3.29)
SES 
score
> 0c (n=227) 29%   (n=65)    1.00 55%   (n=36) 1.00
0 till -2 (n=173) 32%   (n=56)    1.19         (0.78-1.83) 55%   (n=31) 1.00 (0.49-2.05)
2 till -4 (n=112) 31%   (n=35)    1.13         (0.69-1.85) 60%   (n=21) 1.21 (0.52-2.78)
< -4 (n=202) 25%   (n=51)    0.84         (0.55-1.29) 69%   (n=35) 1.76 (0.82-3.80)
Ethnicity Dutchd (n=232) 35%   (n=82)    1.00 NA NA
Turkish (n=150) 37%   (n=56)    1.59         (0.93-2.70) NA NA
Moroccan (n=132) 30%   (n=40)    0.92         (0.52-1.63) NA NA
Surinamese (n=200) 15%   (n=29)    0.54         (0.28-1.01) NA NA
a b Predominant composition of 
c d -
* ** 
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combined with the funnelled invitation design, gave as many individuals as possible the 
opportunity to make an informed decision about participation, acknowledged previously to be 
important but difficult to measure (28, 29). With the fast rise of individuals having access to 
internet we considered using the current online HRA, but after careful deliberation with the 
populations under study decided it would be fruitless (30). The pragmatic stepwise invitation 
approach is most feasible to implement in practice and has the greatest potential of being cost-
effective. However, we cannot conclude which invitation step is most effective and, therefore, 
results are difficult to compare with others usually comparing strategies in parallel. Second, 
we did not receive a response of 30% of the patients. In the scope of reducing health 
inequalities, it is important to reach precisely those individuals about whom we have no 
health risk information at all, to find out whether our responders are the groups at highest risk. 
Third, the HRA was completed by participants themselves, possibly leading to reporting 
errors and mistakes in calculating one’s risk score. Fourth, the telephone calls were performed 
by research assistants, not the GP practice nurse. The average duration of these calls was nine 
minutes, however, this included the time necessary to ask some additional questions needed 
for the study. Approximately six minutes were used to invite a person to participate in the 
HRA and to complete the HRA. The feasibility of this invitation step in the GP practice needs 
to be studied further. Finally, the number of GP practices was small because we aimed to 
recruit practices consisting mainly of specific underserved populations. Therefore, it was 
impossible to perform multi-level analyses. Theoretically, many practice-level characteristics 
could influence response and participation, therefore, our conclusions on the effect of practice 
on outcome measures should be regarded as a first indication and need to be studied further. 
 
Comparison with other studies 
Our postal HRA participation rate was lower compared to the general population (31–33). 
This may, in part, be due to the low percentage of underserved populations in other studies 
and their use of an additional online HRA. Moreover, in these studies HRA results could not 
be calculated by patients themselves, returning the HRA might have worked as an incentive. 
In contrast, a pilot study of the Dutch cardiometabolic health check provided the risk score 
immediately and found similar participation rates as we did (34). 
The telephone invitation increased the number of people making a decision about 
participation. This is in line with a study among non-participants in cardiovascular screening 
in which 40% changed their initial decision after receiving additional information about risks 
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and screening (35). 
The literature suggests that, if used as a separate strategy, face-to-face strategies are more 
effective in reaching underserved populations. We found that if used as an additional step in a 
multi-step strategy, the added value of the face-to-face invitation was negligible. We also saw 
that the individuals left over for face-to-face recruitment were more often the ‘harder-to-
reach’ men and individuals with a low SES. Additionally, face-to-face strategies are labour-
intensive and expensive. Given their lack of feasibility in practice and the high response 
obtained using a postal and telephone invitation, this latter multi-step approach seems 
advisable (16, 17). 
Ethnic differences in response and HRA participation were no longer significant when 
adjusting for ethnic mix of GP practice, possibly because of differences in practice size 
or sociocultural aspects (e.g., stronger assimilation and social cohesion in some 
neighbourhoods). The predominantly non-Western practices had the lowest response and 
participation rates. These practices were larger and located in more deprived neighbourhoods 
where social cohesion is usually lower and both native Dutch and non-Western patients 
may be more illiterate (36). Unfortunately, we did not have individual SES scores. We did, 
however, have individual education information for a sample of participants. Using this data 
did not change our conclusions, justifying the use of a neighbourhood SES score. 
The PC participation rate among our high-risk patients was larger than in the pilot study 
among the general population, but smaller than in two other studies of the Dutch 
cardiometabolic health check (31, 32, 34). In the latter studies, high-risk participants were 
invited for the PC, whereas in both the pilot and our study, high-risk participants were 
personally responsible for scheduling an appointment. In follow-up interviews, high-risk 
participants who had not attended the PC frequently indicated that they had not been aware or 
had not understood they had to schedule their own appointment. Thus, it would be advisable 
for these groups to shift the responsibility of making an appointment to the GP. 
Our PC participation rate was larger than in the British NHS health check (7, 11). However, 
their patients were risk-stratified in advance, and only high-risk individuals were invited. We 
risk-stratified by means of the HRA. High-risk HRA participants were more likely to also 
participate in the PC. 
The lower age threshold for being invited explained the lower HRA risk score among 
Surinamese. This emphasizes that a lower threshold is only useful when an ethnicity-based 
risk score is used (37). 
14549-Groenenberg_BNW.indd   71 27-03-17   12:58
72 
Chapter 3 Response and participation
 
 
The native Dutch with a low SES refrained most often from PC participation. These groups 






Total response was as high as 70% among our underserved populations using a funnelled 
invitation design. Of the responders, 62% participated in the HRA. Postal response was 41%, 
of whom 66% participated. Telephone response was 46% among postal non-responders, of 
whom 59% participated in the HRA. A face-to-face invitation barely increased response and 
HRA participation rates. Of the high-risk individuals, 59% participated in the PC, irrespective 
of invitation step. 
 
Implications and future research 
Underserved populations can be reached by a low-cost culturally adapted postal approach 
with a reminder and follow-up telephone calls. The actual cost-effectiveness of this approach 
needs to be studied. Efforts should be particularly targeted at GP practices in the most 
deprived areas, focusing on why response and participation fall behind less deprived but still 
low socioeconomic areas. Future qualitative (ethnographic) studies could be useful. Though a 
face-to-face approach barely increased response and participation, in the Netherlands, only 
this ‘case-finding’ approach is currently reimbursed by basic health insurance (18). 
Considering the socioeconomic inequalities in health, the feasibility of implementing a 
culturally adapted two-step invitation strategy to increase participation in the HRA should be 
discussed and studied. Moreover, to increase the likelihood of cost-effectiveness of two-stage 
screening, as many high-risk individuals as possible need to comply with attending their GP 
for further testing. If feasible, the responsibility for scheduling an appointment should be 
shifted toward the GP practice or other healthcare organisations. 
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• Already having one or more of the following diseases (in ICPC codes):  
o K74 ANGINA PECTORIS 
o K75 ACUTE MYOCARDIAL INFARCTION 
o K76 OTHER CHRONIC ISCHEMIC HEART DISEASES 
o K77 CONGESTIVE HEART FAILURE 
o K78 ATRIAL FIBRILLATION / -FLUTTER 
o K79 PAROXYSMAL TACHYCARDIA 
o K82 COR PULMONARY 
o K83 VALVE DISEASE NOT RHEUMATIC/NOS 
o K84 OTHER HEART DISEASES 
o K86 HYPERTENSION WITHOUT ORGAN DAMAGE. 
o K87 HYPERTENSION WITH ORGAN DAMAGE. 
o K89 TRANSIENT CEREBRAL ISCHEMIA/TIA 
o K90 CEREBROVASCULAR ACCIDENT (CVA) [EX.TIA] 
o K91 ATHEROSCLEROSIS [EX.CORON.,CEREBR.] 
o K92 OTHER DISEASES PERIFERAL ARTERIES 
o T90 DIABETES 
o T93 LIPID DISORDER 
o U88 GLOMERULONEPHRITIS/NEFROSIS 
o U99 OTHER DISEASES URINARY TRACT 
 
• Use of one of the following drugs (in ATC-classifications):  
o A10 ANTIDIABETICS 
o B01/C01/C02/C03/C07/C08/C09 ANTIHYPERTENSIVES 
o C10 ANTILIPAEMICS 
 
• Complete risk profile with a maximum of one year old with a known measurement for all of the 
following factors:  
o Smoking status 
o Comments on characteristics of diet 
o Physical activity 
o Alcohol use 
o BMI 
o Waist circumference 
o Systolic blood pressure 
o Fasting glucose 
o LDL 
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ADDITIONAL FILE 2 
 
(Cultural) Adaptations to invitation, HRA, and information brochure 
 
Personalization  
In the invitation letter, we used the patient’s demographics, such as gender, last name, and GP name. Examples: 
“Dear Mr. Gül” / “Dear Ms. Gül”.  
“Kind regards, your GP, H.J. van Duijn, M.D.” 
 
Formulation 
Taking into account the lower (health) literacy levels and language barriers of our population, we used short 
sentences and started every sentence on a new line. Example:  
“Maybe you have doubts about testing your health.  
Then please read the brochure.” 
 
Gender and ethnicity targeting  
Targeting refers to designing messages for a subgroup of a population taking into account characteristics shared 
by the subgroup’s members, which we applied to gender and ethnicity.   
• Gender- and ethnic-specific pictures (see example HRAs and brochures). 
• Reference in text to specific ethnic descent. Example:  
“What factors increase your risk of cardiovascular disease, diabetes, and kidney failure?  
 Surinamese origin. 
You have an increased risk of diabetes.” 
• Additional Turkish and Arabic language for Turkish and Moroccan patients (see example HRAs and 
brochures). 
• An anecdote/story of a person with the same gender and ethnic background describing their decision-
making process and what participation had brought them. A common, ethnic-specific last name was 
chosen for this person. 
• Common barriers for these groups to screening attendance and information provision on these topics: 
fear for the test result; no perceived control over one’s health; no perceived effect of the test results; for 
Dutch and Surinamese patients experiencing no health complaints; and for Turkish and Moroccan 
patients already attending screening in home country. 
• A sentence on the person’s right to do this check, as was found to be of importance for these groups. 
 
Example native Dutch male HRA in Dutch 
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Example Turkish female HRA in Turkish 
 
 
Example Surinamese female brochure in Dutch 
 
Example Moroccan male brochure in Arabic 
 
 
Example Surinamese femal  brochure in Dutch Example Moroccan m le brochure in Arabic 
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Cardiometabolic diseases affect underserved groups disparately. Participation in health 
checks is also lower, widening health inequalities in society. Two-stage screening (non-
invasive health risk assessment (HRA) and GP consultations for high-risk individuals) seems 
cost-effective, provided that drop-out rates are low in both steps. We aimed to explore the 
process of decision-making regarding HRA participation among underserved groups (45–
70y): native Dutch with a lower socioeconomic status (SES), Turkish, Moroccan, and 
Surinamese participants. We conducted a cross-sectional questionnaire study. The 
questionnaire comprised the following determinants: a self-formulated first reaction, a 
structured set of predefined determinants, and the most important barrier(s) and facilitator(s) 
for HRA completion. We used univariable and (stepwise) multivariate logistic regression 
analyses to assess which determinants were associated with HRA completion. Of the 892 
participants in the questionnaire, 78% (n=696) also completed the HRA. Moroccans and 
patients from GP practices with a predominantly non-Western population less often 
completed the HRA. A lower SES score, wanting to know one's risk, not remembering 
receiving the invitation (thus requiring a phone call), fear of the test result and/or adjusting 
lifestyle, perceived control of staying healthy, wanting to participate, and perceiving no 
barriers were associated with completing the HRA. We conclude that our ‘hard-to-reach’ 
population may not be unwilling to participate in the HRA. A more comprehensive approach, 
involving key figures within a community informing people about and providing help 
completing the HRA, would possibly be more suitable. Efforts should be particularly targeted 
at the less acculturated immigrants with an external locus of control. 
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Cardiometabolic diseases (cardiovascular disease, diabetes, and kidney disease) are leading 
causes of death in high-income countries (1). An increased risk of cardiometabolic disease is 
associated with a lower socioeconomic status (SES) and ethnicity (2, 3). Among ethnic 
minorities in the Netherlands, cardiovascular disease is particularly prevalent among 
Surinamese and Turkish people (4 - 6). Turkish, Moroccan, and especially Hindustani 
Surinamese people have a higher risk of developing diabetes (7). To early identify individuals 
with an increased risk of cardiometabolic disease, health checks are implemented worldwide 
(8 - 10). Several studies concluded that two-stage screening could be a cost-effective strategy 
(11, 12). Two-stage screening usually refers to a non-invasive risk stratification tool, 
followed by a blood test during an assessment by a healthcare professional. The Dutch 
cardiometabolic health check imbedded in primary care follows this two-stage approach, 
comprising a short health risk assessment (HRA) to be completed at home, and two 
prevention consultations (PCs) with the GP for high-risk individuals according to the HRA 
(13). This approach implies that patients can refrain from participation on two separate 
occasions (14). High drop-out rates may induce an even greater problem among underserved 
groups, as ethnicity and SES are inversely related to health check attendance (15). These 
groups usually have greater difficulties in making an informed decision about participation 
(16). Presumably, higher participation rates in stage one (as a result of more informed 
decision-making) lead to higher participation rates in stage two. To increase informed 
decision-making about HRA completion, insight into its determinants plays a pivotal role. 
Few studies specifically investigated reasons for participation in cardiometabolic health 
checks of underserved groups. Studies reporting determinants in these populations 
exclusively focus on physical assessments at a doctor's office, not two-stage screening with 
risk stratification as a first step. Therefore, we conducted prior qualitative research on 
determinants of hypothetical HRA completion (17). These determinants were mainly of a 
cognitive nature and included (flawed) risk perceptions, health negligence, (health) illiteracy, 
and language barriers. With the current study we aim to explore the process of actual 
decision-making about HRA completion. Research questions were: (1) what are participants' 
self-formulated first reactions regarding the invitation?; (2) what predefined determinants 
play a role in completing the HRA?; (3) what are participants' most important barriers and 
14549-Groenenberg_BNW.indd   85 27-03-17   12:58
86 
Chapter 4 Determinants of participation in the HRA
 
 






Design and study population 
This cross-sectional study is part of a larger study investigating reach and participation of 
underserved populations in the Dutch cardiometabolic health check. 
Between May 2012 and December 2013, patients from six general practices were invited to 
participate. The six practices were located in The Hague and surroundings, and encompassed 
both large group as well as solo practices, and urban as well as rural environments. Patients 
had to be native Dutch with a lower SES or Turkish, Moroccan, or Surinamese. Ethnicity is 
not registered by GPs in the Netherlands, this was estimated by the researchers based on 
family name, and was subsequently checked by the GP. The GP also selected the native 
Dutch patients with a lower SES, which was afterwards corroborated with a neighbourhood 
SES score (average income, proportion of individuals with a low income, with a low 
education, and without a paid job) (18). These attributes are captured in one parameter: the 
socioeconomic status (SES) score and has been shown to be associated with deprivation in a 
community (19). This score is assessed every four years by interviewing persons representing 
nearly each street in the Netherlands. The average SES score in the Netherlands is 0.17. 
Categorization of the SES scores was as follows: average to higher SES (score N 0); lower to 
average SES (score 0 till −1.9); lower SES (score −2 till −3.9); lowest SES (score −4). 
Patients had to be 45–70 years old except for the Hindustani Surinamese. Their lower age 
limit was 35 years because of their genetically increased risk of diabetes. Exclusion criteria 
were: having (had) cardiometabolic disease, using drugs against cardiometabolic disease, 
or having had a complete cardiometabolic risk inventory less than a year ago (Appendix A). 
All patients who met the eligibility criteria (n= 1644) were invited. 
Three culturally targeted and personalized invitation steps were tested following an 
increasingly (cost-)intensive ‘funnelled’ design: (1) all patients received a postal invitation; 
(2) non-reached were approached by telephone; (3) finally non-reached were approached 
face-to-face by their GP (Appendix B). The latter step was not included as participation rates 
were very low. Postal materials were provided in Dutch, and in Turkish/Arabic for 
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Turkish/Moroccan patients, and included the questionnaire and the HRA simultaneously in 
one package. Patients were called by Turkish, Arabic, and Berber (oral-only language) 
speaking research assistants. 
Ethical approval was given by the Committee Medical Ethics from the Leiden University 
Medical Center. The study followed an ‘opt-out procedure’ where patients could sign a 
response form when not interested in participation. The design and results of the larger study 
have been described in detail elsewhere (20). 
The study population of this study consisted of those patients who completed the 
determinants questionnaire (n = 892), divided into two groups: HRA completers and non-
completers. Postal responders filled out a self-administered written questionnaire and 
telephone responders answered the questionnaire by phone. 
 
The questionnaire 
The postal- and telephone-administered questionnaires followed the same structure and were 
based on our previous work (17). This qualitative study was embedded in a theoretical 
framework based on the I-change model (Fig. 1), which aims to explain health behaviours 
and has been applied in studies among native and immigrant populations (21 - 24). The most 
important determinants in the qualitative study were turned into (simply formulated) 
questions. The questionnaire was pilot-tested among the target population. We incorporated 
three steps in the questionnaire: (1) a self-formulated first reaction regarding the invitation for 
the health check, (2) a structured set of predefined determinants that the participant could 
indicate to be of importance to his/her HRA completion, (3) most important barrier(s) and 
most important facilitator(s) regarding HRA completion (Appendix C). 
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Figure 1. The I-change model, from http://www.maastricht-university.eu/hein.devries/interests/change 
 
Step one: self-formulated first reaction 
The questionnaire started with one (open answer) question prompting participants to express 
their thoughts about the invitation. Any reaction was possible: from positive to negative 
attitudes regarding the initiative, and from practical barriers to positive social influences. 
This and the open answer questions of step three were coded inductively and converted into a 
code tree. Coding was performed by the first author and randomly double coded by the 
second author. Both authors categorized the codes in the code tree conform the I-change 
model constructs (Appendix D). Codes and constructs were entered into SPSS. The first 
reactions were then computed into dichotomized variables representing the different reactions 
(0 = not mentioned, 1 = mentioned). 
 
Step two: structured set of predefined determinants 
The questionnaire continued with a structured set of predefined (multiple-choice) determinant 
questions. These determinants were categorized under the appropriate I-change construct (see 
Results, Table 3). Most questions consisted of three answer categories (mostly ‘no’, ‘a little’, 
‘yes’), which were dichotomized for a better distribution. 
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Step three: most important barriers and facilitators 
The final two (open answer) questions aimed to unravel what participants perceived to be the 
most important barrier(s) and facilitator(s) for HRA completion. The telephone questions 
were rephrased to match the willingness to complete the HRA: e.g. when the participant 
indicated to be willing to complete the HRA, the barrier(s) question was rephrased as ‘what 
could be a disadvantage for you of completing the HRA?’. Coding of these questions was 
performed as described under step one. 
 
Measures 
Primary outcome measure was HRA completion (no/yes). Patient characteristics were: 
gender, ethnicity, age, and SES score. We also looked at the predominant patient population 
of a GP practice: native Dutch with a lower SES, mixed, or non-Western immigrants. 
 
Data analyses 
Descriptive analyses were used to describe the patient population. Differences regarding 
sociodemographic characteristics between the patients in the postal versus the telephone step 
were assessed by means of t-tests and ANOVA. 
(Univariable) Logistic regression analyses were performed to explore the associations with 
HRA completion. First, we assessed the influence of the first reactions variable as a 
categorical variable (reference group: not having provided a reaction); second, the influence 
of the structured set of predefined determinants; third, the most important barriers and 
facilitators. The facilitators and barriers were included jointly in the regression model as 
patients could report more than one barrier or facilitator. Significant associations with HRA-
completion (p < 0.05) from these initial analyses were included in a final stepwise 
multivariate logistic regression model. By adding the various constructs in a stepwise 
manner, we investigated which associations remained significant when adjusting for each 
other. The first step included the relevant sociodemographic variables (model 1). Each 
consecutive step added the significant determinants from respectively self-formulated first 
reactions (model 2), predefined determinants (model 3), and most important barrier(s) and 
facilitator(s) (model 4). 
Because the number of telephone participants who did not complete the HRA was very low, 
stratified analyses for the telephone step could not be performed. Only strategy-dependent or 
very notable differences between postal and telephone participants are highlighted in the text. 
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Of the 1644 eligible patients, 1125 responded to the invitation (response rate: 68%) by either 
completing the HRA or answering that they did not want to participate. Of those who 
responded to the invitation, 892 participated in the questionnaire (participation rate: 79%). 
Among the postal responders (n = 681), this percentage was 92% (n = 624); among the 
telephone responders (n = 444), it was 60% (n = 268) (Fig. 2). Not surprisingly, the 
questionnaire participants differed from the non-participants regarding all demographic 
factors except for age (data not shown). The non-participants were more often male (p < 
0.001), Moroccan or Surinamese (p < 0.001), from a GP practice with a predominantly non-
Western patient population, and with a lower SES score (p = 0.039). 
Telephone participants were more often from a GP practice with a predominantly non-
Western patient population and had a lower SES score than postal participants (Table 1). 
Gender, ethnicity, and age were similarly distributed between postal and telephone 
participants. 
Of the questionnaire participants, 78% completed the HRA. Among the postal questionnaire 
participants, the completion rate was 71%, among the telephone questionnaire participants, it 
was 94%. A minority of the patients (7%) who did not fill out the questionnaire did complete 
the HRA. 
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The decision making process 
Step one: self-formulated first reaction to the invitation 
Table 2 presents the association of the self-formulated first reactions with HRA completion. 
In this table, we describe the frequencies of the different first reactions. The first reaction 
variables were entered into a univariable regression analysis (reference group: not having 
provided a reaction) to explore which reactions were most important for HRA completion. 
In total, 13% of the participants did not provide a first reaction, most often when they did not 
complete the HRA. When a first reaction was provided, usually it was a positive or rational 
attitude (‘good’ or ‘useful’). A positive attitude towards the invitation was associated with 
HRA completion, as well as expressing the intention to complete the HRA.  
Paradoxically, those who mentioned negative information factors not remembering having 
received an invitation) and barriers to participating (having no time) were more likely to 
complete the HRA. This was mainly due to the telephone participants who did not remember 
the postal invitation or said to have had no time to participate, but were apparently able or 
willing to answer it when approached by phone (separate analyses on postal participants only, 
ORs not significant anymore: negative information factors p = 0.627, barriers p = 
0.477, data not shown). 
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Step two: structured set of predefined determinants 
Table 3 presents the influence of the predefined determinants on HRA completion, analysed 
by means of univariable logistic regression. Missing values varied from n = 4 (locus of 
control question) to n = 34 (social influences question), but were usually limited. The HRA 
completers were more likely than the non-completers of wanting to know their risk, of 
thinking that staying healthy can be controlled, and of having others finding it important for 
them to participate. Postal participants having one or more health complaints less often 
completed the HRA (separate analyses on postal participants only: OR 0.68, 95% CI 0.48–
0.97, data not shown), while for the group as a whole (postal and telephone participants) we 
found no association. 
 
Step three: most important barrier(s) and facilitator(s) 
Table 4 presents the most important barrier(s) and facilitator(s) and their relation with HRA 
completion. A regression analysis was conducted including both the barriers and facilitators 
to assess which of them were significantly related to HRA-completion. Almost half of the 
participants did not answer the most important barrier(s) question and were less likely to 
complete the HRA. Those who did answer most often reported having no barriers (37%) or 
having a negative or emotional attitude (29%). Positive awareness factors (‘obtaining insight 
into risks’) were most often mentioned as important facilitator(s) (77%). 
Participants who indicated fear (mainly for the test result) to be their most important barrier 
or who perceived no barriers (hence, ability factor) more often completed the HRA. 
Participants who expressed obtaining insight into risks and finding it important as their most 
important facilitator more often completed the HRA. 
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Stepwise model of determinants for HRA completion 
Significant associations with HRA-completion (p < 0.05) from the initial analyses were 
included in a final stepwise multivariate logistic regression model. Step one of the stepwise 
model showed that the probability of HRA completion was highest among participants with a 
lower SES (score−2 till−3.9), and lowest among Moroccan participants and patients from 
non-Western GP practices (Table 5). Each consecutive model added the significant 
determinants from respectively self-formulated first reactions (model 2), predefined 
determinants (model 3), and most important barrier(s) and facilitator(s) (model 4). In model 
2, the self-formulated first reactions significant in the initial analyses remained significantly 
associated with HRA completion when adjusted for characteristics of model 1, except for the 
positive/rational attitude. In model 3, the significant association between HRA completion 
and wanting to know one's risk and perceived control over staying healthy remained 
significant. Positive social influences were no longer significantly associated with HRA 
completion. In the final model the negative information factors and the contemplation state 
remained the only significant first reactions associated with HRA completion. The significant 
associations from model 3 were supplemented with fear regarding the test result and 
reporting no barriers, which both remained positively associated with HRA completion. The 
Nagelkerke R square indicates that 24% of the variance was explained by the final model. 
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Table 5. Stepwise multivariate logistic regression analyses presenting associations with HRA completion for 
postal and telephone participants, OR (95% CI)







E hnicity  Dutch a 1.00 1.00 1.00 1.00
                Turkish 0.58 (0.30-1.10) 0.51   (0.26-1.01) 0.47   (0.23-0.95)* 0.61   (0.29-1.27)
                 Moroccan 0.44 (0.250.78)** 0.40   (0.22-0.73)** 0.35   (0.19-0.66)** 0.38   (0.20-0.74)**
                 Surinamese 0.89 (0.46-1.73) 0.80   (0.40-1.58) 0.68   (0.34-1.38) 0.82   (0.39-1.72)
GP practice Dutch a 1.00 1.00 1.00 1.00
                   Mix 0.70 (0.37-1.33) 0.70   (0.36-1.35) 0.69   (0.35-1.34) 0.67   (0.33-1.34)
                    Non-Western 0.45 (0.23-0.88)* 0.44   (0.22-0.88)* 0.43   (0.21-0.87)* 0.33   (0.16-0.69)**
SES score Average to higher (> 0) a 1.00 1.00 1.00 1.00
                 Lower to average (0 till -2) 1.54 (0.92-2.57) 1.41   (0.83-2.39) 1.52   (0.88-2.60) 1.69   (0.96-2.96)
                 Lower (-2 till -3.9) 1.82 (1.01-3.29)* 1.87   (1.02-3.43)* 1.87   (1.01-3.46)* 2.13   (1.12-4.07)*
1.14 (0.69-1.88) 1.11   (0.66-1.88) 1.12   (0.66-1.91) 1.20   (0.69-2.09)
b:
  Not answered 1.00 1.00 1.00
  Information factors; positive 2.24   (1.23-4.06)** 2.13   (1.17-3.88)* 1.76   (0.94-3.31)
  Information factors; negative 6.75 (1.53-29.79)* 6.98 (1.56-31.20)* 6.57 (1.29-33.43)*
  Motivation factors; positive/rational   
  attitude 1.45   (0.98-2.15) 1.38   (0.92-2.05) 1.22   (0.80-1.88)
  Intention state; contemplation 2.34   (1.27-4.30)** 2.24   (1.22-4.12)* 2.19   (1.16-4.13)*
  Barriers 9.19 (1.20-70.22)* 7.95 (1.04-61.04)* 4.56 (0.57-36.70)
  Awareness factors; knowing risk 2.36   (1.28-4.34)** 1.99   (1.02-3.88)*
  Motivation factors; locus of control 1.61   (1.13-2.30)** 1.63   (1.12-2.36)*
1.25   (0.86-1.82) 1.20   (0.81-1.77)
Most important barrier(s)b:
  Not answered 1.00
  Motivation factors; negative/ 
  emotional attitude 3.25   (1.69-6.25)
***
  Ability factors 3.85   (2.14-6.95)***
Most important facilitator(s)b:
  Not answered 1.00
  Awareness factors; positive 1.12   (0.72-1.74)
  Motivation factors; positive/rational   
  attitude 1.38   (0.81-2.35)
Nagelkerke R square 0.07   0.15 0.17 0.24
a b 
* ** *** 
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More than three quarters of the questionnaire participants also completed the HRA, mostly 
patients in the lower SES group. Those who did not were more often of Moroccan origin or 
from a non-Western GP practice. The self-formulated first reactions were generally positive 
and many participants expressed the wish to participate. Barriers formulated as first reaction 
were mostly not remembering receiving the postal invitation or not having (had) time, thus 
requiring a phone call. Although positive at first, when HRA non-completers further 
considered participation they more often did not want to know their risk and were less certain 
of their ability to control staying healthy. Most of the completers reported having no barriers 
at all. Some of them ventilated fear for the test result, but this did not prevent them from 
completing the HRA. 
 
Strengths and weaknesses 
To our knowledge, this is the first study exploring the decision making process of 
underserved populations regarding their completion in the first stage (HRA) of a 
cardiometabolic health check. The main strength of the study is the exertion to study both 
HRA completers and non-completers in the context of actual decision-making, reducing 
potential hypothetical bias. Given the lower levels of (health) literacy levels among these 
underserved groups, questionnaire missings were limited. This study was embedded in an 
encompassing theoretical framework. We chose this model as health check attendance can be 
seen as a health behavior and in that sense be studied with this comprehensive model. In 
addition to our positive experiences in explaining determinants of hypothetical HRA 
completion (17) we conclude that the I-change model is also valuable in explaining 
determinants of actual HRA completion. 
Some limitations should be noted. First, given the lower (health) literacy levels of our 
populations, it is debatable whether the participants were able to formulate their answers in a 
way that really reflected their opinions. Those with the lowest literacy levels may have more 
often skipped questions that were difficult for them to fill out (i.e. the open answer 
questions). The open answer questions were also more often skipped by the HRA non-
completers. Related to this is the fact that we tried to make the postal and telephone 
questionnaire as similar as possible. It cannot be denied, however, that during the telephone 
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questionnaire our populations may have more easily elaborated on their answers when 
compared to the self-administered questionnaire. Also, our rephrasing of the 
barriers/facilitators question may have resulted in slight differences in information obtained, 
but not rephrasing would have led to unnatural conversations as the research assistant would 
not react to the willingness already expressed by the participant. Second, all GP practices 
were located in The Hague and surroundings. It is, therefore, debatable whether the findings 
from these practices are generalizable to other practices in the Netherlands, let alone other 
countries. Nevertheless, we do not expect major differences with other practices with similar 
lower SES/ethnic groups. We expect the major differences to occur between ethnic groups, 
and between socioeconomic strata. Increasing the chance of generalizability was the fact that 
we included both large group as well as solo practices, and urban as well as rural 
environments. Third, potential residual confounding may have been present due to possible 
errors in the estimation of ethnicity based on last name and because the SES score was a 
neighbourhood score and not an individual score. Fourth, in the larger study we have not 
reached 30% of the patients, of whom we have no information on determinants of their HRA 
non-completion whatsoever. Aiming to reduce health inequalities, obtaining insight into the 
determinants of particularly these non-participants is important. Fifth, we used a cross-
sectional study design. This means that we cannot conclude that the correlates we found 
caused the HRA completion. We can conclude that some differences exist between HRA 
completers and non-completers. Finally, it is possible that our simultaneously sending a 
questionnaire for research purposes led to distrust among some individuals, as we have 
shown before to be a potential problem for these vulnerable groups (17). With this 
simultaneous sending and our structured design of the questionnaire we might also have 
enabled participants to reflect on participation and to make an informed decision about HRA 
completion. However, we have no control group, nor a measure for informed decision 
making, allowing us to draw a conclusion about whether we have succeeded. 
 
Comparison with other studies 
We aimed to explore the process of decision making regarding HRA completion among 
underserved populations. Most first reactions provided were positive, possibly because 
patients felt obliged to react positively or to provide some excuse for not having completed 
the HRA. Which raises the question on the value of these reactions for explaining HRA 
participation. In the final model, most of the associations of these positive first reactions with 
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participation disappeared. The only negative first reaction (not remembering/receiving the 
invitation) remained significantly associated with HRA participation. This implies that this 
determinant may not have been used as an excuse, and follow-up by telephone may actually 
be crucial. 
Despite the generally positive self-formulated first reactions, still about a quarter did not 
complete the HRA. A qualitative investigation among non-responders to the NHS health 
check concluded that participants viewed the health check positively, but lacked personal 
relevance (25). They concluded that, perhaps, people considered themselves in good health or 
had regular contact with primary care for their health complaints. To promote personal 
relevance and more informed decision making, it has been proposed to provide more 
personalized risk communication and using telephone/verbal methods (25, 26). In the current 
study, patients with health complaints less often participated in the postal HRA, but not so in 
the telephone HRA. This indicates that personalized risk communication by telephone may 
increase personal relevance. It has been found that up to 40% of non-participants in 
cardiovascular screening would reconsider their participation decision when given additional 
information (27). 
The argument of not wanting to know one's risk is in line with findings of other studies (28, 
29). The current study adds that participation in a health check is influenced by a perceived 
lack of control over staying healthy. This external locus of control may also imply that the 
HRA non-completers were the less acculturated minorities, as they more often feel that the 
doctor, God, or a higher power could help prevent cardiometabolic disease, rather than they 
themselves (30). Indeed, HRA completion was lowest in non-Western GP practices, situated 
in neighbourhoods with stronger non-Western communities, with generally lower 
acculturation rates. Additionally, Turkish and Moroccan immigrants had the lowest HRA 
completion rates and have been found to be less acculturated than Surinamese immigrants, 
and less often participate in Dutch society (31). Efforts should, therefore, be particularly 
targeted at the less acculturated immigrants, emphasizing the modifiability of 
cardiometabolic disease through lifestyle changes and boosting the confidence in their own 
abilities. 
Interestingly, the most important barrier expressed by the completers was fear of the test 
result. However, as the results of the predefined set of determinants showed, many were not 
actually scared of the test result. This barrier may, thus, have been a potential barrier 
imagined to be applicable to others in the same situation. On the other hand, these 
participants may have participated despite of their anxiety so that in case of a high-risk test 
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result, they would at least know that they would experience the benefits of early diagnosis 
(32, 33). Indeed, a large majority of these HRA completers expressed their most important 
facilitator to be obtaining insight into risks. 
 
Implications and future research 
To explore the influence of perceived personal relevance on informed decision making, 
future studies should focus on personalized/verbalized cardiometabolic risk communication, 
emphasizing the modifiability of cardiometabolic risk factors and boosting the confidence of 
these underserved groups. Most of our underserved participants, often depicted as ‘hard-to-
reach’, had a positive attitude towards the cardiometabolic health check. This, combined with 
the strongest correlates being not remembering having received an invitation and having had 
no time (thus requiring a phone call), gives rise to the idea that these groups may not be hard-
to-reach in the sense that they are unwilling to complete the HRA. The results of this 
pragmatic intervention provide interesting leads for follow-up by means of a controlled study. 
Special efforts should then be made at those ‘hardest-to-reach’. Amore comprehensive 
approach, including the involvement of key figures within a community informing people 
about and providing help with the HRA (reducing the amount of time needed) would possibly 
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Having (had) one or more of the following diseases (in ICPC codes): 
o K74 ANGINA PECTORIS 
o K75 ACUTE MYOCARDIAL INFARCTION 
o K76 OTHER CHRONIC ISCHEMIC HEART DISEASES 
o K77 CONGESTIVE HEART FAILURE 
o K78 ATRIAL FIBRILLATION/-FLUTTER 
o K79 PAROXYSMAL TACHYCARDIA 
o K82 COR PULMONARY 
o K83 VALVE DISEASE NOT RHEUMATIC/NOS 
o K84 OTHER HEART DISEASES 
o K86 HYPERTENSION WITHOUT ORGAN DAMAGE. 
o K87 HYPERTENSION WITH ORGAN DAMAGE. 
o K89 TRANSIENT CEREBRAL ISCHEMIA/TIA 
o K90 CEREBROVASCULAR ACCIDENT (CVA) [EX.TIA] 
o K91 ATHEROSCLEROSIS [EX.CORON.,CEREBR.] 
o K92 OTHER DISEASES PERIFERAL ARTERIES 
o T90 DIABETES 
o T93 LIPID DISORDER 
o U88 GLOMERULONEPHRITIS/NEFROSIS 
o U99 OTHER DISEASES URINARY TRACT 
 
Use of one of the following drugs (in ATC-classifications): 
o A10 ANTIDIABETICS 
o B01/C01/C02/C03/C07/C08/C09 ANTIHYPERTENSIVES 
o C10 ANTILIPAEMICS 
 
Complete risk profile with a maximum of one year old with a known measurement for all of the following 
factors: 
o Smoking status 
o Comments on characteristics of diet 
o Physical activity 
o Alcohol use 
o BMI 
o Waist circumference 
o Systolic blood pressure 
o Fasting glucose 
o LDL
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Figure B1. Results of response and participation in three culturally targeted and personalized invitation steps 
following an increasingly (cost-)intensive ‘funnelled’ design 
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Information factors; positive 
Healthcare professional 
o Initiative GP/researcher/other 
o Attention from GP/researcher/other 
o Knowledge development GP/researcher/other 
o Trust in guidance 
o Relationship with GP 
Information factors 
o Had understood it 
o Taking the target population into account 
o (Remembered) Having received it 
 
Information factors; negative 
Healthcare professional 
o No treatment options 
o Privacy issues 
Obligation 
o Feeling of obligation 
o No Feeling of obligation 
Information factors 
o Had not understood it 
o Language barrier 
o (Health) Illiteracy 
o Not (remembering) having received it 
o Doubts about content aspects 
o Judgment about materials 
 
Awareness factors; positive 
Importance prevention 
Health status 
o Obtain insight into risks 
o Obtain certainty about health 
o (Being) Health(y) 
o Healthy aging 
o Believes to be low-risk and wants to know risk 
o Believes to be high-risk and wants to know risk 
o Decrease risks 
o Risk perception with regard to family history 
o Risk perception with regard to lifestyle 
o Never too old 
o Previous experience with a health check 
o No previous experience with a health check 
 
Awareness factors; negative 
Health status 
o Too old 
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o Already health complaints/already ill/receiving treatment 
o No health complaints 
o Convinced of own health 
Social environment 
o More useful for others 
 





















o Not afraid to have to adjust lifestyle habits 
Locus of control 
o Believes to control staying healthy 
Fear 
o No fear 
o No fear for the test result 
 
Motivation factors; negative/emotional attitude 
Negative 
o Not good 
o Not important 
o Unreliable 
o Not interested 
o Don't feel like it 





o Afraid to have to adjust lifestyle habits 
o Worries about health 
o Ignoring/denial 
Healthcare professional 
o Guinea pig 
Locus of control 
o Believes not to control staying healthy 
o Religious beliefs 
Fear 
o Fear for the test result 
o Fear for the consequences of the test result 
o Fear for doctors/hospitals 
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Motivation factors; positive social influences 
Social environment 
o Action linkage: help from others 
o Important for offspring 
o Others find it important 
 
Motivation factors; negative social influences 
Social environment 
o Social pressure 
o Gossip 
 
Intention state; precontemplation 
(Non-)Participation 
o Not wanting to participate 
o Doubts about participation 
 
Intention state; contemplation 
(Non-)Participation 










o No time 
o Other priorities 
o Job 
o Forgot it 
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Cardiometabolic disease affects underserved groups disparately. Participation in health checks 
is also lower, widening health inequalities in society. Two-stage screening (non-invasive 
health risk assessment (HRA) and practice consultations (PC) for high-risk individuals) seems 
cost-effective, but PC attendance is a vulnerable component. To investigate which 
determinants play a role in PC attendance, we compared attenders with non-attenders in 
underserved groups (45-70y): native Dutch with a lower socioeconomic status, Turkish, 
Moroccans, and Surinamese. 
This study was conducted in six general practices in deprived neighborhoods in the 
Netherlands. Data were obtained during the HRA and during an interview following the PC. 
After a quantitative comparison between PC attenders and non-attenders, qualitative interview 
data were coded inductively, counted, and compared in a quantitative way. 
Of those with a high-risk HRA score, 71% (n=148) attended the PC, least often native Dutch. 
We interviewed 91 high-risk participants, of whom 73% (n=66) attended the PC. We found 
no significant differences between PC attenders and non-attenders in HRA risk parameters or 
HRA total score. When asked during the HRA, later PC attenders significantly more often 
trusted getting the guidance they need when at increased risk, and more often experienced 
health complaints. During the interview following the PC, PC attenders more often 
experienced health complaints (mainly native Dutch), more often had others finding it 
important for them to participate (mainly native Dutch), and more often felt obliged to attend 
(mainly Turkish). The qualitative data added that many participants found it unclear whose 
responsibility it was to make an appointment for the PC. 
Risk communication should cover risk perceptions regarding (lack of) health complaints and 
should target the close social environment. If feasible, the responsibility of making an 
appointment should be shifted towards the healthcare provider. The role of personal feelings 
of obligation should be studied. 
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Cardiometabolic disease (CMD), such as cardiovascular disease (CVD), diabetes mellitus 
(DM), and kidney disease, is a leading cause of death in high-income countries (1). An 
increased risk of CMD is associated with a lower socioeconomic status (SES) and ethnicity 
(2, 3). Among ethnic minorities in the Netherlands, CVD is particularly prevalent among 
Surinamese and Turkish people (4-6). Turkish, Moroccan, and especially Hindustani 
Surinamese people have a higher risk of developing DM (7). To early identify individuals 
with an increased risk of CMD, health checks are implemented in various countries (8-10). 
Several studies concluded that two-stage screening could be a cost-effective strategy (11, 12). 
Two-stage screening usually refers to a non-invasive risk stratification tool, followed by blood 
tests during an assessment by a healthcare professional. The Dutch cardiometabolic health 
check imbedded in primary care follows this two-stage approach, comprising a short health 
risk assessment (HRA) to be completed at home, and two prevention consultations (PC) with 
the GP for individuals at high-risk according to the HRA (13). Although this approach is 
efficient, as only individuals who may be at risk according to the first stage are invited for the 
second stage, it may have drawbacks concerning the possible drop-out risk. This approach 
implies that patients can refrain from participation on two separate occasions (14). High drop-
out rates may be an even greater problem among underserved groups, as ethnicity and SES 
are inversely related to health check attendance (15). Few studies specifically investigated 
reasons for (non-)participation in cardiometabolic health checks of underserved groups. 
Studies reporting determinants in these populations until now exclusively focused on physical 
assessments at a doctor’s office, not on two-stage screening with risk stratification as a first 
step. Therefore, we conducted prior qualitative research on determinants of hypothetical PC 
participation after a high-risk score on the HRA (16). It has been reported that being at risk 
symbolically alters health identity and may produce vulnerability, uncertainty, and anxiety 
(17). In line with this, we found that most determinants of (hypothetical) PC participation 
were of an affective nature, and included risk denial, fear of the outcome and its potential 
consequences (lifestyle changes and medication prescription), and disease-related stigma. To 
investigate which determinants played a role in actual (non-hypothetical) PC attendance 
among those who completed the first stage (the HRA) and had a high-risk HRA score, we 
compared the attenders with the non-attenders of the second stage (PC) regarding: (1) patient 
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and practice characteristics; (2) individual HRA risk parameters and HRA total score; (3) 





Design and study population  
This mixed-method study was part of a larger study investigating response and participation 
of underserved populations in the Dutch cardiometabolic health check (18).  
Between May 2012 and December 2013, patients from six general practices in deprived 
neighbourhoods were invited to participate. Patients had to be either native Dutch with a 
lower SES or of Turkish, Moroccan, or Surinamese origin. Ethnicity is not registered by GPs 
in the Netherlands, therefore, this was judged by the researchers based on family name, and 
checked by the GP. The GP also selected the native Dutch patients with a lower SES, which 
was afterwards corroborated with a neighbourhood SES score (average income, proportion of 
individuals with a low income, with a low education, and without a paid job) (19). Here, a low 
status score means a low neighborhood SES. Patients had to be 45-70 years old except for the 
Hindustani Surinamese, whose lower limit was 35 years because of their genetically increased 
risk of DMII. Exclusion criteria were: having (had) CMD, using CMD medication, or having 
had a complete cardiometabolic risk inventory less than a year ago. In total, 1644 patients 
were invited to participate in the health check. Patients could then decide to complete the 
HRA and the accompanying questionnaire on determinants of their HRA participation (see 
paper on determinants of HRA completion (20)). Patients calculated their own HRA risk 
score; and those with a high-risk score (n=208) were advised to attend the PC. During the PC, 
measurements on height, weight, blood pressure, fasting glucose, and cholesterol were done, 
leading to a 10-years risk estimation for cardiometabolic disease (13). All of those 208 high-
risk patients were approached by telephone for an interview on determinants of their PC 
attendance. Patients were called by (Turkish, Arabic, and Berber speaking) research 
assistants, and received up to four call attempts. All who answered were asked to participate 
in the interview: either at the time of the call or at a more convenient time of their preference. 
We used two scripts for the interview: one for PC attenders and one for non-attenders. The 
status of attender versus non-attender was determined beforehand based on the GP’s medical 
record. A participant was considered an attender when at least two cardiometabolic 
14549-Groenenberg_BNW.indd   120 27-03-17   12:59




parameters (such as smoking status, or cholesterol levels) were measured by the GP less than 
a year ago. For this, it did not matter whether this was done as part of an unrelated 
consultation or not. Both scripts started with an introduction as to the goal of the interview 
and the duration. Patients were asked for their verbal informed consent and received a €10,- 
gift certificate for their participation. 
Ethical approval was given by the Committee Medical Ethics from the Leiden University 
Medical Center (registration number P11.151). The study followed an ‘opt-out procedure’ 
where patients could sign a response form when not interested in participation. The design 
and results of the larger study have been described in detail elsewhere (18). 
 
Correlates of PC attendance 
We compared PC attenders and non-attenders as described in the three research questions and 
made comparisons for the whole high-risk population and for the sample of participants who 
took part in the interview.  
 
Patient and practice characteristics 
Patient characteristics used to describe and compare the populations were: gender; ethnicity 
(native Dutch / Turkish / Moroccan / Surinamese); age (30-44 / 45-49 / 50-54 / 55-59 / 60-64 / 
65+); and SES score (>0 / 0 to -2 / -2 to -4 / <-4). We also looked at the predominant patient 
population of a GP practice (native Dutch with a lower SES, non-Western, or ethnically 
mixed).   
 
Individual HRA risk parameters and HRA total score 
To assess whether specific components of the HRA were more strongly associated with PC 
attendance, we compared the individual HRA risk parameters between PC attenders and non-
attenders. The HRA risk parameters were: age (categories as above); smoking status (no / 
yes); BMI (underweight / healthy weight / overweight / obese); waist circumference (healthy / 
unhealthy); family history of CVD (no / yes); family history of DM (no / yes). We also 
compared the HRA total score between attenders and non-attenders (for the calculation of this 
score, see appendix). A high-risk score was a HRA total score of 30 or more for men and 35 
or more for women. The maximum score for both men and women was 66.  
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Patient-reported determinants of attendance 
To find out what determinants played a role in PC attendance, we quantitatively assessed this 
in a structured way at two separate moments (simultaneously with the HRA and at the time of 
the interview following the PC) and we qualitatively assessed this during the interview 
following the PC. 
The quantitative assessment consisted of a structured set of predefined determinants 
(described in table 3). Two additional PC-specific questions were asked at the time of the 
interview following the PC: one about fear of medications/treatment/doctors/hospitals and one 
about feeling obliged to attend the PC after receiving a high-risk HRA score. The questions 
were multiple-choice questions, mostly consisting of three answer categories (‘no’, ‘a little’, 
‘yes’), which were dichotomized for a better distribution. Participants could provide a 
clarification with every multiple-choice answer. 
The qualitative assessment consisted of a recall of the reactions people felt upon receiving the 
high-risk HRA result, and the most important barriers and facilitators regarding their PC 
attendance. Regarding the barriers, PC attenders were asked to recall their doubts about 
attending the PC, whereas the PC non-attenders were asked about the most important reason 
why they had not attended the PC. Regarding the facilitators, PC attenders were asked about 
the most important reason why they had attended the PC and for suggestions to make it more 
attractive to attend the PC. PC non-attenders were asked for solutions to the most important 
barriers to PC participation they had provided previously.  
 
Data analyses 
Differences regarding patient and practice characteristics and HRA parameters between PC 
attenders and non-attenders were assessed by means of chi-square and ANOVA analyses. For 
the HRA total score, we reported medians and interquartile ranges and Mann-Whitney U tests 
to detect differences between PC attenders and non-attenders. We used chi-square analyses to 
compare the PC attenders with the non-attenders regarding the dichotomized predefined 
determinants, assessed at the time of the HRA and following the PC. With multivariate 
logistic regression analyses we assessed the influence of relevant patient and GP practice 
characteristics on the association between determinants and PC attendance. As PC attenders 
and non-attenders differed in ethnicity and GP practice (table 1) we corrected for these 
characteristics in a multivariate model. We did this separately for ethnicity and GP practice as 
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they were significantly correlated (r=-0.543, p<0.001). We considered associations to be 
significant when p<0.05.  
The qualitative data of the interview were drawn up in notes. These notes were coded 
inductively by IG and discussed with MC. Codes were grouped for the PC attenders and non-





Participant and practice characteristics 
Of the 208 participants with a high-risk HRA score who were advised to attend the PC, a little 
over two thirds (n=148) did (table 1). Those patients who did not attend the PC were more 
often native Dutch, while participants from practices with a predominantly non-Western 
patient population more often attended the PC. 
We managed to interview 91 of the 208 high-risk participants. Among the interviewed were 
significantly more Surinamese than Turkish and Moroccans (p=0.024) and significantly fewer 
participants from GP practices with an ethnically mixed patient population than GP practices 
with a native Dutch patient population (p=0.012) (data not shown). Of the 91 participants 
whom we interviewed, almost three quarters (n=66) was a PC attender. The sample 
interviewed was similar to the whole high-risk group: PC non-attenders were more often 
native Dutch, while PC attenders were more often from practices with a predominantly non-
Western patient population. 
 
Individual HRA risk parameters and HRA total score 
We found no significant differences in HRA risk parameters between PC attenders and non-
attenders (table 2), although PC attenders in the whole high-risk group more often tended to 
have a family history of DM (p=0.054). The HRA total score did not significantly differ 
between PC attenders and non-attenders. We also looked at the differences between PC 
attenders and non-attenders for those who took part in the interview. Again, we did not find 
significant differences in HRA risk parameters or the HRA total score, although the PC 
attenders more often tended to have a family history of CVD (p=0.060). 
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Patient-reported determinants of attendance 
The quantitative assessment 
At the time of the HRA, only the PC attenders in the interviewed sample significantly more 
often trusted to get the guidance they would need in case of an increased risk, when compared 
to non-attenders (table 3), also after correcting for ethnicity and GP practice (table 4). At the 
time of the interview attenders and non-attenders did not significantly differ in their trust in 
guidance anymore.  
At the time of the HRA and also at the time of the interview, the PC attenders had more often 
experienced health complaints than the non-attenders. The vast majority of these health 
complaints were not related to CMD. This association disappeared when correcting for 
ethnicity and for GP practice, at the time of the HRA (not at the time of the PC). This was 
mainly because the native Dutch less often attended the PC, but those who did more often had 
health complaints. 
At the time of the interview following the PC, the PC attenders indicated they more often had 
others finding it important for them to participate (mainly their children and/or spouse). This 
association disappeared when correcting for ethnicity and for GP practice. This was mainly 
because native Dutch less often attended the PC, but those who did more often discussed this 
decision with others and more often had others finding it important for them to attend. 
For different reasons, the PC attenders more often felt obliged to attend the PC, such as 
because they had participated in the first stage (the HRA) already, because the GP asked them 
to, or because of their own health. This association disappeared, however, when correcting for 
ethnicity and for GP practice, mainly because the Turkish more often had this feeling than 
other groups. 
 
The qualitative assessment 
When asked about their first reaction upon receiving the high-risk HRA result, several PC 
attenders (n=23) and non-attenders (n=13) reported that they were already aware of or had 
expected a high-risk test result. A similar group of attenders (n=17) and a number of non-
attenders (n=5) reported they had not been aware of the high-risk test result at the time and 
had not expected it.  
For the PC non-attenders, the most frequently reported barrier was their lack of symptoms 
(n=8). Additional barriers were having forgotten to make an appointment or not having given 
this high priority (n=4). 
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Facilitators for attendance would be improving the information provision about whose 
responsibility it is to make an appointment, or shifting the responsibility towards the GP, and 
offering smooth logistic procedures (such as the possibility of evening consultations) (n=4 for 
all three facilitators). 
When asked for final comments the vast majority of PC non-attenders indicated the intention 
to schedule an appointment for the PC. 
The majority of PC attenders could not come up with a barrier (n=21). Those who could 
mainly reported unawareness of the high-risk test result (n=5), unawareness of their 
responsibility to make an appointment for the PC (n=8), and time issues (n=7). 
Most attenders also had difficulties coming up with facilitating factors (n=11). Those who 
could reported the same factors as the non-attenders: clear information about responsibility 
for making an appointment (n=5), shifting the responsibility towards the GP (n=8), and 
smooth logistic procedures (n=7). Additionally, positive risk perceptions were mentioned as 
facilitators, mainly lifestyle-related (n=5), obtaining insight into risks (n=5), and a wish for 
healthy aging (n=6).  
Table 4. Multivariate analyses presenting associations with PC attendance at the time of the HRA and at the 
time of the interview, corrected for ethnicity and GP practice 
At the time of the HRA At the time of the PC






(n=91),              
OR (95% C.I.)
Sample 
interviewed       
(n=91),                   
OR (95% C.I.)
Do you trust to get the guidance you need 
if you have an increased risk?a NA   6.03 (2.02-17.97) NA
  Corrected for ethnicity NA 13.44 (3.04-59.45) NA
  Corrected for GP practice NA 11.94 (2.82-50.45) NA
Do you have one or more health 
complaints at the moment?a 2.02 (1.09-3.76)   3.08   (1.17-8.11) 5.55 (2.04-15.09)
  Corrected for ethnicity 1.40 (0.72-2.75)   2.16   (0.76-6.12) 5.24 (1.82-15.08)
  Corrected for GP practice 1.66 (0.86-3.18)   2.62   (0.92-7.45) 4.78 (1.65-13.80)
participate?a NA NA 2.73   (1.01-7.41)
  Corrected for ethnicity NA NA 2.48   (0.66-9.29)
  Corrected for GP practice NA NA 2.28   (0.79-6.60)
Did you feel obliged to attend the PC?a NA NA 3.41 (1.05-11.08)
  Corrected for ethnicity NA NA 2.70   (0.75-9.75)
  Corrected for GP practice NA NA 2.78   (0.79-9.75)
OR: Odds Ratio. NA: Not applicable. a Reference category is the answer ‘no’
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Principal findings 
More than two thirds of the participants with a high-risk HRA score attended the second stage 
of the health check (the PC). These attenders more often came from GP practices with a 
predominantly non-Western patient population, whereas non-attenders were more often native 
Dutch. PC attenders and non-attenders did not differ in their HRA risk parameters, nor in their 
HRA total score. PC attenders, and especially the native Dutch, more often experienced health 
complaints than non-attenders; they also more often had children and/or a spouse finding it 
important for them to attend; and more often felt obliged to attend. At the time of the HRA, 
PC attenders more often trusted to get the guidance they would need in case of an increased 
risk. When actually faced with an increased risk, the non-attenders had equal trust to get the 
guidance they need in comparison with the attenders. Those interviewed indicated that the 
information provision about whose responsibility it was to make the appointment should be 
more clear or altogether shifted towards the GP. 
 
Strengths and weaknesses 
To our knowledge, this is the first study exploring determinants of attendance of underserved 
populations regarding their attendance in the second stage (PC) of a two-stage 
cardiometabolic health check. Insight in the determinants of these underserved high-risk 
groups may help to decrease health inequalities within society. The main strength of the study 
is our exertion to include both PC attenders and non-attenders. Considering the lower levels of 
(health) illiteracy levels among these underserved groups, questionnaire missings were 
limited. Additionally, questionnaire data were supplemented with interview data. An 
explanation for our relatively high attendance rate was that both the questionnaire and the 
interview could be done in one’s native language when desired. 
Some limitations of this study should be noted. First and most importantly, we wrote down 
HRA scores in the GP’s medical records, after which some GP practices decided to call their 
high-risk patients and invite them for the PC. We have no insight in how many patients were 
called or whether GP’s brought this HRA score up during an unrelated consultation and, 
subsequently, scheduled a PC. Nevertheless, given the large number of participants in the 
interview who were unaware of their high-risk score or their responsibility of making an 
appointment, we tentatively conclude that this did not happen frequently. Second, patients had 
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to calculate their own HRA risk score and, consequently, make an appointment for the PC in 
case of a high risk. Both actions may be a bridge too far for these vulnerable groups, and 
could potentially increase the PC attendance rate when dealt with. Finally, registration of the 
PC as a specific PC consultation by GP’s was poor. It was usually impossible to decide 
whether measurements were conducted in the context of the PC or not. Our classification of 
PC attenders and non-attenders for the interview was, therefore, slightly arbitrary. When 
participants indicated that our classification of them was wrong, we asked for more 
information, and switched to a different script when necessary. 
 
Comparison with other studies 
PC attendance in our study was considerably higher than in a pilot study among the general 
GP practice population (21) and comparable to two other studies about the Dutch 
cardiometabolic health check (22, 23). In the latter two studies, high-risk patients were invited 
to attend the PC. Both in the pilot study and our study, the patient was responsible for 
scheduling this appointment. Additionally, native Dutch were less inclined to attend the PC in 
our study, and the study population of the other studies were largely composed of native 
Dutch. Our results show that it is feasible to achieve an attendance rate among ‘hard-to-reach’ 
underserved groups that is higher or comparable to the general population. PC attendance in 
our study was also higher than in the British NHS health check in deprived, culturally diverse 
settings, where it was less than 50% (8, 24). In these studies, patients were risk-stratified 
beforehand and only high-risk patients (based on already known data) were invited. We risk-
stratified patients afterwards, based on their HRA. Patients who were faced with their 
calculated high-risk HRA score were possibly more inclined to attend the PC. Additionally, 
these patients may have been more motivated to participate in stage two (the PC) as they had 
already decided to participate in stage one (the HRA). 
The native Dutch with a lower SES refrained most often from PC participation. We have 
described before that the native Dutch more often complete the HRA than the non-Western 
groups (20), so why do they less often attend the PC? After the initial small effort of 
completing the HRA, the native Dutch participants may have dreaded comments on their 
lifestyle habits. We know from the literature that these groups tend to rely less on the GP for 
lifestyle advice (25). Additionally, these Dutch participants less often experienced health 
complaints, which may have hampered the acceptance of the high-risk HRA outcome as it 
may not have fit their illness representations (26). Those native Dutch who did attend the PC, 
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were more often driven by health complaints and were more often encouraged by their social 
environment to attend. Another explanation may be a high willingness especially among 
Turkish and Moroccans to visit the GP to receive medical tests (16). It may also be that the 
reason the non-Western groups less often completed the HRA was that they did not 
experience health complaints (20). Whereas for the native Dutch completing the HRA was 
less of an effort, but attending the PC when not seeing the need (when feeling healthy) was. 
Surprisingly, we found no differences in HRA parameters between PC attenders and non-
attenders. We had expected to find that individuals with an unhealthy lifestyle, such as 
smoking, would be more reluctant to attend the PC, wanting to avoid comments on their 
unhealthy behavior (25). Possibly, the explanation of non-Western immigrants wanting to 
receive medical tests outweighed the fact that one’s lifestyle would be commented on. 
At the time of the HRA, PC attenders had more trust in getting the guidance they would need 
in case of an increased risk than non-attenders. At the time of the interview, however, the 
large majority of PC attenders still trusted in getting the guidance they would need, but now 
the large majority of non-attenders also did. During the interviews it became clear that many 
PC non-attenders were not unwilling to attend, but had simply not understood that they were 
responsible for making the appointment themselves. Even those who had attended the PC 
indicated that the information provision on this topic should be more clear. A recent study on 
the risk communication of GPs on the Dutch cardiometabolic health check also concluded that 
few participants with low health literacy levels seemed to understand and/or appreciate the 
advice to visit their GP when at increased risk (27). The researchers communicated real-life 
personal risks, however, subsequent decisions participants made in this study were only 
hypothetical. The researchers conclude that if people would actually (non-hypothetically) be 
invited by their own GP and perform the test at home, they would possbily be more convinced 
of the need to visit their GP in case of an elevated risk. Testing this in a real-life setting is 
exactly what we have done and these researchers hypothesis proved not to be true. Leaving 
the patient in charge of making that appointment, thus, seems unadvisable, at least for these 
underserved groups.   
The finding that PC attenders more often felt obliged to attend is interesting. A previous study 
described that Turkish patients felt obliged to go for hepatitis B screening, which was 
explained by a feeling of obligation to act upon the invitation from a medical organisation and 
a Muslim’s duty to take care of one’s body (28). Moreover, participants in this study indicated 
that making the screening obligatory would not only increase participation rates, it would also 
reduce the gossip associated with the taboo surrounding the screening: who does and does not 
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attend and what is the outcome? Making the cardiometabolic screening mandatory is 
impossible and undesirable, but it would be interesting to investigate whether this personal 
feeling of obligation might be an interesting angle for future risk communication. 
 
Implications and future research 
Attendance rates of underserved groups in a two-stage cardiometabolic health check were 
comparable to attendance rates of the general population. This makes a two-stage screening 
also feasible for underserved populations. To further increase PC attendance, it seems 
advisable to shift the responsibility of making an appointment away from the individual 
towards the healthcare provider. If not feasible, risk communication should more clearly state 
that it is the individual’s responsibility to schedule an appointment. It should also address 
illness perceptions in which individuals do not accept a high-risk result as long as they do not 
experience any health complaints, and it should additionally target the close social 
environment of the individual as they influence a person’s decision to attend or not. The role 
that personal feelings of obligation may play in this respect should be studied. 
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HRA risk score calculation for men 
What is your age? I am: 30 – 44 years 
45 – 49 years 
50 – 54 years 
55 – 59 years 
60 – 64 years 
65 years or older 






   
Do you smoke? No 
Yes 
  0 p 
  9 p 
   




  0 p 
  0 p 
  4 p 
12 p 
   
What is your waist circumference? Less than 94 cm 
94 cm or more 
  0 p 
  3 p 
   
Has your father, mother, brother, 
or sister had a cardiovascular 
disease before the age of 65? 
No 
Yes 
  0 p 
  1 p 
   
Does your father, mother, brother, 
or sister have diabetes type 2? 
No 
Yes 
  0 p 
  4 p 
   
 HRA total score = … p 
   
Score less than 30 and all answers black: no increased risk  
Score less than 30 and one or more answers red: slightly increased risk 
Score of 30 or more: increased risk 
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HRA risk score calculation for women 
What is your age? I am: 30 – 44 years 
45 – 49 years 
50 – 54 years 
55 – 59 years 
60 – 64 years 
65 years or older 






   
Do you smoke? No 
Yes 
  0 p 
  9 p 
   




  0 p 
  0 p 
  4 p 
  7 p 
   
What is your waist circumference? Less than 80 cm 
80 – 87 cm 
88 cm or more 
  0 p 
  2 p 
  6 p 
   
Has your father, mother, brother, 
or sister had a cardiovascular 
disease before the age of 65? 
No 
Yes 
  0 p 
  4 p 
   
Does your father, mother, brother, 
or sister have diabetes type 2? 
No 
Yes 
  0 p 
  3 p 
   
 HRA total score = … p 
   
Score less than 35 and all answers black: no increased risk  
Score less than 35 and one or more answers red: slightly increased risk 
Score of 35 or more: increased risk 
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The guideline for Dutch GPs PreventieConsult module Cardiometabool risico (PC) follows a 
two-stage approach: (1) an (online) health risk assessment (HRA), (2) additional tests at the 
general practice for participants with a risk score above the cut-off value. Prerequisites for cost-
effectiveness are approaching high-risk groups (lower socioeconomic status (SES) or 
immigrants) and retaining as many participants as possible in both stages. We investigated in 
the high-risk patients who went to the GP for additional tests, what risk factors were recorded, 
and what subsequent actions were undertaken. 
 
Methods 
Cross-sectional GP record study in six GP practices in deprived areas of The Hague and 
surroundings. Between 05-2012 and 12-2013, we invited 1645 patients. Target population: 
native Dutch with a lower SES, Turkish, Moroccan, and Surinamese (45-70yrs; Hindustani 
35-70yrs) with a risk score above the cut-off value (n=208). GP record data were derived 
from the CVRM-protocol, laboratory data, and GP log. 
 
Results 
The number of indicated additional tests conducted was relatively high (71%, n=148), but 
least so among the native Dutch. Because of incomplete recordings, we could calculate the PC 
risk score of consultation data for only 3% (n=4) of the participants, which was above the cut-
off value for all. We could calculate the CVRM score for 44% (n=66) of the participants, of 
whom 39% (n=26) fell in the ‘yellow’/’red’ box of the risk table. Medication was prescribed 
in 20% (n=29) of the cases: from 5% (n=7) oral antidiabetics to 11% (n=17) statins. Lastly, 
69% (n=44) of the smokers received a quit-smoking advice, and 36% (n=53) of the 
participants received other lifestyle advice. 
 
Discussion 
It is possible to reach a participation rate among ‘hard-to-reach’ groups comparable to or even 
higher than among the general population. Focus of attention is that the GP should not only 
record patient data covered by the classic guidelines but also the other risk factors associated 
with cardiometabolic disease (like family history), and the (lifestyle) advices provided. 
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Possibly, appropriate compensation will promote adequate recording of data and follow-up 
actions, especially important for vulnerable groups. The crucial role that the GP plays 
especially for these groups is all the more important now the PC has been replaced by the 




WHAT IS KNOWN? WHAT IS NEW? 
 
1. The guideline for Dutch GPs, The Prevention Consultation, module Cardiometabolic 
risk (PC), follows a two-stage approach: (1) (online) risk assessment, (2) additional 
(lab) tests at the GP for participants with a risk score above the cut-off value (practice 
consultations). 
2. Inequalities in health gains from screening need to be prevented by targeting high-risk 
groups (low socioeconomic status (SES) or non-Western immigrants) and retaining as 
many individuals as possible in both stages. 
3. By means of a stepwise invitation strategy it is possible to accomplish a practice 
consultation participation rate of 71% among ‘hard-to-reach groups’, which is 
comparable to or even higher than among the general population. 
4. Due to incomplete GP consultation recordings we could calculate the PC risk score for 
a very small percentage of participants only. 
5. We could calculate the CVRM score for 44% (n=66) of the participants, of whom 
39% (n=26) fell in the ‘yellow’/’red’ box of the risk table. 
6. Medication was prescribed to 20% (n=29) of the participants: from 5% (n=7) oral 
antidiabetics to 11% (n=17) statins, 69% (n=44) of the smokers received a quit-
smoking advice, and 36% (n=53) of the participats received other lifestyle advice. 
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The guideline for Dutch GPs, The Prevention Consultation, module Cardiometabolic risk, was 
introduced in 2010, complementing existing guidelines. This guideline described the active 
and systematic detection of, and the care for, individuals with an increased risk of 
cardiovascular disease, diabetes type 2, and chronic kidney damage. It focused on so-called 
indicated prevention (1). Recently, the Prevention Consultation (PC) has been replaced by the 
Personal Health Check (PHC), which also includes a COPD risk test and the so-called 
Prevention Compass. Additionally, it incorporates the implementation possibilities beyond 
primary care (2).  
The PC follows a two-stage approach: (1) participants complete the (online) health risk 
assessment (HRA), (2) individuals with a risk score above the cut-off value receive the advice 
for additional (lab) tests at the GP’s office. Although the separate components are evidence-
based, the cost-effectiveness of the whole method still needs to be established. Certain studies 
conclude that two-stage screening can be cost-effective (3, 4). Screening is particularly useful 
when it reaches not only the ‘worried well’ but especially the vulnerable, hard-to-reach 
groups, who more often have an increased risk. Among others, these groups are the non-
Western immigrants and natives with a low socioeconomic status (SES) (5-8). A non-Western 
descent and a low SES are associated with lower health check attendance (8). This selective 
attendance results in inequalities in health gains which can potentially be achieved by 
screening. Additionally, retaining as many participants as possible in both stages of the 
screening process is of great importance. Previous studies about the PC among the general GP 
population showed substantial drop-out rates, and these rates are potentially higher among 
groups already harder to reach (7).  
To investigate the yield of the PC among aforementioned vulnerable groups, we conducted 
the CHECK’D (Cultural Health check Evaluating Cardiometabolic and Kidney Disease) 
study. With this study we aimed to increase the participation rates of hard-to-reach high-risk 
groups in both stages of the Prevention Consultation by means of a (culturally) adjusted 
stepwise invitation strategy (9). In this paper we report a substudy within CHECK’D: a GP 
record study in which we investigated what risk factors were found among participants with a 
high-risk HRA result, and what follow-up actions were conducted. Our research questions 
were: 1) What risk factors were recorded by the GP? 2) Among what percentage of the 
patients did the GP/practice nurse conduct follow-up actions (prescription of medication and 
providing quit-smoking and other (lifestyle) advices)? 
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Study population and design CHECK’D 
This cross-sectional GP record study is part of a larger study called CHECK’D. The 
CHECK’D study was a pragmatic primary care intervention with a stepwise invitation 
strategy. Between May 2012 and December 2013, we invited 1645 native Dutch with a low 
SES and non-Western immigrants (Turks, Moroccans, and Surinamese) for participation in 
the PC. These patients came from six GP practices in deprived neighbourhoods in The Hague 
and surroundings. We estimated ethnicity on the basis of last name and this was checked by 
the participating GPs. The GPs selected the native Dutch with a low SES. This was verified 
by us on group level with a SES status score based on postal code (10). This SES score is a 
measure for the social status of a neighbourhood. Participants were between 45-70 years old, 
except for the Hindustani Surinamese, who were invited from the age of 35 years because of 
their increased risk of diabetes type II (DMII) from an early age. Exclusion criteria were: 
known cardiometabolic disease; use of antihypertensives, lipid-lowering drugs, or 
antidiabetics; or an already completed cardiometabolic risk profile of less than a year old. We 
deployed a culturally-adapted, personalized, stepwise invitation strategy for participation in 
the HRA: (1) all patients received a written invitation; (2) non-responding patients were 
approached by telephone; (3) telephone non-responders were approached by their GP when 
they attended a (non-related) consultation. Written materials were send both in Dutch as well 
as in Turkish/Arabic to Turkish/Moroccan patients. Turkish and Moroccan patients were 
called by Turkish, Arabic, and Berber speaking research assistants. During the first practice 
consultation, physical measurements (weight, height, and blood pressure) were carried out 
and a referral for lab tests (fasting glucose and cholesterol levels) was provided. Also, the 
answers of the HRA were checked with the participants. During the second practice 
consultation, the results of the lab tests were discussed, the 10-year risk of cardiometabolic 
diseases was calculated, lifestyle advice was provided, and (if necessary) medication was 
prescribed. For the ease of interpretation of the results we will refer to the two practice 
consultations as if it were one consultation. Participation in the study followed an ‘opt-out 
procedure’: patients could return a reply card on which they indicated that they did not want 
to participate. The CHECK’D study was approved by the medical ethical committee of the 
LUMC (registration number P11.151). The design and the results of the CHECK’D study 
have been described in detail elsewhere (9).  
14549-Groenenberg_BNW.indd   143 27-03-17   12:59
144 
Chapter 6 Risk factors and follow-up actions
 
 
Study population and design of this study 
Of the 1645 individuals invited, 713 completed the HRA, of whom 29% (n=208) had a risk 
score above the cut-off value: the study population for this paper. After completing the HRA, 
these high-risk patients received the test result straight away and were adviced to visit their 
GP for a practice consultation. 
The first author (IG) visited the participating GP practices early 2014 and noted how many 
patients had attended the practice consultations, as well as the GP record data of these alleged 
high-risk patients. This data came from the CVRM guideline (provided that this was used), 
lab results, and the log. Noted data were the date of the practice consultation and the relevant 
cardiometabolic parameters: smoking status, height, weight, waist circumference, family 
history of cardiovascular diseases (CVD) and/or DMII, blood pressure, cholesterol ratio, 
fasting glucose, cardiometabolic medications prescribed (antihypertensives, statins, oral 
antidiabetics), and quit-smoking, and other lifestyle advices provided. We used these data to 
calculate the percentage of patients of whom the HRA was checked by the GP and the 
percentage of patients of whom the parameters from the CVRM and DMII guidelines had 
been recorded. Besides that, IG noted what factors may have played a role in non-attending 
the practice consultation (e.g. changing GP practice) from the GP records of no-shows.  
 
Data analysis 
We investigated differences in (patient) characteristics (ethnicity, age, SES score, and HRA 
result) between attenders and non-attenders by means of t-tests and ANOVAs. We present the 
risk factors in frequency tables: both the HRA parameters checked during the practice 
consultation (1) as well as the recorded data based on the CVRM and DMII guidelines (11, 






Approximately 2/3 of the high-risk patients (n=208) attended the practice consultation [Table 
1]. Native Dutch with a low SES attended the practice consultation less often than patients 
from non-Western descent. In 78% (n=47) of the no-shows, we found no indications in the 
GP records of possible reasons for their non-attendance. For the other non-attenders, mental 
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health problems, changing GP practice, mental retardation, not wanting follow-up actions, or 
a combination of these factors potentially played a role. 
 









































[Table 2] presents the HRA parameters of the patients who attended the practice consultation. 
These were the answers the patient had filled out in the HRA, which should be checked by the 
GP. Notable was the large number of non-recorded data: varying from 35% (n=52) missing 
smoking status data to 87% (n=129) missing waist circumferences. Due to all these missing 
data, we could calculate the formal PC risk score for 3% (n=4) of the participants only. All 
four individuals had a risk score above the cut-off value.
Table 1. Characteristics of participants in the practice consultation
High-risk patients according to the HRA (n=208)
p valueNon-attenders practice 
consultation (n=60), n (%)
Attenders practice 
consultation, (n=148), n (%)
Ethnicity
  Native Dutch 37 (62) 45 (30)
<0.001a
  Turkish   9 (15) 47 (32)
  Moroccans 10 (17) 30 (20)
  Surinamese   4   (7) 26 (18)
Age (years) Mean: 56 (±7.4) Mean: 56 (±6.2)
  30-44   2   (3)   0   (0)
0.078
  45-49 10 (17) 27 (18)
  50-54   8 (13) 40 (27)
  55-59 17 (28) 34 (23)
  60-64 13 (22) 30 (20)
  65+ 10 (17) 17 (11)
SES scoreb Mean: -1.3 (±2.1) Mean: -2.0 (±2.4)
  > 0 20 (33) 46 (31)
0.097
  0 tot -2 22 (37) 34 (23)
  -2 tot -4   9 (15) 26 (18)
  < -4   9 (15) 42 (28)
HRA resultc Mean: 40 (±7.3) Mean: 39 (±6.3) 0.491
a Practice consultation attendance was lower among native Dutch than among other ethnicities.
b A lower SES score represents a lower social status of a neighbourhood.
c A lower HRA result represents a lower estimated risk of cardiovascular disease, diabetes type 2, and chronic 
kidney damage (range: 0-66).
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[Hier graag invoegen: ‘Table 2. Parameters needed to calculate the PC risk score (HRA parameters checked 
















































[Table 3] presents the parameters based on the GP guidelines CVRM and DMII. Although the 
missing data was not as notable as for the PC parameters, still many parameters were 
unknown: varying from 20% (n=29) missing glucose levels to 35% (n=52) missing smoking 
status data. We were able to calculate the CVRM risk score for almost half of the participants. 
Of these individuals, approximately two out of five (39%, n=26) had an (slightly) increased 
Table 2. Parameters needed to calculate the PC risk score (HRA parameters checked during the practic   
consultation)
 Attenders practice consultation, (n=148), n (%)
Agea 
  30-45     0     (0)
  45-49   23   (16)
  50-54   38   (26)
  55-59   37   (25)
  60-64   31   (21)
  65+   16   (11)
  Missing     3     (2)
Smoking statusa
  No smoker   32   (22)
  Smoker   64   (43)
  Missing   52   (35)
BMI
  Underweight     3     (2)
  Healthy weight   14     (9)
  Overweight   31   (21)
  Obese   30   (20)
  Missing   70   (47)
Waist circumference
  Healthy     2     (1)
  Unhealthy   17   (11)
  Missing 129   (87)
Family history CVD
  No   35   (24)
  Yes   19   (13)
  Missing   94   (64)
Family history DMII
  No     9     (6)
  Yes   26   (18)
  Missing 113   (76)
PC risk score
  No increased risk     0     (0)
  Slightly increased risk     0     (0)
  Increased risk     4     (3)
  No conclusion possible 144   (97)
a 
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risk (‘yellow’ or ‘red’ box in the risk table (11)). Of those patients with a known glucose 
level, 23% (n=27) had impaired glucose tolerance or diabetes: relevant in the context of the 
DMII guideline. In part, these were the same patients who fell under the CVRM guideline. 
Regarding the follow-up actions during the practice consultation: medication was prescribed 
to 20% (n=29) of all patients. Oral antidiabetics were prescribed to 5% (n=7) of the patients, 
antihypertensives to 8% (n=12), and statins to 11% (n=17). Of those patients who were 
recorded by the GP to be a smoker (n=64), 69% received a quit-smoking advice. In total, 36% 
(n=53) of the patients received a lifestyle advice regarding nutrition or physical activity or a 
referral to a dietician or a physical activity coach. 
 
[Hier graag invoegen: ‘Table 3. Parameters needed to calculate the CVRM risk score and needed to classify 






































Table 3. Parameters needed to calculate the CVRM risk score and needed to classify according to the DMII 
guideline 




  <120 mmHg   22   (15)
  120 tot 140 mmHg   51   (34)
  140 tot 160 mmHg   23   (16)
  160 tot 180 mmHg   11     (7)
    4     (3)
  Missing   37   (25)
Total cholesterol/HDL ratio
  62   (42)
  5   24   (16)
  6   16   (11)
  7     6     (4)
    6     (4)
  Missing   34   (23)
CVRM risk score  
  No increased risk   40   (27)
  Slightly increased risk   17   (12)
  Increased risk     9     (6)
  No conclusion possible   82   (56)
Fasting glucose 
  Normal   92   (62)
  Impaired   15   (10)
  Diabetes   12     (8)
  Missing   29   (20)
a 
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Answer to the research question 
Two out of three patients with a HRA score above the cut-off value actually attended the 
practice consultation. Many of the HRA parameters were not checked by the GP/practice 
nurse during the practice consultation, or if they were checked they were not recorded, 
resulting in a lot of missing data. Of the small number of patients of whom all data was 
known, everyone had a risk score above the cut-off value. Risk factors for which the 
GP/practice nurse proceeded to follow the classic guidelines were recorded best, even though 
still approximately a quarter of the data were missing. More than a quarter of all patients fell 
into the CVRM guideline and also almost a quarter fell into the DMII guideline (in part the 
same individuals). Medication was prescribed to one out of five participants. Of all patients, 
1/3 received lifestyle advice regarding nutrition or physical activity, or a referral to a dietician 
or physical activity coach. More than 2/3 of the smokers received a quit-smoking advice. 
 
Strengths and weaknesses 
Strength is that we set up the logistics of this study completely according to the practice 
guideline of the PC, which is useful for the PHC as well. We (culturally) adapted the design 
and accompanying materials to the specific target populations (9). We obtained the required 
data in different ways from the GP records. 
A limitation of the study was that we estimated ethnicity based on last name, since this is not 
registered in the Netherland. ‘Mixed’ marriages could have resulted in the incorrect exclusion 
of non-Western women married to a native Dutch man, and of native Dutch women married 
to a non-Western man. However, the GPs checked the lists with last names, which makes the 
likelihood of this bias small.  
Even though the GP record study should be a factual reflection of the execution of the 
practice consultation, we have not obtained insight in what actually has happened during the 
practice consultation due to the inadequate recordings. We suspect that some components of 
the PC may have been executed/discussed, but not recorded.  
The number of patients provided by the different GP practices varied, in particular because of 
the varying practice sizes. As a result, possible selection bias cannot be ruled out. 
Additionally, the quality of the recordings differed substantially between the GP practices. 
However, the number of patients and practices were too small to stratify the data. Finally, the 
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willingness of GPs to participate in the study may have resulted in an overly optimistic 
picture. 
 
Consequences of the results and results of previous research 
Participation in the practice consultation in our study was considerably higher than in the pilot 
study of Nielen et al among the general GP practice population (13). It was comparable to two 
other studies about the PC in which also about 2/3 attended the practice consultation (14, 15). 
In the latter two studies high-risk patients were invited for participation in the practice 
consultation. Both in Nielen’s pilot and in our study the patient was responsible for making an 
appointment. Our results show that it is feasible to achieve a participation rate among ‘hard-
to-reach’ groups that it is comparable to the general population, which also holds for the new 
PHC. We specifically targeted high-risk groups (native Dutch wit a low SES and non-Western 
immigrants). Study materials were based on exisiting materials of the Dutch Association of 
GPs but were further developed for these high-risk groups specifically. The materials are 
suitable and available for GP practices with a (large) proportion of these high-risk patient 
populations. 
Participation in the practice consultation in our study was also higher than that in the British 
NHS health check, which was less than 50% there (16, 17). In these studies, patients were 
risk-stratified beforehand and only high-risk patients were invited. In our study, this risk-
stratification took place on the basis of a patient’s HRA. As a result, HRA completers with a 
high-risk result were possibly also more inclined to attend the PC as well. 
Our detection rates of patients needing care according to a guideline were higher than what 
was found in studies among the general population. For example, 8% of our patients were 
diagnosed with diabetes, whereas in the 3 other Dutch studies this percentage varied from 1-
3% (13-15). The number of patients who, after the practice consultation, fell in the ‘red’ box 
of the CVRM risk table was 6% in our study, comparable to the 3-6% that was found in other 
studies (14, 15).  
A notable finding is that parameters used within the existing guidelines (CVRM and DMII) 
had less missing data than the parameters used only within the PC. In part, this may be 
explained by us entering the HRA results in the GP records. Perhaps GPs thought it 
unnecessary to verify the data, or they did not record deviations between their measurements 
and the HRA results. 
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Another possible explanation is that adequate recording of parameters for the CVRM and 
DMII guidelines is directly related to the financial reimbursement. In a recent Dutch study 
Nouwens et al showed that cardiovascular risk indicators were monitored better for 
contracted, and, thus, financed diabetes care than for the (at the time) uncontracted, 
unfinanced COPD care (18). An additional financial incentive for adequate implementation of 
the PHC will, most likely, improve the quality of the follow-up care. GPs in the United 
Kingdom (UK) record lifestyle (advices) better than GPs in other European countries, 
explained in the literature by the fact that they are financially well rewarded for this within 
their “Quality and Outcome Framework (19). This study showed that the smoking status of a 
staggering 97% of patients in the UK was recorded, relative to 65% in our study. A quit-
smoking advice was given in 85% of the cases in the UK, whereas in our study this was 69%. 
Our percentage is even relatively high for Dutch standards: a study among Dutch patients who 
visited their GP showed that in 56% of the cases the GP had informed about their smoking 
status and that in 44% of the cases a quit-smoking advice was given (20). Dutch research 
showed that the lack of scientific evidence and the perceived workload (time invested) are the 
most important barriers to implementation of the PC, next to the uncertainty about the 
financial reimbursement (21). An ongoing large-scale study must provide the evidence of the 
cost-effectiveness of the PC (22). Our study shows that adoption of the PC must be combined 
with thorough implementation arrangements, for example about recording and follow-up of 
non-responders. 
The British also provided other lifestyle advice (nutrition and/or physical activity) more often 
than the GPs in our study. Notable in our study was, again, the inadequate recordings: often 
only ‘lifestyle advice given’ was noted in the GP records. This makes it impossible to 
continue the counselling in follow-up consultations. Additionally, an occasional referral to a 
dietician and/or physical activity coach was noted: whether or not community 
facilities/interventions were used remained unclear. This is a challenge for the new PHC: 
making use of the numerous community initiatives and adequate GP recording of (the use of) 
these initiatives. During our study, no protocol for lifestyle advice existed. As a result, content 
and responsibilities were unclear. Currently, the Healthcare modules Lifestyle have been 
published by the Dutch Association of GPs (23). There are Modules available about alcohol, 
physical activity, smoking, and nutrition. There are also guidelines regarding general aspects 
of lifestyle advice: self-management, immigrants and low literacy, social map, and 
collaboration. Especially the second and third are documents that can play an important role 
in the further implementation of the PC among these groups. 
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To achieve the goals set for the new PHC the vulnerable groups require special attention, 
because they are often harder to reach and more often have an increased risk. Our study shows 
that GPs can play an important role in approaching these high-risk groups (selective 
prevention). Unfortunately, the active involvement of GPs is no longer an explicit part of the 
PHC (24). Even though this new design of the PHC facilitates the implementation outside 
primary care, it may hinder the important role of the GP in approaching high-risk groups. 
A second important implication of this study is that GPs need to improve their recording of 
existing risk factors and lifestyle advices provided, especially when they fall outside the 
classic guidelines. The current inadequate recording does not only limit scientific research, 
but definitely also limits adequate guidance and follow-up of patients with existing risk 
factors. Finally, from the results of this study we can conclude that an active role of GPs in 
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Underserved groups have a poorer (quality-adjusted) life expectancy and an increased risk of 
cardiometabolic disease. These are the same groups shown to be least likely to attend health 
checks. This differential uptake of health checks may lead to suboptimal health gains from 
cardiometabolic screening and contributes to the widening of health inequalities in society. 
Increasing participation in a health check by improving informed decision-making among 
these underserved groups is eminent. The aim of this dissertation was, therefore, to obtain 
insight into the (psychosocial) determinants of participation of underserved groups in both 
stages of the Dutch cardiometabolic health check (Prevention consultation, module 
cardiometabolic risk) as well as into the actual response and participation rates in the two 
stages. 
 
MAIN FINDINGS OF THIS THESIS 
 
During focus group discussions with vulnerable groups (chapter 2), potential reasons for 
not completing the health risk assessment (HRA) were mainly cognitive: (flawed) risk 
perceptions, health negligence, (health) illiteracy, and language barriers. A face-to-face 
invitation from a reliable source and a community outreach to raise awareness were 
perceived as factors facilitating participation. Reasons for not attending the practice 
consultations (PC) overlapped, but were also more affective: risk denial, fear about the 
outcome, its potential consequences (lifestyle changes and medication prescription), and 
disease-related stigma. 
 
The actual response rate among vulnerable groups to an invitation for a cardiometabolic 
health check was 70% (n=1152), of whom 62% (n=712) completed the HRA (chapter 3). 
Of these 712 HRA participants, 29% (n=207) were considered high-risk, of whom 59% 
(n=123) attended the PC. 
 
The HRA participation rate was lowest among patients from GP practices with a 
predominantly non-Western patient population (chapter 4). The HRA participation rate 
was primarily accomplished through the postal and telephone invitations, while the added 





value of a face-to-face invitation by the GP was negligible (chapter 3). Reasons for 
completing the HRA were: wanting to know one’s risk, not remembering receiving the 
postal invitation (thus requiring a phone call, after which they participated), paradoxically: 
fear of the test result and/or need for adjustment of lifestyle, perceived control of staying 
healthy, and wanting to participate (chapter 4). 
 
The PC participation rate was lowest among native Dutch with a low SES (chapter 5). 
HRA risk parameters did not differ between PC attenders and non-attenders. Reasons for 
PC attendance were: trust in getting the guidance needed in case of an increased risk, 
experiencing health complaints, having others finding it important for them to participate, 
feeling obliged to attend. Many participants found it unclear whose responsibility it was to 
make an appointment for the PC. 
 
The GP records of the PC attenders were incomplete: in only 3% (n=4) of the cases the GP 
had verified all HRA parameters, which were indeed all above the cut-off (chapter 6). For 
44% (n=66) of the cases we could calculate the cardiovascular risk, which indicated a 
(slightly) increased risk for 39% (n=26) of the PC attenders. The GPs prescribed 
medication to 20% (n=29) of the PC attenders, 36% (n=53) received lifestyle advice, and 
69% (n=44) of the smokers received a quit smoking advice. 
 
 
REFLECTION ON MAIN FINDINGS 
 
Reach  
With this study, we have managed to reach 70% of our target population whom we provided 
the opportunity to make an informed decision about participation in a cardiometabolic health 
check. Still, this means that we did not manage to reach 30% of our target population. From 
chapter 3 and 4 we know that reach and HRA participation rates were lowest among those 
from GP practices with a predominantly non-Western patient population, specifically Turkish 
and Moroccans. These practices were situated in neighbourhoods with stronger non-Western 
communities, with generally lower acculturation rates. It has been reported that less 
acculturated minorities more often feel that the doctor, God, or a higher power could help 
prevent disease, rather than they themselves (external locus of control) (1). A perceived lack 
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of control was indeed seen more often among HRA non-completers than among completers 
(chapter 4). Additionally, Turkish and Moroccan immigrants have been found to be less 
acculturated than Surinamese immigrants, and less often participate in Dutch society (2). 
These observations give rise to the hypothesis that it may be the least acculturated 
immigrants, with an external locus of control, whom we have not reached despite our extra 
efforts.  
 
HRA participation  
The response rate to the invitation for our cardiometabolic health check was 70% (n=1152), 
of whom 62% (n=712) completed the HRA. Thus, the HRA participation rate in the overall 
study population (n=1690) was 42%. This was lower compared to what was found in other 
studies in the Netherlands (3-5). Those studies found completion rates of 75%, 69%, and 55% 
respectively. This is most likely explained by the lower percentage of underserved 
populations in those studies, and their use of an additional online HRA. In those studies, the 
HRA score was not calculated by patients themselves, as it was in our study. A pilot study of 
the Dutch cardiometabolic health check in which, identical to our study, participants had to 
calculate their own risk score, found a lower HRA participation rate than we did, namely 33% 
(6). This gives rise to the idea that finding out the HRA result from the GP may have worked 
as an ‘incentive’ to return the HRA.  
 
PC participation 
Of the 207 participants who were considered high-risk according to the HRA, 59% (n=123) 
attended the PC. This PC participation rate was lower than what was found in other studies in 
the Netherlands (3-5). Those studies found attendance rates of 72%, 69%, and 73% 
respectively. The pilot study of the Dutch cardiometabolic health check found a lower PC 
participation rate, namely 36% (6). In the previous paragraph we suggested the hypothesis 
that finding out an indication of the personal risk seems to be an incentive for returning the 
HRA. Our PC participation results may imply the same: not providing an indication of the 
personal risk will result in the incentive of finding out the test result when attending the PC, 
thus, increasing PC participation rates. Additionally, participants may not have been aware of 
their responsibility for making the appointment for the PC themselves. From the interviews in 
chapter 5 we learned that in a large proportion of the cases the non-attenders were not 





unwilling to attend but had simply not understood that they had a high-risk or that it was their 
responsibility to make the appointment for the PC.  
Our PC participation rate was higher than what was found in studies on the British NHS 
health check in deprived, culturally diverse settings (7, 8). It should be noted, however, that of 
their patients, only high-risk individuals (based on already known data) were invited. Our 
patients were risk-stratified afterwards, based on their HRA. Patients who were faced with 
their calculated high-risk score were possibly more inclined to attend the PC. Additionally, 
these patients may have been more motivated to participate in stage two (the PC) as they had 
already decided to participate in stage one (the HRA). 
 
Method of invitation 
Based on findings from our qualitative research (chapter 2) and from the literature we had 
expected the face-to-face invitation strategy by the GP to be most successful (9). The 
literature suggests that, if used as a separate strategy, face-to-face invitation methods are more 
effective in reaching underserved groups. We found that, if used as an additional step in a 
multi-step strategy, the added value of the face-to-face invitation was negligible. Given the 
related labour-intensity and costs, a multi-step approach combining mailed materials and 
telephone approaches seems most recommendable. Suggestions to increase the effectiveness 
of this multi-step approach will be discussed later in the Implications section. 
 
Reasons for (not) participating in the health check 
An important aspect of non-participation was flawed risk perceptions. Both in our qualitative 
study and in our subsequent intervention study we found that a lack of personal relevance in 
participating in the health check was due to the individual not experiencing any health 
complaints. One possible solution for this problem is to raise public awareness about the often 
asymptomatic nature of cardiometabolic disease (10). Another, probably more effective, way 
to increase personal relevance is to individually tailor the invitation for the health check to 
important risk factors from the individual’s already known cardiometabolic risk profile (age, 
smoking status, BMI, etc.) (11). 
From our focus group discussions and the literature we knew that many individuals would 
fear the outcome of a health check and would not want to know their risk (12, 13). 
Interestingly, we saw in chapter 3 that reported fear of the test result was not consistent when 
asked in a different manner. When asked for the most important barrier in an open-answer 
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fashion, the participants reported fear of the test result. However, when asked in a multiple-
choice manner many respondents turned out not to be scared of the test result. Consequently, 
this barrier may have been a potential barrier imagined to be applicable to others in the same 
situation, not to the person self. On the other hand, these individuals may have participated 
despite of their anxiety so that in case of a high-risk test result, they would at least know that 
they would experience the benefits of early diagnosis (14, 15). Indeed, a large majority of the 
participants expressed their most important facilitator to be obtaining insight into risks.  
Our findings suggest that beside the internal motivation of wanting to know one’s risk, 
external motivations play an important role as well. A well-known example of this is having 
significant others, such as family members, finding it important for them to participate, 
described in chapter 2 and 5, as well as in the literature (16-18). A different and contrasting 
aspect of these social influences is the fear of gossip and social stigma surrounding medical 
affairs, such as screening. Relatively new is the phenomenon of a personal feeling of 
obligation, which is not well-described in the literature. In chapter 2 we found that mainly the 
native Dutch had an aversion of feeling forced to participate, whereas in chapter 5 we found 
that mainly the Turkish felt obliged to participate. In a Dutch study on hepatitis B screening, 
this phenomenon was explained by a feeling of obligation to act upon the invitation from a 
medical organisation, and a Muslim’s duty to take care of one’s body (19). Participants in our 
study indicated that making the screening obligatory would not only increase participation 
rates, it would also reduce the gossip associated with the taboo surrounding the screening. 
 
Increasing the yield of the PC 
In chapter 6 we found that the GP records of the PC attenders were very incomplete. For these 
kinds of prevention programs to work, follow-up of those at risk is crucial. Not surprisingly, 
the classic cardiovascular and diabetes parameters for which specific care is reimbursed in the 
Netherlands were much better recorded. The number of cases in which nutrition or physical 
activity advice was provided substantially fell behind the quit-smoking advices. In the UK, all 
types of lifestyle advice is better registered in the GP records than in every other European 
country, likely because GPs are financially rewarded for this in their Quality and Outcomes 
Framework (20). This framework has, however, been cause of much debate recently. 
Although it has reduced socioeconomic inequalities in the delivery of care, it is also related to 
problems: larger practices getting systematically higher payments than smaller practices for 
the same level of quality; problems with defining the codes so that people with less specific 





codes vanished from the registers and subsequently receiving worse care; and a high 
administrative burden (21). Two advisors of the Quality and Outcomes Framework state that 
it was not a magic bullet to improve quality and reduce variation, but that quality and safety 
improvement require multiple strategies (combining persuasion, collaboration, and close 
alignment of professionals and managers, with the more technical elements of a quality 
improvement initiative), sustained over time (21). Other European countries, like the 
Netherlands, should look at what worked in this Framework and adopt these factors to 





In 2015, the Prevention consultation blended into the new “Persoonlijke Gezondheidscheck” 
(Personal Health check). The Personal Health check also incorporated tools such as the COPD 
risk assessment and “PreventieKompas” [Prevention Compass]. The latter is an online tool 
providing employees the opportunity to identify lifestyle, psychological, physical, and family 
aspects increasing the risk of illness, with the aim to decrease or prevent occupational 
absenteeism and incapacity. Questionnaires and (optional) supplementary physical 
examinations and/or lab tests define one’s (online) health report (figure 1). The health report 
presents modifiable health factors and modifiable disease processes. An individual can click 
on each of the modifiable health factors and disease processes and receive information about 
one’s status with regard to that factor. Along with this information one receives practical 
advice as well as referrals to facilities in the community for follow-up examinations or 
interventions. In line with its predecessor (the Prevention Consultation), the Personal Health 
check also offers evidence based risk assessments and interventions only, thereby providing a 
scientifically sound response to the fragmented supply of (sometimes unreliable) health 
checks. The Personal Health check is available as an online tool online, and is provided by an 
individual’s GP, employer, or municipality. An individual can also take the initiative to visit 
the website and complete some (basic) modules him- or herself.  
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Figure 1. Health report of the Personal Health check 
[Beïnvloedbare gezondheidsfactoren] Modifiable health factors: physical activity; smoking; nutrition; 
motivation for a healthy lifestyle; weight and waist circumference; blood pressure; cholesterol; alcohol; 
resilience; glucose; physical occupational balance; and occupation capacity.  
[Beïnvloedbare ziekteprocessen] Modifiable disease processes: heart and vascular system; kidneys, lungs, 
psyche; and mental occupational balance. 
 
Below, we will describe what has changed since the Prevention consultation became part of 
the Personal Health check, and what the implications of our findings are for the deployment 
of cardiometabolic screening initiatives such as the Personal Health check. Also, we will 
discuss the implications of our findings for future research. And finally, we will summarize 
what the implications of our findings for prevention among underserved groups in general are. 
 
Implications for screening among underserved groups 
Method of invitation 
The 70% reach of our target population was most likely attributable to the low-cost 
(culturally) adapted and personalized postal invitation strategy with follow-up telephone call. 
The postal invitation strategy was the standard method of invitation at the time. We found that 
the follow-up telephone call increased the number of people making a decision about 





participation. This is in line with a Danish study among non-participants in cardiovascular 
screening, in which 40% changed their initial decision after receiving additional information 
about risks and screening (22). The Personal Health Check, relies solely on an online method. 
This does not seem to fit the underserved groups as good as it fits non-immigrants and those 
with a higher SES. In a decade’s time, the use of e-health services overall has increased: 
access to the internet increased, as well as the number of people who used an e-health service 
(23). However, immigrants and those living in low SES neighbourhoods are still less likely to 
use e-health services. What is worse, disparities by ethnicity and SES seem to widen over 
time (23). Focusing solely on online methods, therefore, will rather increase health 
inequalities than reduce them.  
Invitation strategies for screening initiatives have relied to a large extent on traditional 
methods: postal, telephone, face-to-face, online, etc. We believe, however, that reach can be 
increased, especially among underserved groups, by expanding these basic strategies with a 
more comprehensive community approach (24-26). This approach can include, and may not 
be limited to: mouth-to-mouth publicity from key figures, and family and friends advising to 
participate or participating themselves; community workers explaining what to expect from 
the health check and the potential benefits; health check participation in a well-known 
location within the community, preferably with (supported) internet access provided, leading 
to more flexible drop-in, a more informal location and staff, and more opportunities to 
receive, understand, and ask questions about (the results of) the health check; involving 
family and friends in the patient’s lifestyle advice and/or treatment to increase acceptance and 
diminish the stigma associated with ‘being different’ (ill or high-risk); key figures within the 




The Prevention Consultation was especially embedded in primary care, whereas the Personal 
Health check is also embedded in settings outside primary care, such as the occupational 
environment and the home environment (in case health insurance companies or municipalities 
provide this service). Also for the Personal Health check high-risk patients will remain 
visiting their GP for a practice consultation. The reason for a focus on recruitment outside 
primary care is that structural financing remains a problem in the primary care setting. One of 
the main reasons is the current lack of evidence concerning the cost-effectiveness of the 
Prevention Consultation. However, the social business case, based on the Social Return On 
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Investment method, has shown to be positive (27). Every euro invested the Prevention 
Consultation yields €2,38 in social value (such as prolonged occupational participation and 
reduced burden of disease). Unfortunately, the costs and benefits are not equally distributed 
among stakeholders (figure 2): primary healthcare professionals invest more money than they 
get in return. Therefore, the healthcare insurance companies have been approached to 
embrace the Personal Health check, because a large proportion of the benefits are theirs. 
Some health insurance companies now offer their clients the opportunity to participate in the 
Personal Health check with supplementary insurance arrangements. We believe that this will 
less often benefit the underserved groups, as people with a lower income (usually those with a 
lower SES) less often choose for a supplementary insurance policy (28). Also, certain 
employers now offer their employees a voucher for the Personal Health check. Unfortunately, 
people with a low and middle educational level, usually those with a lower SES, are twice as 
often unemployed as people with a high educational level (29). Non-Western immigrants are 
even three times as often unemployed as native Dutch (29). Finally, municipalities have been 
approached to play a role in the implementation of the Personal Health Check. It is at this 
time unclear whether municipalities will put extra efforts in underserved groups. If they will, 
this provides excellent opportunities. Municipalities are well aware of their most deprived 
neighbourhoods and can target these communities specifically. The social business case also 
calculated the cost/benefit ratio of a combined primary care/municipal health service effort 
(27). In that scenario, the municipal health service would take care of the guidance towards 
the first stage (HRA) of the Prevention Consultation; primary care professionals would take 
care of the second stage (PC). The social business case of this scenario remained negative: GP 
practices would still have to invest more than they would receive in return. However, our 
studies add certain elements that may turn this business case positive (thus, the (social) yield 
is larger than the money invested), at least when deployed to reach underserved groups. First, 
the municipal health services are well suited to provide the community outreach described 
above. Secondly, the trusting relationship with the GP as authority to provide screening such 
as this (24, 30). Finally, structural reimbursement for the implementation of the Personal 
Health Check is likely to increase the number of participating GP practices, which in turn will 
decrease the overall costs (27).  
 





Figure 2. Social Return On Investment (SROI) overview of social and economic costs and benefits of the 
Prevention Consultation 
[Investering/input] Investment/input from health insurance company (€209,-), employer (€31,-), healthcare 
professional (€19,-), and participant (€2,5). 
[Klant/output] Customer/output, the Prevention Consultation. 
[Stakeholder/outcome] Stakeholder/outcome, health insurance company (€282,-), participant (€270,-), 
employer (€70,-), Ministry of Social Affairs (€15,-), and municipality (€11,-). 
[Indicatoren/impact] Indicators/impact in the form of savings in hospital care (€264,-), participation (€214,-), 
burden of disease (€56,-), productivity (€42,-), occupational incapacity (€22,-), savings in primary care (€18,-
), savings in social benefits (€15,-), savings in costs from the Social Support Act (€11,-), and absenteeism 
(€6,-). 
 
Appointment for the PC 
We found (in chapter 3) that almost 60% of those with an increased risk according to the 
HRA attended the PC. This means that about 40% of those who are advised to attend the PC 
did not do this. As we described above, this may in part have been the lack of ‘incentive’ of 
finding out the test result from the GP, and in part the unawareness of the own responsibility 
of making an appointment for the PC. A prerequisite of cost-effectiveness of the 
cardiometabolic health check is PC attendance of as many high-risk participants as possible: 
lifestyle changes and risk reductions purely based on a high-risk HRA result are highly 
unlikely. Under the heading Implications for future research hereunder, the issues with regard 
to the (lack of) evidence regarding cost-effectiveness are further described. Shifting the 
responsibility of making the appointment for the PC towards the GP, and disclosing the HRA 
result in the ensuing consultation seem promising in optimizing health gains from screening. 
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Naturally, the practical implications regarding, for example, privacy and technical aspects of 
such a measure need to be carefully sorted out first. 
 
Implications for future research 
Hardest-to-reach 
As we described above, our observations give rise to the hypothesis that it may be the least 
acculturated immigrants, with an external locus of control, whom we have not reached despite 
our extra efforts. It would be an interesting challenge to investigate whether the least 
acculturated groups in the Netherlands are indeed the ‘hardest-to-reach’ among the 
underserved groups. Non-response research is difficult, and it may be virtually impossible to 
ever reach everyone within a certain population. An important question to ask is, therefore, 
how much extra effort do we want to invest in these groups who really are the hardest-to-
reach among the underserved groups? What is the cut-off for accepting which proportion of 
the Dutch population will never be reached? Setting a clear cut-off for reach may be 
undesirable, however, striving for engaging in a dialogue with every individual in a study (or 
other project) population seems plausible. Less acculturated immigrants have been shown to 
have a higher perceived susceptibility to disease (1). Perceived susceptibility has been 
correlated with taking preventive action. This may provide a unique opportunity for 
healthcare professionals to start the dialogue, and provide the individual with the correct 
information about the modifiability of cardiometabolic risk factors. The concept of 
(culturally) tailoring would be interesting to further study in this context. The two most 
important elements of tailoring are: 1) it is directed toward individuals, not groups (which is 
called ‘targeting’ in that case); and 2) it is based on known (i.e. measured) differences that 
exist between individuals (31). Although culture is a shared group characteristic, individuals 
can have varying levels of certain cultural beliefs. Tailoring a health-related message may, 
thus, also be based on relevant cultural elements that are more compelling to some than 
others. The findings of our studies may be used to further investigate the effect of the cultural 
tailoring we used to promote informed decision-making among underserved groups to 
participate in a cardiometabolic health check. For this, the ‘black box’ of tailoring needs to be 
systematically unravelled and incorporated in the design of a future study. A useful 
framework would be that of Hawkins et al who propose a 2 x 3 matrix of two classes of goals 
and three strategies of tailoring in which some strategies match better to some goals than to 
others (32). The two classes of goals comprise: 1) enhancing cognitive preconditions for 





message processing; and 2) enhancing message impact through modifying behavioural 
determinants of goal outcomes. The three tailoring strategies comprise: 1) personalization to 
increase attention or motivation to process messages by conveying, explicitly or implicitly, 
that the communication is designed specifically for ‘you’; 2) feedback to present individuals 
with information about themselves, obtained during assessment or elsewhere; and 3) content 
matching to direct messages to individuals’ status on key theoretical determinants 




We saw in our studies that many (flawed) risk perceptions are present among underserved 
groups, one of the most prominent being that individuals feel healthy because of the often 
asymptomatic nature of cardiometabolic disease and, thus, are less motivated to take action. 
Besides tailoring risk information to the individual, it has been justly pointed out in the 
literature that risk factor control is a multidimensional challenge of which patient motivation 
is only one element (33). It requires knowledge of the disease and its precursors and is 
strongly influenced by the environment in which patients live. Promising results have been 
shown to increase an individual’s adherence to preventive cardiovascular (drug) therapies 
when coronary artery calcium imaging was used in addition to risk stratification (34, 35). 
Cost-effectiveness of this approach has not been established but it may also provide an 
interesting lead to raise public awareness. Strategies from cancer awareness campaigns may 
provide an interesting basis. For example, the international body of literature supports 
pictorial cigarette pack warnings as much more effective than text-only warnings (36). A 
similar approach to visualize asymptomatic cardiometabolic risk to raise public awareness 
may warrant future research. 
 
Cost effectiveness 
One of the most important questions to ask, however, is whether screening - and more 
specifically two-stage screening - is (cost-)effective for underserved groups. Although the 
components of the Dutch cardiometabolic health check are evidence-based and validated, its 
overall cost-effectiveness is still under study (37). As a result, there has been much debate 
about whether to screen for cardiometabolic disease and, if so, what approach works best. 
Those who support (two-stage) cardiometabolic screening argue that, although the cost-
effectiveness of the Dutch cardiometabolic health check has not been shown, there is 
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sufficient international literature indicating the cost-effectiveness of a two-stage screening. 
For example, Khunti et al state that a risk stratification tool followed by a screening blood test 
is the most cost-effective method of screening for diabetes and abnormal glucose tolerance 
(38). Also, Pandya et al state that non-laboratory based cardiovascular risk assessment can be 
useful as the initial component of a multistage screening approach in primary cardiovascular 
disease prevention, potentially avoiding 25-75% of laboratory testing (39). A risk 
stratification tool as a first step is simple, fast, inexpensive, non-invasive, and reliable (40, 
41). Additionally, pilot studies using a two-stage screening approach report satisfactory 
response and yield (3, 4, 42, 43).  
Those who do not support (two-stage) cardiometabolic screening argue that the questionnaire 
as first risk stratification tool is an obstacle for patients and that a higher response rate can be 
obtained when individuals are invited for a consultation directly (44). They also argue that the 
current lack of insurance compensation for costs made (such as the €10,- start-up costs of the 
Personal Health Check, and the costs of the additional laboratory tests) disadvantage the 
underserved groups unequally. Non-Caucasians and people with a low SES are less future-
oriented, which affects their health and disease management in various ways, for example, by 
feeling less susceptible to the consequences of disease (45, 46). If that is the case, then why 
pay costs for a situation (unknown disease) perceived to be unlikely? Health behaviour 
competes for people’s time and energy (and money!) against other activities. Taken into 
account their increased disease and mortality risks and their decreased investment in health 
behaviour, the final inequality in health outcomes is greater than the initial inequality in 
socioeconomic conditions (47). Then, there is the argument that risk scores are too much 
driven by age: those younger than 45 years hardly ever have increased risk, while those older 
than 60 almost always have. Population risk rates are translated into personal risks leading to 
medicalization of a group of people who are not (yet) ill. This absolute risk approach is said to 
lead to overdiagnosis and overtreatment of the elderly at the expense of younger people (48, 
49). Focus should therefore not be on risk stratification tools, but on modifiable risk factors of 
all individuals, young and old. Lastly, a systematic review did not show that health checks 
reduce morbidity or mortality, neither overall nor for cardiovascular causes, although they 
increased the number of new diagnoses (50). However, a couple of remarks to these findings 
should be made. First, changes in risk factors or delivery of preventive services were not 
investigated. Second, most of the included trials were from years ago and consequently 
diagnosis and treatment differed from what would be used today. Third, as many physicians 
already screen for cardiovascular risk factors in patients whom they judge to be at risk during 





a consultation for an unrelated issue, many people at high-risk may have already been 
identified. This dilutes the potential benefits from systematic screening. Finally, individuals 
participating in an health check more often have a higher socioeconomic status, a Western 
origin, lower cardiovascular risk, less cardiovascular morbidity, lower mortality, and are more 
often health-conscious (42, 50-52).  
Thus, the high-risk two-stage approach to cardiometabolic disease prevention in its current 
form seems to widen health inequalities and is an example of the “Inverse Care Law”. This 
Inverse Care Law states that the availability of good medical care tends to vary inversely with 
the need for it in the population served. Those in the poorest health gain the lowest net health 
benefits from intervention. This disadvantage can occur at every stage in the process, from 
the person’s beliefs about health and disease, and actual health behaviour, to presentation, 
screening, risk assessment, negotiation, participation, program persistence, to treatment 
adherence (53). Consequently, focus should be on underserved groups.  
The cost-effectiveness of the high-risk two-stage approach specifically targeting underserved 
groups is currently under study, both in the Netherlands as elsewhere (37, 53).  
 
 
Implications for prevention in the future 
In the previous paragraph we argued that cardiometabolic screening should be more directed 
at underserved groups. However, we believe that this is not enough to tackle the health gap. A 
coordinated approach combining cardiometabolic screening targeting underserved groups 
with population-based prevention approaches may be most effective in tackling the ever-
growing health gap between groups in a society. Is the time right for such a combined 
approach? 
 
The Government’s focus on own responsibility 
As we described above, the current political environment in the Netherlands has a focus on 
curative (not preventive) healthcare, and relies to a large extent on a person’s own 
responsibility (an ‘active patient’ or ‘active civilian’). Policy documents contain terms such as 
“the patient as partner”, “self-management”, and “autonomous control”. In 2011, a new 
definition of health was developed by Huber et al.: The ability to adapt and self-manage in 
the face of social, physical, and emotional challenges of life (54). This definition fits the 
current opinion that people should and are capable of playing an active role regarding their 
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health. In 2006, the idea of active patients taking their own responsibility received another 
boost by the introduction of the Healthcare Law (‘Zorgverzekeringswet’) and the Healthcare 
Market Law (‘Wet Marktordening Gezondheidszorg’): individuals were all of a sudden 
customers or clients in the competitive healthcare market. The idea was that when people 
chose their insurance company they would consciously look at the quality of the healthcare 
purchased by insurers. However, each year only a limited number of people actually change 
insurance companies and if they do so, financial considerations play the most important role 
(55). Also, even though the government is capable of coercive measures against unhealthy 
behaviour, such as fines and taxes, these measures are not broadly implemented because they 
would go against the right of self-determination. Finally, an unhealthy lifestyle is a substantial 
source of tax revenues for the government, for example, from cigarettes and alcohol. This 
deliberate lack of focus on preventive measures is clearly demonstrated by the healthcare 
expenditures. In 2011, slightly more than 89 billion euros was spent on healthcare, of which 
only a fraction was spent on prevention in healthcare: namely a little over 2,5 billion euros 
(3%) (56). And this number is falling: in 2007 some 13 billion euros was spent on prevention, 
of which 3 billion euros was spend within healthcare (57). And this was even a 2% decline 
since 2003. The majority of the prevention expenditures (10 billion euros) is, thus, spend 
outside healthcare, for example, on air pollution control and promoting road safety. 
Healthcare prevention expenditures (3 billion euros) were largely (83%) spent on illness 
prevention (vaccination, screening, and preventive medication), whereas health promotion 
measures such as lifestyle education received only 17%. 
 
Health literacy as an essential prerequisite for own responsibility  
Unfortunately, not everyone is equally capable of taking their own responsibility for a healthy 
life(style). The World Health Organization considers health literacy to be a fundamental 
predictor of health inequalities (58). Definitions of health literacy vary, from basic reading 
and language skills (literacy) to a more complex conglomeration of literacy levels, 
psychological, and social skills. Almost half of the Dutch individuals finds it (very) difficult 
to play an active role in managing their health and illness, especially those with a lower 
education (59-61). Efforts should be put into increasing health literacy levels of those with 
low health literacy levels to enable them to take responsibility for managing their health and 
disease. At the same time, the government should invest in population-based prevention, as 
this type of prevention reaches a diverse population through a variety of routes that extend 
beyond clinics and traditional health services (62). Additionally, cost-effectiveness of 





population-based prevention is generally higher when the prevalence of a condition is high 
(which is the case for cardiometabolic disease) (62). 
 
Combined screening and population-based prevention in Europe 
A successful example comes from Sweden, where researchers combined population-based 
health and health sector interventions with systematic cardiovascular risk factor screening and 
counselling specifically aiming to evaluate the health gap between social groups (63). The 
researchers created local health promotion collaborations between healthcare providers, 
grocery stores, schools, and municipal authorities. The predicted cardiovascular mortality risk 
was reduced by 36% in the intervention area compared to 1% in a control community. What is 
more, socioeconomically less privileged groups benefited most from the program. 
Also, policy advisors share the opinion of a coordinated prevention approach. In the words of 
Prof. Em. Vanholder, chair of the European Kidney Health Alliance: Increasing screening of 
the at-risk population, promoting healthy diets and lifestyle modifications, working with 
industry to develop healthier food products and easier to understand food labelling, and 
starting early in schools to improve health literacy amongst the European population would 
have significant impacts in terms of public health and lead to a sustainable reduction of the 
prevalence of chronic diseases in Europe (64). 
 
Opportunities for population-based prevention in the Netherlands 
As a reaction to the letter written by the Minister and State Secretary for the Ministry of 
Health, Wellbeing, and Sports regarding their solutions to problems with prevention in the 
current healthcare system, the Director of the Dutch journal ‘De Eerstelijns’ [‘The Primary 
care’] published some additional sustainable solutions to problems with putting prevention 
into practice (65): 
• The government finances population-based prevention from tax revenues and the 
implementation is delegated to the municipalities. This local policy is monitored, 
publicly disclosed, and municipalities are redirected where necessary. Practice- and 
evidence-based e-tools are made freely available by the government through internet 
and applications. 
• Health insurance companies finance individual prevention through a remittance to a 
prevention fund, which generates structural revenues. This fund is available to all 
insured and all citizens of a municipality, and is deployed locally in a non-competitive 
manner by the insurance companies in consultation with the municipalities. 
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• Individuals finance prevention themselves. By tax exemptions desired behaviour is 
encouraged and undesirable behaviour is discouraged. 
These solutions demand major transformations within the current healthcare system, and 
require stamina of the government. However, with the ever-growing gap in (quality-adjusted) 





Underserved groups have a poorer (health-related) life expectancy, an increased risk of 
cardiometabolic disease, and are least likely to attend health checks. This differential uptake 
of health checks leads to suboptimal health gains from cardiometabolic screening and 
contributes to the widening of health inequalities in society. Although the cost-effectiveness 
of the Dutch cardiometabolic health check is still under study, it seems advisable to focus on 
the underserved groups, as they have the most to gain from systematic screening. Our findings 
provide strategies to optimize uptake and may be used to design future studies on this topic. 
To further provide underserved groups the best possible opportunities for a healthy life(style), 
the Government should invest in population-based prevention and move away from the trend 
of taking own responsibility.  
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With a high burden of cardiometabolic disease among native Dutch and non-Western 
immigrants in the Netherlands, their participation in preventive screening is eminent. It is, 
therefore, worrisome that these groups are particularly underrepresented in screening 
initiatives, as this may widen health inequalities in a society. To increase participation of 
these underserved groups in two-stage cardiometabolic screening, insight into the motivations 
and determinants of these groups is essential. The aim of this dissertation was to obtain 
insight into the psychosocial determinants of participation of underserved groups in both 
stages of the Dutch cardiometabolic health check (Prevention consultation, module 





We present a qualitative study on determinants of (hypothetical) participation in the 
cardiometabolic health check in chapter 2. With this study we aimed to investigate which 
determinants played a role among underserved groups to participate in the first stage (the 
HRA) of the health check and which determinants played a role in the second stage (the PC). 
To obtain insight in these determinants of hypothetical participation, we conducted 21 focus 
groups with non-Western immigrants, adult children from one of these descents, native Dutch 
with a lower SES, and healthcare professionals working with these groups. The analyses 
revealed that the determinants of HRA non-completion were mainly cognitive and included 
(flawed) risk perception, health negligence, (health) illiteracy, and language barriers. 
Facilitating HRA completion would be a face-to-face invitation from a reliable source and 
community outreach to raise awareness. Determinants of PC non-attendance were in part 
cognitive but were also of a more affective nature and included risk denial, fear about the 
outcome, its potential consequence (lifestyle changes and medication prescription), and 
disease-related stigma. Overall, the findings of this study indicated that the choice of 
invitation method seems important when designing a two-stage health check, as does training 





healthcare professionals in techniques to effectively handle patients’ (flawed) risk perception 
and attitudinal ambivalence. Furthermore, focus should be on promoting informed choices by 
providing accurate information. 
The findings of the qualitative study, as well as an extensive literature search, resulted in the 
design of a semi-quantitative intervention. With this intervention we aimed to investigate the 
actual response and participation rates and the actual determinants of participation of 
underserved groups in the Dutch cardiometabolic health check. In chapter 3 we describe the 
response and participation rates in both the HRA and the PC. For this, we used a ‘funnelled’ 
invitation design comprising three consecutive increasingly cost-intensive culturally adapted 
steps: (1) a postal invitation for all eligible patients; (2) a telephone approach for postal non-
responders; (3) a face-to-face approach by the GP for final non-responders. We found an 
overall response rate of 70% (n=1152), of whom 62% (n=712) completed the HRA. This was 
primarily accomplished through the postal and telephone invitations, not the face-to-face 
invitation. However, we found that participants from GP practices in the most deprived 
neighbourhoods had the lowest response and HRA participation rates. Of the HRA 
participants, 29% (n=207) received a high-risk score, of whom 59% (n=123) attended the PC. 
PC attendance was lowest among the native Dutch with a low SES. Based on these results, we 
concluded that underserved groups can be reached by a low-cost culturally adapted postal 
invitation and follow-up telephone calls, and that the added value of the more expensive face-
to-face invitation was negligible. The PC participation rates were acceptable. However, to 
further increase reach among underserved groups, efforts should be particularly targeted at GP 
practices in the most deprived areas.  
Chapter 4 and 5 cover the determinants among underserved groups of (actual) participation in 
both the HRA and the PC respectively. In chapter 4 we describe a cross-sectional 
questionnaire study in which we aimed to explore the process of decision-making regarding 
HRA completion among underserved groups. The questionnaire comprised the following 
aspects: a self-formulated first reaction, a structured set of predefined determinants, and the 
most important barrier(s) and facilitator(s) for HRA completion. More than three quarters of 
the questionnaire participants (n=892) also completed the HRA (n=696). Those who did not 
complete the HRA were more often Moroccans and patients from GP practices with a 
predominantly non-Western population. Determinants increasing the likelihood of HRA 
completion were a lower SES score, wanting to know one’s risk, not remembering receiving 
the invitation (thus requiring a phone call), fear of the test result and/or adjusting lifestyle, 
perceived control of staying healthy, wanting to participate, and perceiving no barriers. From 





this study we concluded that our ‘hard-to-reach’ population may not be unwilling to complete 
the HRA. To increase the participation rate, a more comprehensive approach, involving key 
figures within a community informing people about and providing help completing the HRA 
would possibly be more suitable, as we had already seen in the qualitative study. In addition 
to the advice to particularly target GP practices in the most deprived neighbourhoods as 
described in chapter 3, we noted that special attention should be paid to the less acculturated 
immigrants with an external locus of control. 
In chapter 5 we describe a quantitative and qualitative assessment of determinants of PC 
attendance. The aim of this study was to compare PC attenders with non-attenders in their 
determinants of PC participation. For this, we used questionnaire and interview data. We 
found that 71% (n=148) of the participants with a high-risk HRA score attended the PC, and 
that those participants were least often native Dutch with a lower SES. We interviewed 91 
high-risk participants, of whom more than three quarters (n=66) attended the PC. We 
compared PC attenders with non-attenders in their HRA risk parameters and HRA total score, 
but found no significant differences. When asked about their determinants at the time of the 
HRA, later PC attenders significantly more often trusted they would get the guidance they 
would need in case of an increased risk and they more often experienced health complaints. 
When asked about their determinants at the time of the interview following the PC, the PC 
attenders also more often experienced health complaints, more often had others finding it 
important for them to participate, and more often felt obliged to attend the PC. Finally, many 
participants found it unclear whose responsibility it was to make an appointment for the PC. 
We concluded that risk communication should cover risk perceptions regarding (lack of) 
health complaints and it should target the close social environment of the individual. We 
suggested that, if feasible, the responsibility of making an appointment should be shifted 
towards the healthcare provider. It would be interesting to further study the role of personal 
feelings of obligation. 
Lastly, we aimed to get some insight into the yield of the PC among underserved groups, 
which we describe in chapter 6. We performed a cross-sectional GP record study among 
high-risk HRA participants who went to the GP for the PC and investigated what risk factors 
were recorded and what subsequent actions were undertaken. What we found, first of all, that 
recordings were very incomplete. We could calculate the Prevention consultation risk score of 
consultation data for only 3% (n=4) of the participants, which was indeed above the cut-off 
value for all. We could calculate the CVRM score for 44% (n=66) of participants, of whom 
39% (n=26) indeed fell in the ‘yellow’/’red’ box of the risk table. Medication was prescribed 





to one in five (n=29) of the participants. Of those who smoke, 69% (n=44) received a quit-
smoking advice and 36% (n=53) of the participants received other lifestyle advice. In line 
with our other studies, we conclude that it is possible to reach a PC participation rate among 
‘hard-to-reach’ groups comparable to or even higher than among the general population. We 
noted, however, that the GP should not only record patient data covered by the classic 
cardiovascular and diabetes guidelines, but should also record other risk factors associated 
with cardiometabolic disease (such as family history) and the (lifestyle) advices provided. 
Finally, we emphasized the important role of the GP, especially for these groups, which is all 
the more important now the Prevention consultation has been replaced by the Personal Health 





It has been well established that underserved groups have an increased risk of cardiometabolic 
disease and are less likely to attend health checks. This differential uptake of health checks 
leads to suboptimal health gains from cardiometabolic screening and contributes to the 
widening of health inequalities in society. The cost-effectiveness of the Dutch 
cardiometabolic health check is still under study, but with the knowledge we already have it 
seems advisable to focus primarily on the underserved groups, as they have the most to gain 
from systematic screening. The findings described in this thesis provide strategies to optimize 
uptake and may be used to design future studies on this topic. In the general discussion we 
also advocate that the Government should invest in population-based prevention and move 
away from the trend of taking own responsibility as this may provide underserved groups the 
best possible opportunities for a healthy life(style). 



















Autochtonen en niet-Westerse immigranten in Nederland ervaren een hoge ziektelast door 
cardiometabole aandoeningen. Deelname van deze groepen aan preventieve screening is bij 
uitstek van belang. Het is daarom zorgelijk dat met name deze groepen 
ondervertegenwoordigd zijn bij screeningsinitiatieven. Dit kan gezondheidsverschillen in de 
maatschappij vergroten. Om de deelname aan tweetraps cardiometabole screening van deze 
kwetsbare groepen te vergroten is het essentieel om inzicht te verkrijgen in de determinanten 
die daarbij een rol spelen. Het doel van dit proefschrift was inzicht vergaren in de 
psychosociale determinanten van deelname, evenals daadwerkelijke respons en deelname, aan 






We presenteren een kwalitatieve studie naar determinanten van (hypothetische) deelname aan 
het Preventieconsult in hoofdstuk 2. Het doel van deze studie was om te onderzoeken welke 
determinanten een rol speelden bij kwetsbare groepen om deel te nemen aan de eerste stap (de 
HRA) en welke om deel te nemen aan de tweede stap (het PC). Om inzicht te krijgen in deze 
determinanten, hebben we 21 focusgroepen gehouden met niet-Westerse immigranten, 
volwassen kinderen van niet-Westerse komaf, autochtonen met een lage SES en zorgverleners 
die veel met deze groepen werken. Uit de analyses bleek dat de determinanten van HRA niet-
deelname met name van cognitieve aard waren, waaronder (onjuiste) risicopercepties, 
onachtzaamheid met betrekking tot de eigen gezondheid, lage gezondheidsvaardigheden of 
analfabetisme en taalbarrières. Bevorderende factoren voor HRA deelname zouden zijn: een 
face-to-face uitnodiging van een betrouwbare bron en een wijkgerichte aanpak om de 
bewustwording te vergroten. Determinanten van PC niet-deelname waren deels van 
cognitieve aard, maar hadden ook een meer emotioneel karakter, waaronder risico-
ontkenning, angst voor de uitslag, de mogelijke gevolgen (leefstijlaanpassingen en 





medicijngebruik) en ziektegerelateerd stigma. Al met al geven de resultaten van deze studie 
aan dat de keuze voor een uitnodigingsstrategie belangrijk lijkt bij het vormgeven van een 
tweetraps health check, evenals het trainen van zorgverleners in technieken om op een 
effectieve manier om te gaan met (onjuiste) risicopercepties en ambivalenties van patiënten. 
Bovendien zou de focus moeten liggen op het bevorderen van het maken van geïnformeerde 
beslissingen door het aanbieden van accurate informatie. 
De resultaten van de kwalitatieve studie, evenals een omvangrijke literatuurstudie, hebben 
geleid tot de vormgeving van de semi-kwantitatieve interventie. Het doel van deze interventie 
was om te onderzoeken wat de daadwerkelijke respons en deelname was van kwetsbare 
groepen aan het Preventieconsult, evenals de daadwerkelijke determinanten die hierbij een rol 
speelden. In hoofdstuk 3 beschrijven we de respons en deelname aan zowel de HRA als het 
PC. Hiervoor gebruikten we een gesluisde (‘trechter’) uitnodigingsstrategie, bestaande uit drie 
opeenvolgende en in toenemende mate duurdere en intensievere stappen: (1) een schriftelijke 
uitnodiging voor alle patiënten die in aanmerking kwamen; (2) een telefonische benadering 
voor schriftelijke non-responders; (3) een face-to-face benadering door de huisarts voor 
uiteindelijke non-responders. Alle stappen waren cultureel aangepast. We vonden een totale 
respons van 70% (n=1152), van wie 62% (n=712) de HRA invulde. Dit werd met name 
bereikt door de schriftelijke en telefonische uitnodigingen, niet de face-to-face benadering. 
We zagen dat deelnemers van huisartspraktijken in de meest achtergestelde wijken de laagste 
respons en HRA deelname hadden. Van de HRA deelnemers had 29% (n=207) een hoog-
risico score, van wie 59% (n=123) naar het PC ging. PC deelname was het laagst onder 
autochtonen met een lage SES. Naar aanleiding van deze resultaten concludeerden wij dat 
kwetsbare groepen bereikt kunnen worden middels een relatief goedkope, cultureel 
aangepaste, schriftelijke uitnodiging en follow-up telefonische benadering. Daarnaast was de 
toegevoegde waarde van de duurdere face-to-face benadering verwaarloosbaar. PC deelname 
was acceptabel, maar om deze verder te verhogen zouden inspanningen met name gericht 
moeten worden op huisartspraktijken in de meest achtergestelde wijken. 
Hoofdstuk 4 en 5 gaan over de determinanten van kwetsbare groepen met betrekking tot 
(daadwerkelijke) deelname aan respectievelijk de HRA en het PC. In hoofdstuk 4 beschrijven 
we een cross-sectionele vragenlijststudie welke als doel had te exploreren hoe het 
besluitvormingsproces van kwetsbare groepen aangaande HRA deelname in zijn werk ging. 
De vragenlijst bestond uit de volgende onderdelen: een zelf-geformuleerde eerste reactie, een 
gestructureerde set van vooraf gedefinieerde determinanten en de belangrijkste barrière(s) en 
bevorderende factor(en) van HRA deelname. Meer dan driekwart van de deelnemers aan de 





vragenlijst (n=892) vulde ook de HRA in (n=696). De HRA niet-deelnemers waren vaker 
Marokkaans en patiënten van huisartspraktijken met een voornamelijk niet-Westerse 
patiëntpopulatie. Determinanten die de kans vergrootten de HRA in te vullen waren een 
lagere SES score, het willen weten van het risico, het niet herinneren een uitnodiging te 
hebben ontvangen (dus een telefonische benadering nodig hebben), angst voor de uitslag en/of 
het moeten aanpassen van de leefstijl, het ervaren van controle over de eigen gezondheid, de 
wens deel te nemen en geen barrières ervaren. Van deze studie concluderen wij dat onze 
‘moeilijke bereikbare’ groep niet onwelwillend tegenover HRA deelname staat. Om deelname 
te vergroten zou een meeromvattende aanpak wellicht geschikter zijn, zoals we ook al zagen 
in de kwalitatieve studie. Een aanpak die sleutelfiguren in een gemeenschap betrekt zodat zij 
individuen kunnen informeren en hen helpen de HRA in te vullen. In aanvulling op het advies 
uit hoofdstuk 3 om met name aandacht te schenken aan huisartspraktijken in de meest 
achtergestelde wijken, constateerden we dat inspanningen moeten worden gericht op de 
minder ingeburgerde immigranten met een externe locus of control.  
In hoofdstuk 5 gaan we in op een kwantitatieve en kwalitatieve beschrijving van 
determinanten van PC deelname. Het doel van deze studie was om de determinanten van PC 
deelnemers te vergelijken met die van niet-deelnemers. Hiervoor gebruikten we vragenlijst- 
en interviewdata. We zagen dat 71% (n=148) van de deelnemers met een hoog-risico HRA 
score naar het PC ging en dat autochtonen met een lage SES het minst vaak gingen. We 
hebben 91 hoog-risico patiënten geïnterviewd, van wie meer dan driekwart (n=66) naar het 
praktijkconsult was gegaan. We vergeleken de HRA risicoparameters en de HRA totaalscore 
van PC deelnemers met die van niet-deelnemers, maar vonden daarbij geen significante 
verschillen. Als men gevraagd werd naar determinanten die een rol speelden ten tijde van de 
HRA, gaven latere PC deelnemers significant vaker aan dat ze vertrouwen hadden in de 
noodzakelijke begeleiding mochten ze een verhoogd risico hebben. Daarnaast ervaarden zij 
vaker gezondheidsklachten. Als men gevraagd werd naar determinanten ten tijde van het 
interview volgend op hun PC bezoek, gaven de PC deelnemers ook vaker aan 
gezondheidsklachten te ervaren. Daarnaast hadden ze vaker anderen die het belangrijk vonden 
dat ze naar het PC gingen en ervaarden ze vaker een gevoel van verplichting om naar het PC 
te gaan. Ook vonden veel deelnemers het onduidelijk wiens verantwoordelijkheid het was om 
een afspraak te maken voor het PC. Wij concludeerden dat er in de risicocommunicatie moet 
worden ingegaan op risicopercepties aangaande (het gebrek aan) ervaren gezondheidsklachten 
en dat het ook gericht moet zijn op de nabije sociale omgeving van het individu. Daarnaast 
stelden we voor om, indien haalbaar, de verantwoordelijkheid voor het maken van de afspraak 





voor het PC, verschoven dient te worden naar de zorgverlener. Tot slot zou het interessant zijn 
om de rol die gevoelens van verplichting spelen verder te bestuderen in deze context. 
Met onze laatste studie, welke beschreven staat in hoofdstuk 6, hadden wij als doel om 
inzicht te verkrijgen in de opbrengst van het PC bij kwetsbare groepen. We hebben een cross-
sectionele dossierstudie uitgevoerd onder hoog-risico HRA deelnemers die naar het PC zijn 
gegaan. Bij hen hebben we onderzocht welke risicofactoren geregistreerd waren en welke 
vervolgacties ondernomen waren. Allereerst ontdekten we dat de dossiers erg incompleet 
waren. Met de beschikbare consultdata konden we slechts voor 3% (n=4) van de deelnemers 
de Preventieconsult risicoscore berekenen, van wie allen inderdaad een risicoscore boven het 
afkappunt hadden. We konden voor 44% (n=66) van de deelnemers de CVRM score 
berekenen, van wie 39% (n=26) inderdaad in het ‘gele’ of ‘rode’ vakje van de risicotabel viel. 
Eén op de vijf deelnemers (n=29) kreeg medicatie voorgeschreven. Van de rokers kreeg 69% 
(n=44) een stoppen-met-roken advies en 36% (n=53) van de deelnemers kreeg een ander 
leefstijladvies. In lijn met de conclusies die we trokken uit eerdere onderzoeken, 
concludeerden we dat het mogelijk is om bij ‘moeilijk bereikbare groepen’ een PC deelname 
te behalen die vergelijkbaar is, of zelfs hoger is dan, onder de algemene populatie. Daarbij 
merkten we op dat de huisarts niet alleen data zou moeten registreren die staan beschreven in 
de klassieke cardiovasculaire en diabetes richtlijnen, maar ook risicofactoren die geassocieerd 
zijn met cardiometabole aandoeningen (zoals familiaire belasting) en de leefstijladviezen die 
zij geven. Tot slot benadrukten we de belangrijke rol van de huisarts, met name voor deze 
groepen, welke nog belangrijker is geworden nu het Preventieconsult is vervangen door de 





Het is algemeen bekend dat kwetsbare groepen een verhoogd risico hebben op cardiometabole 
aandoeningen en dat zij minder vaak deelnemen aan screeningsinitiatieven. Deze ongelijke 
deelname aan health checks leidt tot suboptimale gezondheidswinst welke bereikt kan worden 
met cardiometabole screening en draagt bij aan de vergroting van gezondheidsverschillen in 
de samenleving. De kosteneffectiviteit van het PreventieConsult wordt momenteel 
onderzocht, maar met de bestaande kennis lijkt het raadzaam om de focus primair op de 
kwetsbare groepen te leggen, aangezien zij het meest te winnen hebben bij systematische 




screening. De resultaten die we in dit proefschrift beschrijven bieden aanknopingspunten om 
deelname te optimaliseren en kunnen gebruikt worden bij het vormgeven van toekomstige 
studies over dit onderwerp. In de algemene discussie pleiten we er ook voor dat de Overheid 
de trend van eigen verantwoordelijkheid nemen deels los zou moeten laten en meer zou 
moeten investeren in preventieve maatregelen op populatieniveau, omdat dit de kwetsbare 
groepen de beste kansen biedt op een gezond leven en een gezonde leefstijl.  
Nederlandse samenvatting
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Mijn promotores Pim Assendelft en Anne Stiggelbout ben ik dankbaar voor de wijze waarop 
zij  mij hebben begeleid, altijd constructief en motiverend. Pim, mijn dank is groot dat je 
vertrek naar het Radboudumc geen invloed had op je betrokkenheid bij mijn promotie. En als 
ik geloofde in reïncarnatie… jij kent het antwoord wel. Anne, ik waardeer het zeer dat je het 
‘gat’ dat Pim achterliet vulde door jouw begeleiding te intensiveren, precies wat ik nodig had 
in de afrondende fase.   
Mijn copromotor Matty Crone wil ik ook bedanken voor haar fijne begeleiding. Matty, jij 
weet hoe je begeleiding af moet stemmen op de persoon. Daarnaast ben je methodologisch zo 
sterk. Mede door jou verliep mijn promotietraject zeer prettig, met als jaarlijks hoogtepunt 
uiteraard de ‘coupe de camembert’.  
Daarnaast ben ik mijn overige projectgroepleden dankbaar voor hun bijdragen aan de 
totstandkoming van dit proefschrift. Barend Middelkoop, Sandra van Dijk en Jamila Ben 
Meftah, tijdens het maandelijkse projectgroepoverleg en op schriftelijke stukken gaven jullie 
altijd waardevol commentaar, ieder vanuit jullie eigen expertise. 
Het uitvoeren van het CHECK’D onderzoek was onmogelijk geweest zonder de hulp van de 
onderzoeksmedewerkers en secretaresses van de afdeling PHEG. Ook was de hulp van mijn 
stagiaires en onderzoeksassistenten, die meestal Arabisch, Berbers en/of Turks spraken, 
onmisbaar. De fijne sfeer van de promovendi onderling; het sparren, het klagen, het delen van 
de successen, droeg ook positief bij aan het verloop van mijn promotietraject.   
Toen ik na het aflopen van mijn LUMC-contract bij de Nierstichting aan de slag ging stelden 
mijn leidinggevenden Katja van Geffen en wijlen Lidy Vlaskamp zich flexibel op bij het 
inlassen van ‘proefschriftdagen’. Veel dank daarvoor. 
Tevens wil ik op deze plek de leden van de promotiecommissie bedanken voor het beoordelen 
van mijn manuscript; Andrea Evers, Hanno Pijl, Maria v.d. Muijsenberg en Dirk Ruwaard. 
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Dankwoord
Naast bovenstaande professionele relaties wil ik graag de mensen bedanken die altijd 
interesse hebben getoond in mijn werk en op deze wijze hebben bijgedragen aan de 
totstandkoming van mijn proefschrift. Al mijn lieve vriendinnetjes uit Venlo en uit Leiden (en 
omstreken): bedankt voor de broodnodige ontspanning buiten het werk. Familie en 
schoonfamilie: bedankt voor jullie niet-aflatende interesse en voor het oppassen op de 
groeiende kinderschare. 
. Femke, Sanne en Nicole, mijn 
oudste vriendinnetjes, mijn paranimf drie-eenheid. Ik voel me gesterkt dat jullie achter me 
zullen staan tijdens de verdediging, zowel fysiek als in gedachten.  
Mijn speciale dank gaat uit naar mijn vriend Joep, mijn prins op paarse schoenen en roze 
pony: zonder jouw onvoorwaardelijke geloof in mij had ik dit proefschrift nooit af kunnen 
ronden. Mijn lieve kindjes Puk, Seph en Wies: jullie zijn de beste reden dat dit proefschrift 
pas na 7 jaar was afgerond.
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